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Summary: 
 
The present study investigates the function of two large presynaptic proteins, Piccolo and 
Bassoon, in regard to synapse formation and regulation. Synapses are sites of 
neurotransmission between neuronal cells. The presynaptic compartment of each synapse is 
filled with 50-nm clear centered synaptic vesicles (SV) that dock and fuse in an activity 
dependent manner with a specialized region of plasma membrane, called the active zone. 
Fusion of SV with the active zone releases the neurotransmitters, which generate a new 
signal at the postsynaptic site by binding to neurotransmitter receptors. Piccolo and Bassoon 
are high molecular-weight components of the cytoskeletal matrix assembled at the active 
zone (CAZ), and are hypothesized to participate in active zone formation and the regulated 
release of neurotransmitter. However, most evidence supporting this hypothesis remains 
circumstantial in part due to the apparent redundancy between these molecules and 
challenges associated with knocking out all of the alternatively splice isoforms of Piccolo and 
Bassoon. In the present study, interference RNAs were developed and used to eliminate the 
expression of Bassoon and/or Piccolo from cultured hippocampal neurons.  
Primary cultures of rat hippocampal neurons elaborate synaptic active networks that are 
invaluable for studying the molecular, cellular, and physiological mechanisms underlying 
neuronal morphogenesis, nascent synapse formation and synaptic function. To further 
facilitate the study of any presynaptic proteins in these cultures, new technologies were 
developed for delivery and expression of recombinant molecules at near endogenous levels. 
This was accomplished in part by developing methodologies to cryopreserve and store stocks 
of glial cells and neurons for months that had been genetically manipulated. In addition, a 
range of plasmid, lentiviral, and adenoviral vectors were created allowing the expression of 
fluoescent protein (XFP-)-tagged synaptic reporter proteins as well as several short-hairpin 
RNAs (shRNAs) eliminating expression of the AZ proteins Piccolo and Bassoon. Together 
these technologies permit the cell autonomous and synapse specific assessment of collections 
of synaptic proteins using high-resolution fluorescent and electron microscopy and allow 
collaborators to more efficiently share reagents. 
Interference RNAs targeting all Piccolo isoforms revealed that while this active zone 
protein is not required for glutamatergic synapse formation, it plays a fundamental role in the 
translocation, docking and fusion of SVs at active zones. Mechanistically, Piccolo was found 
to negatively regulate neurotransmission by modulating the dispersion kinetics of Synapsin1a 
and the recruitment of CamKII by regulating the activity dependent assembly of presynaptic 
F-Actin. These data demonstrate that Piccolo functions primarily within presynaptic boutons 
to coordinate the dynamic assembly of F-Actin during SV cycling. This function is not 
shared by the highly homologous protein Bassoon, indicating that Piccolo has a unique role 
in coupling the mobilization of SVs in the reserve pool to events within the active zone. 
To uncover redundant functions of Piccolo and Bassoon, short-hairpin RNAs were used 
to knockdown the expression of both of these two large AZ proteins (by >95%) form cultured 
hippocampal neurons. Results of these studies show that these proteins are essential for 
maintaining SV pools within presynaptic boutons and synapse integrity. Mechanistically, 
Bassoon and Piccolo were found to maintain SV pool size by negatively regulating the 
activity of the E3 ubiquitin ligase Siah1, and thus the ubiquitination and degradation of SV-
associated proteins. These findings demonstrate a novel role for Bassoon and Piccolo as 
regulators of presynaptic ubiquitination and proteostasis. 
Taken together these studies provide fundamental insights into how presynaptic CAZ 
proteins are central organizers of presynaptic boutons performing functions that not only 
direct the activity dependent fusion of SVs but also more global facets of presynaptic 
function which include the maintenance, efficient delivery, and recycling of SVs at the active 
zone.  
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Zusammenfassung 
 
Im Zentrum der vorliegenden Arbeit stehen die Fragen, ob und inwieweit die beiden 
präsynaptischen Proteine Piccolo und Bassoon an der Entstehung und Regulation neuronaler 
Synapsen beteiligt sind. Synapsen sind Orte der Reizübertragung zwischen Neuronen. 
Hierfür befinden sich auf der präsynaptischen Seite einer Synapse 50 nm große synaptische 
Vesikel (SV), die in Reaktion auf einen elektrischen Reiz mit der Aktiven Zone (AZ), einer 
spezialisierten Region der präsynaptischen Plasmamembran, fusionieren können. Durch die 
Fusion der SV mit der AZ wird Neurotransmitter in den synaptischen Spalt freigesetzt, um 
auf der postsynaptischen Seite durch Aktivierung von Neurotransmitterrezeptoren einen 
neuen elektrischen Reiz zu generieren. Piccolo und Bassoon sind Bestandteile der Cytomatrix 
an der Aktiven Zone (CAZ), und es wird vermutet, dass sie eine Rolle bei der Entstehung von 
Aktiven Zonen und der Regulation der Neurotransmitterausschüttung spielen. Allerdings 
beruht diese Hypothese vorwiegend auf indirekten Hinweisen, da Piccolo und Bassoon 
offensichtlich eine große Redundanz in ihren Funktionen besitzen und sich Knockout-
Experimente, bei denen alle alternativen Spleißvarianten von Piccolo und Bassoon eliminiert 
werden, bisher als schwierig erwiesen. Für diese Arbeit wurden daher neue RNA-
Interferenzvektoren und lentivirale Expressionsvektoren zur Eliminierung der Expression von 
Piccolo und/oder Bassoon in kultivierten hippokampalen Neuronen entwickelt. Diese 
Vektoren erlaubten nicht nur die Identifizierung und Charakterisierung von Funktionen, die 
spezifisch für Piccolo sind, sondern auch von solchen, die sowohl von Piccolo als auch von 
Bassoon erfüllt werden. 
 
Für die Experimente, die in dieser Arbeit beschrieben werden, wurden primäre Kulturen 
hippokampaler Neuronen von Ratten genutzt. Die Neuronen in diesen Kulturen bilden aktive 
Netzwerke, anhand derer die molekularen, zellulären und physiologischen Mechanismen 
neuronaler Morphogenese, Synaptogenes und synaptischer Aktivität untersucht werden 
können. Um die Verwendbarkeit neuronaler Zellkulturen zur Untersuchung präsynaptischer 
Proteine wie Piccolo und Bassoon weiter zu verbessern, wurden im Rahmen dieser Arbeit 
neue Techniken entwickelt, die eine Expression rekombinanter Proteine auf endogenem 
Niveau gewährleisten. Außerdem sollte die Eignung dieser Art von Zellkulturen für 
Kooperationen zwischen verschiedenen Arbeitsgruppen erhöht werden. Letzteres wurde zum 
Teil durch die Entwicklung neuer Methoden zur Kryopräservierung und Langzeitlagerung 
von genetisch manipulierten Neuronen und Gliazellen erreicht. Darüber hinaus wurden 
verschiedene Plasmide sowie lenti- und adenovirale Vektoren konstruiert. Mit ihrer Hilfe 
wurden präsynaptische Reporterproteine mit Molekulargewichten von 15kD (VAMP2) bis zu 
420kD (Bassoon) in Neuronen exprimiert und mit fluoreszierenden Proteinen fusioniert. 
Außerdem konnten sie genutzt werden, um mittels shRNA (short-hairpin RNA) die 
Expression von endogenem Piccolo und Bassoon zu eliminieren. Diese neuen Techniken 
erlauben zellautonome und Synapsen-spezifische Untersuchungen mit hochauflösender 
Fluoreszenz- und Elektronenmikroskopie.  
 
Untersuchungen mit shRNAs gegen alle Isoformen von Piccolo ergaben, dass Piccolo auf 
der einen Seite nicht essentiell für die Synaptogenese ist, auf der anderen Seite jedoch eine 
fundamentale Rolle bei Translokation, Anlagerung und Fusion von synaptischen Vesikeln an 
der Aktiven Zone spielt. Dabei konnte gezeigt werden, dass der dieser Funktion von Piccolo 
zugrundeliegende Mechanismus auf einer Regulation des aktivitätsabhängigen Aufbaus 
präsynaptischen F-Aktins beruht. Hierdurch wird sowohl die Dispersionskinetik von 
Synapsin1a als auch die Rekrutierung von CaMKII an die Präsynapse reguliert. Diese 
Ergebnisse zeigen, dass die primäre Funktion von Piccolo in Präsynapsen in der 
Koordination des Aktinzytoskeletts während des Kreislaufes synaptischer Vesikel besteht. 
Diese Funktion wird nicht vom homologen Protein Bassoon geteilt und Piccolo spielt daher 
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eine besondere Rolle bei Kopplung synaptischer Vesikel des Reservepools mit Ereignissen 
an der Aktiven Zone. 
 
Um mögliche gemeinsame Funktionen von Bassoon und Piccolo zu ermitteln, wurden 
shRNAs eingesetzt, die die Expression beider Proteine in hippokampalen Neuronen um mehr 
als 95% verringern. Ergebnisse dieser Experimente belegen, dass beide Proteine nötig sind 
für die Erhaltung verschiedener Untergruppen von synaptischen Vesikeln und für die 
synaptische Integrität. Dabei konnte gezeigt werden, dass der Mechanismus für die Erhaltung 
verschiedener synaptischer Vesikelpools auf einer negativen Regulierung der E3 Ligase 
Siah1 und damit der Ubiquitinierung und Degradation von SV-assoziierten Proteinen beruht. 
Diese Daten zeigen eine neue Funktion von Bassoon und Piccolo als Regulatoren 
präsynaptischer Ubiqutinierung und Proteostasis. 
 
Die vorliegende Arbeit konnte damit neue fundamentale Erkenntnisse zur Rolle von CAZ 
Proteinen als zentrale Organisatoren von Präsynapsen liefern. Dabei umfassen ihre 
Funktionen nicht nur die Regulation der aktivitätsabhängigen Fusion synaptischer Vesikel 
mit der Plasmamembran sondern auch der Erhaltung, Translokation und Recycling von 
synaptischen Vesikeln an der Aktiven Zone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   7 
	  
	   	   Contents	  	  
	   8 
Contents 
 
Contents                8 
Figures and tables             11 
1. Introduction              12 
 1.1 Neuronal structure            13 
 1.2 Synapse structure            15 
 1.3 The post-synaptic specialization          15 
 1.4 Presynaptic Structure and Function          17 
 1.5 Active Zones             18 
 1.6 RIMs             19 
 1.7 Munc13             20 
 1.8 CAST/ELKS             21 
 1.9 Liprin-α             22 
 1.10 Bassoon and Piccolo            23 
 1.11 Aims             26 
2. Materials and methods            27 
 2.1 Materials             27 
  2.1.1 Chemicals            27 
  2.1.2 Bacterial cells           27 
  2.1.3 Bacterial culture media and antibiotics         27 
  2.1.4. Molecular biology reagents, buffers and kits        27 
  2.1.5 Cells lines and media          28 
  2.1.6 Primary antibodies           28 
  2.1.7 Secondary antibodies          29 
  2.1.8 Immunocytochemistry          29 
  2.1.9 Biochemistry           30 
  2.1.10 Animals            30 
  2.1.11 Plasmid transfections          30 
  2.1.12 Live cell imaging reagents and solutions        30 
 2.2 Methods             30 
  2.2.1 Molecular biological methods          30 
   2.2.1.1Genotyping of Pclo mutant mice        31 
    2.2.1.1a DNA extraction for genotyping Pclo mutant mice     31 
    2.2.1.1b Polymerase chain reaction (PCR) for genotyping     31 
   2.2.1.2 Bacterial transformations         31 
   2.2.1.3 Growing bacterial colonies for plasmid minipreps      32 
   2.2.1.4 Plasmid DNA minipreps         32 
   2.2.1.5 Preparing endotoxin-free maxiprep plasmid DNA      32 
   2.2.1.6 Separating DNA fragments using agarose gel electrophoresis     33 
   2.2.1.7 DNA purification from gel slices        33 
   2.2.1.8 DNA restriction enzyme digestion        33 
   2.2.1.9 Removal of phosphate from DNA using calf intestine alkaline 
phosphatase CIP          33 
   2.2.1.10 Ligation of DNA fragments        34 
   2.2.1.11 Annealing oligonucleotides        34 
   2.2.1.12 Phosphorylation of oligonucleotides       34 
   2.2.1.13 PCR amplification         34 
  2.2.2 Design and generation of vectors         35 
   2.2.2.1 Generation of the pZOff vector        35 
   2.2.2.2 Design and cloning of shRNAs        35 
   2.2.2.3 Generation of FUGW H1 vector        35 
   2.2.2.4 Generation of EGFP::SynIa, SV2::EGFP and Vamp::HRP  
constructs as well as the Pclo28 and Bsn16 shRNAs      36 
   2.2.2.5 Creation of tricistronic lentiviral vectors       36 
   2.2.2.6 Creating an shRNA-resistant (Bsn16) full-length Bassoon     37 
   2.2.2.7 Construction of an adenoviral vector expressing mRFP-BsnSM16    37 
   2.2.2.8 Creating mCherry-tagged Piccolo and Bassoon zinc finger domains    38 
  2.2.3 Biochemical methods          38 
   2.2.3.1 Preparation of cellular lysates        38 
   2.2.3.2 Separating proteins via SDS-polyacrylamide electrophoresis     38 
 
	   	   Contents	  	  
	   9 
   2.2.3.3 Western blotting          39 
   2.2.3.4 Immunoblot detection of protein bands       39 
  2.2.4 Heterologous cell culture techniques         39 
   2.2.4.1 Growth and passage of mammalian cell lines       39 
  2.2.5 Hippocampal and glial primary cultures        40 
   2.2.5.1 Coverslip preparation         40 
   2.2.5.2 Glial culture preparation         40 
   2.2.5.3 Sub-culturing rat glial cells         40 
   2.2.5.4 Hippocampal neuronal culture preparation       41 
  2.2.6 Gene transfer into cells          41 
   2.2.6.1 Cell transfections with Lipofectamine 2000       41 
   2.2.6.2 Cell transfections by electroporation        42 
   2.2.6.3 Lentivirus production         42 
   2.2.6.4 Lentivirus infection of neurons        42 
  2.2.7 Immunocytochemistry and electron microscopy        43 
   2.2.7.1 Lorene’s fixative solution         43 
   2.2.7.2 Immunohistochemistry         43 
   2.2.7.3 Image acquisition for immunocytochemistry       43 
   2.2.7.4 Electron microscopy of VAMP2-HRP expressing neurons     43 
  2.2.8 Live cell microscopy and analysis         44 
   2.2.8.1 Live imaging of XFP-tagged synaptic proteins      44 
   2.2.8.2 FM loading/destaining of neuronal synapses       44 
   2.2.8.3 Calculating the size of the readily releasable pool (RRP) of SVs 
as well as neurotransmitter release probability (Pr)       45 
   2.2.8.4 Fluorescent recovery after photobleaching (FRAP), acquisition and  
analysis           45 
   2.2.8.5 Defining EGFP::SynIa dispersion kinetics       46 
   2.2.8.6 Quantification of EGFP::SynIa dispersion and FM destaining  
kinetics           47 
   2.2.8.7 Image analysis of live cell experiments       47 
3. Results              48 
 3.1 Optimization and characterization of cryopreserved astrocyte cultures and hippocampal 
neuronal cultures            48 
  3.1.1 Cryopreservation of glial cells         48 
  3.1.2 Viability of cryopreserved dissociated hippocampal neurons      50 
  3.1.3 Morphological characterization of cryopreserved neurons      50 
  3.1.4 Characterization of lentiviral use in cryopreserved neurons      52 
  3.1.5 Electrophysiological characterization of cryopreserved neurons      55 
 3.2 Development of vectors for the effective expression of recombinant protein and shRNA in 
cultured hippocampal neurons          57 
  3.2.1 Custom design of a short hairpin RNA expression vector for the efficient  
knockdown of multiple synaptic proteins        57 
  3.2.2 Design of shRNAs for selective and efficient knockdown  
of Piccolo and Bassoon          58 
  3.2.3 Assessment of shRNAs for selective and efficient knockdown of Piccolo and  
Bassoon            59 
  3.2.4 Harnessing viruses for the efficient expression of shRNAs and recombinant  
proteins in cultured neuronal cells         62 
  3.2.5 Expressing recombinant proteins at endogenous levels with lentivirus     62 
  3.2.6 Development of a bicistronic lentiviral vector for the down-regulation of  
presynaptic proteins           64 
  3.2.7 Design of a tricistronic lentiviral vector for the down-regulation of multiple  
synaptic proteins           66 
  3.2.8 Expressing full-length Bassoon for rescue experiments using a  
helper-dependent adenoviral vector (HDAd)         69 
 3.3 Assessing the role of Piccolo in presynaptic assembly and function      71 
  3.3.1 Loss of Piccolo does not affect synapse formation or morphology      71 
  3.3.2 Synapses lacking Piccolo exhibit faster rates of SV exocytosis      75 
  3.3.3 Piccolo modulates the dispersion kinetics of Synapsin1a       77 
  3.3.4 Changes in SV exocytosis and Synapsin dynamics are not observed at  
synapses lacking Bassoon          80 
  3.3.5 Loss of Piccolo enhances the CaMKII sensitivity of Synapsin 1a      82	  
  3.3.6 Synapsin1a is hypophosphorylated in the absence of Piccolo      84 
	   	   Contents	  	  
	   10 
  3.3.7 Altered Synapsin phosphorylation does not mediate the Piccolo LOF  
phenotypes            84 
  3.3.8 Activity-dependent F-actin assembly is disrupted in the absence of Piccolo     85 
  3.3.9 CaMKII dynamics are altered in axons lacking Piccolo       89 
  3.3.10 PcloΔEx14 -/- mice exhibit normal F-actin assembly       89 
	   3.4 Assessing the role of Bassoon and Piccolo on the maintenance of Synaptic Vesicle Pools    93 
	   	   3.4.1 Characterization of synapses lacking Bassoon and Piccolo      93 
	   	   3.4.2 Decreased SV pool size in the absence of Bassoon and Piccolo      95 
	   	   3.4.3 SV pool size is rescued by the expression of full-length,  
shRNA-resistant, Bassoon          97 
	   	   3.4.4 Ultrastructure of boutons lacking Bassoon and Piccolo       99 
	   	   3.4.5 SV degradation is enhanced in the absence of Bassoon and Piccolo   101 
  3.4.6 Bassoon and Piccolo zinc finger domains mediate synaptic vesicle  
elimination in DKD neurons        103 
4. Discussion            107 
 4.1 Cyropreserving hippocampal neurons        107 
 4.2 Assessing the role of Piccolo and Bassoon in the assembly, function and integrity  
of excitatory hippocampal synapses        109 
 4.3 Roles of CAZ proteins at presynaptic boutons       110 
 4.4 Changes in the rates of SV exocytosis in neurons lacking Piccolo can be linked to 
altered Synapsin dynamics         111 
 4.5 Altered phosphorylation of Synapsin in boutons lacking Piccolo cannot account  
for Piccolo dependent changes in SV exocytosis and Synapsin dispersion.    112 
 4.6 Piccolo is an essential regulator of activity dependent presynaptic F-actin assembly  113 
 4.7 Piccolo dependent presynaptic phenotypes are not exhibited by neurons cultured  
from PcloΔEx14 mice          114 
 4.8 Bassoon and Piccolo regulate of SV proteostasis      115 
 4.9 ZnF domains in Bassoon and Piccolo modulate SV pool size     117 
 4.10 Ubitination in presynaptic structure and function      118 
 4.11 Ubiquitination and neurodegeneration       119 
5. General conclusions           119 
6. Bibliography            121 
7. Abbreviations            132 
8. Curriculum Vitae           135 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figures and Tables 
	   11 
Figures and Tables 
 
Table 2.1. Bacterial cells             27 
Table 2.2. Bacterial culture media and antibiotics          27 
Table 2.3. Molecular biology reagents, buffers and kits         28 
Table 2.4. Cells line and medias            28 
Table 2.5. Primary antibodies            29 
Table 2.6. Secondary antibodies            29 
Table 2.7. Immunocytochemistry reagent           30 
Table 2.8. Biochemistry reagent            30 
Table 2.9. Animals             30 
Table 2.10. Transfection reagents            30 
Table 2.11. Live cell imaging reagents           30 
Table 2.12. Primer Sequence for PCR for genotyping wildtype and Pclo KO       31 
Table 2.13: Thermocycling set up program for genotyping         31 
Table 2.14: PCR amplification process time and temperature cycles        34 
Fig. 3.1 Cryopreserved glia support the growth and differentiation of rat hippocampal neurons     49 
Fig. 3.2 Viability of cryopreserved neurons and normal differentiation        51 
Fig. 3.3 Synaptic contacts and lentiviral infections of cryopreserved hippocampal neurons     53 
Fig. 3.4 Infected cryopreserved neurons form normal numbers and functional synapses      54 
Fig. 3.5 Cryopreserved hippocampal neurons exhibit normal electrophysiological properties     56 
Fig. 3.6 Schematic flow diagram used to create the pZoff shRNA expression vector      58 
Fig. 3.7 shRNA mediated knock down of EGFP-Piccolo         59 
Fig. 3.8 shRNA mediated knockdown of Piccolo and Bassoon with the pZoff vector in  
cultured hippocampal neurons           61 
Fig. 3.9 Lentiviral expression of EGFP::Synapsin1a at endogenous levels and schematic diagram  
 of the lentiviral vector (FUGW) used to express XFP-tagged proteins and shRNA     63 
Fig. 3.10 Lentivirus mediated knockdown of Piccolo with interference RNAs       64 
Fig. 3.11 Lentivirus mediated knockdown of Piccolo and Bassoon        65 
Fig. 3.12 Schematic diagrams of double knock down vectors         67 
Fig. 3.13 Western analysis of Piccolo and Bassoon doubleknockdown (DKD       68 
Fig. 3.14 Expressing full-length mRFP tagged Bassoon via Adenovirus        70 
Fig. 3.15 Piccolo is not essential for the clustering of key pre and postsynaptic proteins      72 
Fig. 3.16 Ultrastructural characterization of excitatory synapses with Horseradish  
peroxidase (HRP) tagged VAMP2           73 
Fig. 3.17 Ultrastructural characterization of excitatory synapses lacking Piccolo       74 
Table 3.1 Quantitative ultrastructural analysis of synapses with or without Pclo28      75 
Fig. 3.18 Synapses lacking Piccolo have functional boutons         76 
Fig. 3.19 Loss of Piccolo enhances the rate and does not affect the size of the readily  
 releasable pool of synaptic vesicles          77 
Fig. 3.20 Loss of Piccolo increases the solubility and exchange kinetics of synapsin1a  
 within presynaptic boutons           79 
Fig. 3.21 Loss of Piccolo increases Synapsin1a dispersion and FM5-95 destaining kinetics     81 
Fig. 3.22 Loss of Piccolo but not Bassoon from presynaptic boutons alters the dispersion  
kinetics of Synapsin1a and the destaining kinetics of FM5-95        82 
Fig. 3.23 CaMKII inhibition rescues Pclo28 phenotypes and synapsin1a is  
hypo-phosphorylated in the absence of Piccolo         83 
Fig. 3.24 Aberrant Synapsin1a phosphorylation does not cause the Pclo28 phenotypes      86 
Fig. 3.25 Inhibiting F-actin assembly with Jasplakinolide rescues the Pclo28 phenotypes      87 
Fig. 3.26 Presynaptic localization of EGFP::Actin markers         88 
Fig. 3.27 CaMKIIα recruitment to presynaptic boutons is impaired in Piccolo knockdown neurons     90 
Fig. 3.28 Piccolo isoform expression in PcloΔEx14 mice and rat hippocampal neurons  
expressing Pclo28 shRNA           91 
Fig. 3.29 PcloΔEx14 mice exhibit normal presynaptic F-Actin assembly       92 
Fig. 3.30 Double knockdown of Bassoon and Piccolo reduces the expression of synaptic vesicle proteins  
 but not hippocampal neuronal differentiation, made smaller synapses but does not affect  
 synapse density             94 
Fig. 3.31 Loss of Piccolo and Bassoon reduces SV pool size in presynaptic boutons      96 
Fig. 3.32 Expression of mRFP::Bsn-SM16 rescues SV pool size at DKD boutons      98 
Fig. 3.33 Quantification of synaptic ultrastructure in boutons lacking Bassoon and Piccolo                100 
Fig. 3.34 Protein degradation drives SV loss in the DKD background      102 
Fig. 3.35 Bassoon and Piccolo interact with Siah1 and modulate its activity     104 
Fig. 3.36 Zinc finger domains in Piccolo and Bassoon regulate SV loss in DKD neurons    106 
                                                                                                                                  Introduction 
	   12 
1. Introduction. 
Interest in how our brains work began long ago, in fact the ancient Egyptians are 
responsible for the oldest written record using the word "brain" and have provided the first 
written accounts of the anatomy of the brain, the meninges and cerebrospinal fluid. The word 
"brain" appears on a papyrus written around the year 1700 BC, but is based on text that go 
back to about 3000 BC. This document is considered to be the first medical document in the 
history of mankind. Teaching in Athens ~387 BC, Plato states that he “believes the brain is 
the seat of mental process”. Galen, 130-200 AD, puts forth the idea that the brain receives 
sensory information and is responsible for motor control, using the mechanism of fluid 
energies. René Descartes, 1596-1650, states that nerves contain fluids, or "animal spirits", 
which are responsible for the flow of sensory and motor information in the body. Johannes 
Purkinje, 1787-1869, was the first to describe a nerve cell, contributing extensively to the 
field of experimental psychology through his work on sensory and visual experience after 
stimulation, e.g. by applying pressure and electrical current to the eyeball. He also discovered 
the large nerve cells in the cerebellum, "Purkinje Cells” which have the most beautiful 
dendrites’ arbors in the brain. Korbinian Brodmann, 1868-1918, was the first to categorize 
the brain into 52 distinct regions based on the cellular organization of neuronal networks in 
the cortex, thus providing support to the “Localist” view, which was already very strong. 
This was accomplished through histological tissue stains to visualize the different cell types. 
This also led to the concept that neurons have sub-regions, called “cytoarchitectonics”, that 
define their cellular architecture. Camillo Golgi, 1843-1956, was the first to develop a silver 
stain that permitted the full visualization of single neurons, revolutionizing our understanding 
of the cellular organization of the brain.  However, he interpreted his images to conclude that 
the brain was a continuous mass of tissue that shares a single cytoplasm. This concept was 
challenged by Santiago Ramón Y Cajal, 1852-1934, who used Golgi’s silver stain technique 
to show that neurons were discrete unitary entities, and that they might conducted electrical 
signals in only one direction. Importantly, Cajal established the “Neuron Doctrine” of the 
brain, which is the fundamental organizational and functional principle of the nervous system, 
stating that the neuron is the anatomical, physiological, genetic and metabolic unit of the 
nervous system. In 1897, Sir Charles Scott Sherrington introduces the term Synapse (from 
the Greek “Clasp”) to define the cellular junction formed between nerve cells. In 1938, the 
concept defined by the Neuron Doctrine was further refined by Fulton stating that the neuron 
is the anatomical, physiological, genetic and metabolic unit of the nervous system. There are 
three main parts of this doctrine namely, a) neurons are discrete and autonomous cells that 
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can interact, b) synapses are gaps that separate neurons, c) information is transmitted in one 
direction from dendrites (input) to the axon (output). 
Studies over the last half-century have sought to refine our understanding of how neurons 
function within neuronal networks to define cognitive function and behavior. Important open 
questions remain such as where are neurons born, how do they reach their final position in 
the brain and what governs their differentiation. Other include, how do neurons form 
functional synaptic connections and how does this affect neuronal network function. All of 
these issues are influenced by genetics, the dynamic properties and life times of individual 
molecules, and cellular programs that regulate the removal of mis-folded or functionally 
inactive proteins, RNAs etc. Emerging data indicate that dysfunctions at all of these levels 
contribute to neuropsychiatric disease, developmental disorders, cognitive function and 
neuro-degeneration. In my thesis work, I have tried to contribute core information on how 
synapses in the developing nervous system form and function. Much of my work has focused 
on two molecules, Piccolo and Bassoon, of the presynaptic active zone (AZ), and their role in 
regulating the docking and fusion of synaptic vesicles (SVs) at the AZ and the release of 
neurotransmitter substances in an activity dependent manner. My data show that Piccolo and 
Bassoon are large multidomain proteins that regulate the functional assembly of the 
presynaptic AZ and modulate the activity dependent assembly and dynamics of Filamentous 
Actin (F-actin) as well as the machinery involved in the docking, fusion and recycling of SVs 
and their proteins. Particularly exciting, I have discovered that Piccolo and Bassoon also 
regulate the local ubiquitination of presynaptic molecules by regulating the activity of an E3 
ubiquitin ligase, Siah. Importantly, loss of function of Piccolo and Bassoon, leads to local 
imbalances of poly-ubiquitination resulting in the degradation of SV proteins and synaptic 
degeneration. Below I provide an overview of neuronal differentiation and the molecular 
mechanisms thought to underlie synaptogenesis and synaptic degeneration. 
 
1.1 Neuronal structure. 
The nervous system is comprised of many different kinds of cells. The two principle 
classes of cells include nerve cells (neurons), and glial cells (glia). Neurons are the minimal 
cellular unit for information acquisition and processing in the nervous system, while glial 
cells are thought to primarily serve a supporting role including: physical protection, guidance 
for cell/neuron migration, separating and insulating axons, buffering extracellular ions, 
clearance of neurotransmitters and providing synaptotrophic factors that facilitate neuronal 
differentiation and synaptogenesis.  
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Although glia are interesting in their own right, it is the formation of neuronal networks 
that are crucial for sensory perception, information acquisition and processing, motor control, 
cognition and behavior. Thus understanding how neurons establish, maintain, modulate and 
eliminate selective connections is essential for elucidating how neuronal networks carry out 
their diverse functions. Critical to addressing this fundamental question is a clear 
understanding of the cellular mechanisms that guide neuronal differentiation and function. 
Neurons are polarized and highly specialized cells designed to rapidly and reliably 
transmit signals to other neurons, muscles and glands. Neuron contain three morphologically 
distinct regions: the cell body (or soma) where a majority of cellular metabolism occurs, 
dendrites a highly differentiated set of processes designed for receiving and processing 
neurotransmitter signals and axons highly differentiated processes involved in conducting 
electrical signals known as action potentials as well as the regulated release of 
neurotranssmiters from presynaptic boutons beaded along their length (Kandel, Klein et al. 
1986; Siegelbaum and Kandel 1991). Generally, neurons extend several dendrites and one 
axon from the cell body. Dendrites are relatively large in diameter, taper over their length and 
usually have extensive branches. The main function of dendrites is to receive and process 
inputs from other neurons. In contrast, axons are generally thin caliber processes that can also 
be highly branched yet capable of being very long, e.g. 1m in length (Banker and Goslin 
1988; Banker and Goslin 1998). The main function of an axon is to initiate and propagate 
action potential from the cell soma/axon-hillock to distal sites of cell-cell contact call 
synapses. Synapses can either be electrical, passing current directly through gap junctions 
between nerve cells or chemical. Chemical synapses are much more common in vertebrates 
converting electrical signals to chemical signals through the regulated release and reception 
of small molecules or peptide referred to as neurotransmitters. Generally neurons produce 
and release only one neurotransmitter e.g. glutamate, acetylcholine, dopamine, serotonin, 
nor-epinephrine, glycine or gamma-amino-butyric acid (GABA), and/or neuropetides. 
Synaptic connections between neurons or other excitable cells (e.g. a muscle cell) or 
glands are highly specific both with respect to the cells they form contacts as well as in the 
transmitter released (Hill-Eubanks, Werner et al. 2011). Synapses are highly evolved neural 
processors that ensure rapid and efficient communication between neurons. They are the 
building blocks of learning and memory, cognition, behavior and consciousness (Cline 1998). 
This accurate and regulated neural transmission requires a complex and highly ordered 
structural organization. A typical chemical synapse is composed of a presynaptic bouton, 
where neurotransmitters and neuropeptides are stored in discrete membrane packets called 
SVs and released via SV fusion with the plasma membrane. Presynaptic bouton are situated 
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juxtaposed to postsynaptic cells, which receives signals in the form of neurotransmitters 
released from the pre-synaptic terminal (Jessell and Kandel 1993). Between these pre- and 
post-synaptic compartments lies the synaptic cleft, a narrow space 20-50nm consisting of 
cell-adhesion and extracellular matrix molecules. 
 
1.2 Synapse structure. 
It was not until the advent of high-resolution electron microscopy (EM) that the synapses 
could be classified on the basis of their morphological characteristics. For example, Gray, in 
1959, was the first to describe the two main types of synapses. Type I, or asymmetric 
synapses, are typically found along dendritic arbors and are characterized by a pronounced 
electron-dense thickening of postsynaptic membrane, referred to as the postsynaptic density 
(PSD). The PSD is situated juxtaposed to the presynaptic bouton. Type II or symmetric 
synapses were observed along the soma or dendrites of neurons. These had roughly equal 
amount of electron-dense material associated with the pre and postsynaptic plasma 
membranes. Generally, excitatory synapses are asymmetric, with a pronounce PSD, while 
inhibitory synapses are associated with symmetric type II synapses (Garner and Kindler 
1996). 
The presynaptic boutons of type I and type II synapses exhibit similar structural features. 
These include a large pool of SVs, filled with neurotransmitter, clustered at a specialized 
region of the pre-synaptic plasma membrane, juxtaposed to the PSD, referred to as the Active 
Zone (AZ).  SVs dock, fuse and release their cargo into the synaptic cleft at the AZ. The 
speed and efficiency of synaptic transmission requires precise formation of these specialized 
compartments. Several subtypes of SVs are found within presynaptic boutons: one is 
approximately 30-50 nm in diameter and appears to have clear centers. These are filled with 
fast-acting neurotransmitters like amines and amino acids. The second is larger in diameter 
(from 80 to 200 nm) has an electron dense core and contains slower-acting neuropeptides 
(Burns and Augustine 1995). 
 
1.3 The post-synaptic specialization. 
The postsynaptic plasma membrane is specialized for the reception and processing of 
information transmitted by neurotransmitters released from presynaptic boutons. At 
excitatory synapses, the PSD was originally defined ultrastructurally by its electron-dense 
thickening associated with the cytoplasmic side of the postsynaptic plasma membrane (Gray 
1959; Gray 1959; Kim and Ko 2006). This is a region with a high concentration of 
neurotransmitter receptors, ion channels, scaffolding proteins as well as regulatory proteins, 
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kinases, phosphatases etc (Boeckers 2006; Gundelfinger, Boeckers et al. 2006). 
Biochemically the PSD is rather insoluble in nonionic detergents, allowing it to be isolated 
and characterized (Montgomery, Zamorano et al. 2004; Baron, Boeckers et al. 2006). To date 
over 500 distinct proteins have been identified, including receptors, scaffolding proteins, 
cytoskeletal elements, kinases and adhesion molecules among other, (Langnaese, 
Seidenbecher et al. 1996; Ziff 1997; Beresewicz 2007). (Maas, Torres et al. in press). 
At excitatory synapses, glutamate receptors are key signaling components of the PSD, 
comprised of both metabotropic and ionotropic receptors. Metabotropic receptors appear to 
be localized peri-synaptically around the PSD (Lujan, Roberts et al. 1997; Nusser, Lujan et al. 
1998; Awatramani and Slaughter 2001). In contrast, ionotropic receptors, like N-methyl-D-
aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) 
receptors are localize and concentrate at PSDs. These receptors can be inserted, tethered and 
removed independently from each other allowing for example immature synapses to contain 
primarily NMDA receptors (e.g. silent synapses) that acquire AMPA receptors only upon 
activation (Nusser, Lujan et al. 1998; Malenka and Nicoll 1999; Takumi, Ramirez-Leon et al. 
1999; Malinow and Malenka 2002; Petralia, Sans et al. 2005; Citri and Malenka 2008) The 
subsynaptic and functional segregation of metabotropic and ionotropic glutamate receptors 
suggest the existence of specific intracellular scaffolding proteins important for forward 
trafficking and immobilization of neurotransmitter receptors within synaptic subdomains 
(Montgomery, Zamorano et al. 2004; Jeyifous, Waites et al. 2009; Waites, Specht et al. 2009). 
Of the many PSD proteins thus far identified, those with multidomain structures have 
emerged as key regulators in the assembly of the PSD and in defining receptor specific 
signaling complexes (Montgomery, Zamorano et al. 2004; Okabe 2007; Sheng and 
Hoogenraad 2007). Of theses, members of the MAGUK family of membrane associated 
guanylate kinases (MAGUK) have been shown to play pivotal roles in the assembly of the 
PSD and the clustering and targeting of glutamate receptors to their synaptic sites (Xu 2011). 
These proteins are characterized by the presence of one or more PDZ domains, an SH3 
domain, and a guanylate kinase-like (GK) domain, all of which are actively involved in 
protein-protein interactions (Cho, Hunt et al. 1992; Kistner, Wenzel et al. 1993; Kornau, 
Schenker et al. 1995; Muller, Kistner et al. 1995; Kim, Cho et al. 1996; Muller, Kistner et al. 
1996; Montgomery, Zamorano et al. 2004). 
These prototypically multidomain proteins do more than just cluster and localize 
receptors to the PSD. For example, they also scaffold specific signaling and regulatory 
protein complexes in the vicinity of NMDA receptors and AMPA receptors, which allow the 
regional and rapid modulation of synaptic function and plasticity (Montgomery, Zamorano et 
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al. 2004; Okabe 2007; Sheng and Hoogenraad 2007; Jeyifous, Waites et al. 2009; Waites, 
Specht et al. 2009; Xu 2011). Although further studies are needed, it is clear that the 
MAGUKs proteins are important for the assembly of the PSD (Montgomery, Zamorano et al. 
2004). 
 
1.4 Presynaptic Structure and Function. 
Although pre-synaptic boutons emerge from the end of axons as at the neuromuscular 
junction (NMJ), most are exist as varicosities/boutons along the length of axons forming 
synapses en passant with thousands of postsynaptic targets. Intriguingly, presynaptic 
boutons/terminals contain all the machinery necessary for the regulated release of 
neurotransmitters. These include trans-synaptic cell-cell adhesion molecules that maintain 
registry between the presynaptic AZ and PSD as well as molecules involved in the docking 
and calcium regulated fusion of SVs with the AZ plasma membrane (Garner, Kindler et al. 
2000; Dresbach, Qualmann et al. 2001; Garner, Zhai et al. 2002; Ziv and Garner 2004; 
Waites, Craig et al. 2005; Fejtova and Gundelfinger 2006). 
Although aldehyde fix specimens have provided tremendous insights in to the ultra-
structure of synapses, Electron Microscopy (EM) tomography combine with high pressure 
freezing has reveal remarkable details of the fine architecture of presynaptic boutons (Peters 
2007; Hoopmann, Rizzoli et al. 2012; Robert, Cloix et al. 2012; Zhao, Studer et al. 2012). 
The most remarkable feature is the AZ, a region of the plasma membrane where SVs dock 
and fuse (Landis 1988; Landis, Hall et al. 1988; Owald and Sigrist 2009; Sigrist and Schmitz 
2011). Typically, hundreds of SVs are localized in the vicinity of AZs. These can be 
functionally divided into a) a readily releasable pool (RRP) that are physically docked at the 
AZ plasma membrane, b) a recycling pool that readily undergo fusion with synaptic activity 
and c) a reserve pool that largely remains quiescent. The latter two pools represent most of 
the SVs within presynaptic boutons and are generally situated far from the AZ plasma 
membrane (100 nm) (Galli and Haucke 2004; Kuromi and Kidokoro 2005; Cheung and 
Cousin 2011). Docked vesicles are surrounding by a network of cytoskeletal and structural 
proteins (Garner, Kindler et al. 2000; Kuromi and Kidokoro 2005; Schoch and Gundelfinger 
2006; Sigrist and Schmitz 2011). Most are multidomain proteins similar to the MAGUK 
family that function to organize the SV docking and fusion machinery (Garner, Kindler et al. 
2000; Waites, Craig et al. 2005; Owald and Sigrist 2009; Robert, Cloix et al. 2012)(see also 
below). 
One of the best-studied presynaptic proteins is Synapsin. It has been shown to associate 
and cross-link SVs within the reserve and recycling pools (Greengard, Valtorta et al. 1993; 
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Ryan, Li et al. 1996; Jovanovic, Czernik et al. 2000; Jovanovic, Sihra et al. 2001). Studies on 
the biochemical properties of Synapsin have shown that it also binds F-actin providing a 
potential link for SVs with the Actin-based cytoskeleton. Importantly, Synapsin undergoes 
activity dependent phorphorylation and dephosphorylation that regulates its cross-linking 
activity and thus the availability of SVs in the reserve and recycling pools to translocate to 
the AZ where they dock and fuse (Rosahl, Geppert et al. 1993; Bloom, Evergren et al. 2003; 
Gitler, Xu et al. 2004; Evergren, Benfenati et al. 2007; Bykhovskaia 2011). Synaptic activity 
also regulates the dynamic assembly of F-actin from monomeric Globular-Actin (G-actin). 
Together with Synapsin, this dynamics is crucial for regulating three aspect of presynaptic 
function (Cole, Villa et al. 2000; Colicos, Collins et al. 2001; Bloom, Evergren et al. 2003; 
Dillon and Goda 2005; Cingolani and Goda 2008). For example, F-actin assembled at the 
plasma membrane is thought to create a barrier that restrains SV fusion at the AZ, thus 
reducing SV release probability (Pr) (Morales, Colicos et al. 2000; Cingolani and Goda 2008). 
In concert with Synapsin, F-actin also plays a role in maintaining the reserve pool and 
through the actions of myosin the translocation of SVs to the RRP (Greengard, Benfenati et 
al. 1994; Cingolani and Goda 2008). Intriguingly, the dynamic assembly of F-actin also 
regulate SV endocytosis and the recycling of synaptic proteins through endosomal pathways 
(Shupliakov, Bloom et al. 2002; Bloom, Evergren et al. 2003; Engqvist-Goldstein and Drubin 
2003; Fenster, Kessels et al. 2003; Dillon and Goda 2005; Evergren, Benfenati et al. 2007). 
Each of these steps greatly facilitates SV fusion and recycling, ensuring that sufficient 
numbers of SVs are available for fusion even under periods of high neuronal activity. 
A fundamental questions regarding presynaptic function is how SVs fusion is restricted to 
the presynaptic AZ. Knowledge gained over the last few decades have shown that a complex 
network of multidomain scaffold proteins assembled at the AZ plasma membrane are 
extremely important for defining and regulating the activity dependent recruitment and 
recycling of SVs pools (Garner, Kindler et al. 2000; Dresbach, Qualmann et al. 2001; Garner, 
Zhai et al. 2002; Fejtova and Gundelfinger 2006; Schoch and Gundelfinger 2006). 
 
1.5 Active Zones. 
The Active Zone (AZ) is a site of SV docking and fusion where neurotransmitter is 
release into the synaptic cleft (Garner, Kindler et al. 2000; Dresbach, Qualmann et al. 2001; 
Garner, Zhai et al. 2002; Fejtova and Gundelfinger 2006; Schoch and Gundelfinger 2006). 
The regulated fusion of SVs, e.g. exocytosis requires a number of specialized proteins. Those 
involved in SV docking with the AZ plasma membrane are known as SNAREs (Soluble NSF 
(N-ethylmaleimide-sensitive factor) Attachment Protein Receptor). These include 
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SynaptobrevinII/VAMP2 located on vesicle membrane, Syntaxin-1 and synaptosome-
associated protein 25 kDa (SNAP-25) both located on the plasma membrane, which form a 
complex and represent the minimal machinery for fusion (Jahn and Sudhof 1999; Galli and 
Haucke 2004; Pobbati, Stein et al. 2006). Progressive zippering of the four helix bundle that 
comprise the SNARE complex drives fusion of SVs with the plasma membrane. Syntaxin I 
and SNAP-25 are localized to the plasma membrane at AZ, but neither of them is solely 
concentrated at AZs (Garcia, McPherson et al. 1995; Sigrist and Schmitz 2011). This 
suggests that other proteins present within the AZ cytoskeletal matrix (or CAZ) are 
responsible for regulation of SV exocytosis. A growing number of studies have begun to 
characterize the core CAZ proteins. These include member of the RIM, Munc13, 
CAST/ELKS, Liprin, RIM-BP and Piccolo families (Garner, Kindler et al. 2000; Dresbach, 
Qualmann et al. 2001; Garner, Zhai et al. 2002; Fejtova and Gundelfinger 2006; Schoch and 
Gundelfinger 2006; Owald and Sigrist 2009). 
 
1.6 RIMs. 
RIM was first identified in a screen for effectors of the SV-associated proteins, Rab3A 
and Rab3C. These Rab Interacting Molecules (RIM) are highly enriched in synaptic 
junctional preparations and tightly associated with AZs. Immuno-EM studies of the most 
abundant isoform RIM1 demonstrate that it is concentrated within presynaptic boutons at the 
AZ (Wang, Okamoto et al. 1997). RIM1 is a 180kDa protein that contains an N-terminal zinc 
finger domain, a PDZ domain, and two calcium/phospholipid binding C2 domains. 
Intriguingly, the C2A and C2B domains in RIM1 lack the five consensus charged amino acid 
residues (aspartate or glutamate) that are essential for Ca2+ binding. This suggests that these 
domains do not bind Ca2+ but instead serve as sites of protein-protein interaction (Sudhof and 
Rizo 1996; Wang, Okamoto et al. 1997). This is supported by studies showing that the C2 
domains of RIM1 do not bind calcium but do bind with high affinity the C2 domains of 
Synaptotagmin 1. Importantly, Synaptotagmin 1 is a known calcium sensor at the AZ and is 
critical for SV fusion in an activity dependent manner, implying that RIM1 may indirectly 
control of SV fusion (Coppola, Magnin-Luthi et al. 2001). Further support for this concept 
come from studies showing that RIM1 forms a tripartite complex via it’s Zinc Finger (ZF) 
domains with Munc13 and Rab3, both of which are important for priming of SV with the AZ 
(Dulubova, Lou et al. 2005). Furthermore, RIM1 uses it multidomain structure to form a 
complex with several other AZ proteins including ELKS, RIM-Binding Protein 1(RIM-BP1) 
and the cytoplasmic domains of presynaptic N- and P/Q-type voltage gated Ca(2+) channels 
(VGCC) (Wang, Okamoto et al. 1997; Wang, Sugita et al. 2000; Betz, Thakur et al. 2001; 
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Hibino, Pironkova et al. 2002; Ohtsuka, Takao-Rikitsu et al. 2002; Schoch, Castillo et al. 
2002; Wang, Liu et al. 2002; Ko, Na et al. 2003; Lu, Li et al. 2005; Andrews-Zwilling, 
Kawabe et al. 2006; Kaeser, Kwon et al. 2008; Kaeser, Deng et al. 2011). These interactions 
are thought to mediate the clustering of VGCC at AZs, thus facilitating activity dependent 
SV fusion (Han, Kaeser et al. 2011). RIM1 loss of function studies are consistent with this 
concept revealing that RIM1 is necessary for efficient neurotransmitter release from AZ 
(Schoch, Castillo et al. 2002; Kaeser, Deng et al. 2011). Finally, RIM1 has been found to be a 
substrate for Protein Kinase A (PKA) phosphorylation, a modification that is associate with 
presynaptic forms of long-term potentiation (preLTP) increasing, for example, SV release 
probability (Castillo, Schoch et al. 2002; Lonart, Schoch et al. 2003) 
 
1.7 Munc13.  
Munc13 is the mammalian homolog of the C. elegans unc-13 protein that was originally 
identified as member of an uncoordinated (unc) group of mutant phenotypes in worms 
(Brenner 1974; Brose, Hofmann et al. 1995). Interestingly, Munc13-1 and its isoforms, 
ubMunc13-2, and Munc13-3, are enriched at presynaptic AZs (Betz, Ashery et al. 1998). 
Munc13-1 is a 200 kDa protein that contains three C2 domains and a C1 domain similar to 
that found in protein kinase C (PKC) (Kazanietz, Lewin et al. 1995; Betz, Ashery et al. 1998). 
As mentioned previously, disruption of the C. elegans and Drosophila unc-13 (dunc-13) as 
well as the mouse unc13 (Munc13-1) genes dramatically suppresses both spontaneous and 
evoked release of neurotransmitter (Aravamudan, Fergestad et al. 1999; Augustin, Betz et al. 
1999; Augustin, Rosenmund et al. 1999; Richmond, Davis et al. 1999). This is likely due to a 
loss of vesicle priming which precludes fusion of docked vesicles with the plasma membrane. 
Munc13 family members appear to regulate SV priming at AZs (Rosenmund, Sigler et al. 
2002; Rosenmund, Rettig et al. 2003). For example, in mouse, the absence of Munc13.1 
completely blocks SV fusion and transmitter release (Varoqueaux, Sigler et al. 2002; 
Varoqueaux, Sons et al. 2005). Munc13 proteins are regulated by a variety of proteins, 
making SV priming and release a complex and highly dynamic regulated process 
(Rosenmund, Rettig et al. 2003). Intriguingly, Munc13-1 can form a homodimer that can 
switch to a heterodimer with RIM1 proteins. This molecular switch is thought to be a key 
step regulating SV priming and presynaptic forms of short-term plasticity (Lu, Machius et al. 
2006). Importantly, Munc13-1 homodimerization inhibits its priming function, leading to the 
concept that RIM1 activate priming by disrupting Munc13-1 homodimerization (Deng, 
Kaeser et al. 2011). 
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1.8 CAST/ELKS.  
Both CAST and ELKSα are structurally related proteins of ∼120 kDa containing four 
coiled-coil (CC) regions and a unique C-terminal amino acid motif, IWA. In C. elegans and 
Drosophila, CAST/ELKS is encoded by a single gene, CeCAST and Bruchpilot, respectively 
(Deken, Vincent et al. 2005; Kittel, Wichmann et al. 2006; Wagh, Rasse et al. 2006). In 
vertebrates, CAST belongs to a protein family that also includes ELKS (Nakata, Kitamura et 
al. 1999; Monier, Jollivet et al. 2002; Wang, Liu et al. 2002; Deguchi-Tawarada, Inoue et al. 
2004) and importantly, the genes for CAST and ELKS are located on different chromosomes 
in mice, rats and humans (Nakata, Kitamura et al. 1999). ELKSα is predominantly expressed 
in the brain (Deguchi-Tawarada, Inoue et al. 2004) and shows a relatively high homology 
with CAST at the protein level (∼70% identical). Similar to CAST, RIM1, Munc13 and 
Bassoon, ELKSα is localized in the vicinity of the presynaptic plasma membrane in the 
mouse cerebellum (Ohtsuka, Takao-Rikitsu et al. 2002). Immuno-EM of photoreceptor cell 
ribbon synapses have shown that CAST is localized at the base of the ribbon near the 
archiform density where SV dock and fuse, whereas ELKSα is localized more peripherally 
around the ribbon (Deguchi-Tawarada, Inoue et al. 2006). These observations suggest that 
CAST and ELKS have distinct functions at synapses in spite of their high degree of 
homology. CAST and ELKS can directly interact with Bassoon, Piccolo and RIM1, and 
indirectly to Munc13-1, forming a large molecular complex at AZ (Ohtsuka, Takao-Rikitsu et 
al. 2002). The subsynaptic localization of CAST and ELKS and their interactions with other 
AZ proteins suggest that the CAST/ELKS family is involved in the formation and/or 
maintenance of AZs. This conclusion is supported by genetic studies in Drosophila (Kittel, 
Wichmann et al. 2006; Wagh, Rasse et al. 2006), where EM studies of neuromuscular 
junctions (NMJs) revealed that null mutations in bruchpilot cause the loss of the electron-
dense T-bar structures and the declustering of VGCCs (Kittel, Wichmann et al. 2006; Wagh, 
Rasse et al. 2006). Intriguingly, while evoked synaptic transmission is profoundly impaired, 
spontaneous neurotransmitter release is unaffected, indicating that the fundamental 
mechanism of exocytosis is still preserved in these mutants. Consistent with a role in 
regulating VGCC, Bruchpilot was recently shown to directly interact with the α-subunit of 
Ca2+ channels in Drosophila (Fouquet, Owald et al. 2009). 
In vertebrates, the inhibition of CAST–Bassoon binding significantly impairs 
neurotransmission (Takao-Rikitsu, Mochida et al. 2004). In contrast to Bruchpilot loss of 
function in Drosophila, no gross changes in the size or morphology of AZs is seen in CAST 
knockout mice (Kaeser, Deng et al. 2009), a finding similar to CeCAST loss of function in C. 
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elegans (Deken, Vincent et al. 2005). One reasonable explanation for this phenomenon is that 
ELKS may be somewhat functionally redundant with CAST at central nervous system 
synapses in mice. Functionally, CAST loss of function in mice has no effect on excitatory 
synaptic transmission, though the release of neurotransmitter from inhibitory synapse is 
increased as is the size of the RRP of SVs (Takao-Rikitsu, Mochida et al. 2004). A particular 
confound in these studies is that the deletion is not a null and shorter isoform of CAST (∼95 
kDa) are still expressed in these mice (Kaeser, Deng et al. 2009). Thus, it remains unclear 
whether CAST plays a direct role in the regulated release of neurotransmitters, as seen for 
Bruchpilot, Munc13 and RIM1 or whether its role is more indirect by e.g. efficiently 
scaffolding other AZ proteins.  
 
1.9 Liprin-α.  
The Liprin-α family of proteins was first characterized by their ability to bind to the 
cytoplasmic domains of LAR (the receptor protein tyrosine phosphatase (RPTP) leukocyte 
common antigen-related) (Serra-Pages, Kedersha et al. 1995) in a yeast two-hybrid screen. 
Liprin-α and LAR can influence one another’s subcellular distribution. For example, LAR 
mislocalization is sufficient to change the distribution of Liprin-α (Serra-Pages, Kedersha et 
al. 1995), and Liprin-α can localize LAR to the proximal edges of focal adhesions (Serra-
Pages, Kedersha et al. 1995). Vertebrate genomes generally encode four Liprin-α (Liprin α 
1-4), whereas Drosophila and C. elegans each have one (Liprin-α and Syd-2, respectively) 
(Stryker and Johnson 2007). 
The interaction between LAR and Liprin α is also conserved in Drosophila (Kaufmann, 
DeProto et al. 2002). Fly liprin-α mutants display dramatic reductions in the size and branch 
complexity of NMJs. LAR mutants in Drosophila have a nearly identical phenotype 
(Kaufmann, DeProto et al. 2002), which is consistent with a model in which Liprin-α and 
LAR work together to control synapse formation. Pre-synaptic overexpression of LAR is 
sufficient to increase synaptic size. This effect depends on the presence of Liprin-α, 
demonstrating that LAR requires Liprin-α to function at the NMJ (Stryker and Johnson 2007). 
Both Liprin-α and LAR mutants have reduced evoked synaptic responses and a nearly 50% 
reduction in quantal content (Kaufmann, DeProto et al. 2002), which suggests a defect in the 
function of the SV fusion machinery in both mutants. 
Liprin-α interacts with a diverse array of proteins that regulate the formation of AZs 
(Zhen and Jin 2004). They are essential for regulated SV release and interact with the SV 
trafficking protein Rab3A. CAST/ELKS family members form large oligomeric complexes 
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with other known AZ proteins and influence the subcellular localization of both Liprin-α (Ko, 
Na et al. 2003) and RIM1 (Ohtsuka, Takao-Rikitsu et al. 2002), targeting these proteins to 
presynaptic sites. Liprin-α is essential for active zone localization of RIM1 (Dai, Taru et al. 
2006; Stigloher, Zhan et al. 2011)  
Liprin-α also binds the MALS/Veli-Cask-Mint1 scaffolding complex, a ternary complex 
of PDZ-domain-containing proteins that regulates the replenishment of SVs in the RRP from 
the reserve SV pool (Olsen, Moore et al. 2005). Although MALS mutants have no visible 
defects in Liprin-α localization, they do have larger synaptic areas and decreased excitatory 
post-synaptic currents, which is similar to Liprin-α mutants in C-elegans (Olsen, Moore et al. 
2005). Given that Liprin-α mutants have defects in evoked responses (Kaufmann, DeProto et 
al. 2002), that RIM1α regulates SV release, it is conceivable that Liprin-α, RIM1α and the 
MALS/Veli-Cask-Mint1 complex functions to facilitate SV priming and neurotransmitter 
release at AZs (Stryker and Johnson 2007). 
Liprin-α colocalizes with Piccolo clusters at the AZ, presumably via interactions with 
RIM1 and CAST/ELKS (Ko, Kim et al. 2003). Invertebrates lack both Piccolo and Bassoon, 
leading to the suggestion that Bruchpilot may assume some of their functions during AZ 
morphogenesis. The phenotypic differences between bruchpilot and liprin-α mutants suggest 
that, although both proteins regulate AZ formation, they likely function in distinct pathways. 
Nevertheless, the observation that the localization of Bruchpilot to the AZ is reduced almost 
30% in liprin-α mutants (Miller, DeProto et al. 2005) suggests some kind of functional 
interaction between Bruchpilot and Liprin-α during active zone assembly.  
 
1.10 Bassoon and Piccolo. 
Piccolo and Bassoon are two high-molecular-weight (520 and 420 kDa) structurally 
related vertebrate specific AZ proteins that are specifically concentrated at AZs (Cases-
Langhoff, Voss et al. 1996; tom Dieck, Sanmarti-Vila et al. 1998; Fenster, Chung et al. 2000; 
Garner, Kindler et al. 2000; Gundelfinger and tom Dieck 2000; Dresbach, Qualmann et al. 
2001; Zhai, Vardinon-Friedman et al. 2001; Fenster and Garner 2002). In addition to being 
some of the first synaptic proteins to cluster at nascent synapses, immunoreactivity for 
Piccolo and Bassoon is observed within the presynaptic boutons of nearly all 
neurotransmitter types, including glutamatergic, GABAergic, cholinergic, dopaminergic and 
serotonergic among others, implying a core set of functions for these AZ proteins (tom Dieck, 
Sanmarti-Vila et al. 1998; Richter, Langnaese et al. 1999; Zhai, Olias et al. 2000). 
Structurally, Piccolo and Bassoon share a great deal of homology that is concentrated in a 
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series of ten Piccolo-Bassoon homology (PBH) domains that are scattered along their length 
(Fenster, Chung et al. 2000; Fenster and Garner 2002). Several PBH domains contain 
identifiable region such as Zinc Finger (ZF) and coiled-coil (CC) domains. In addition, 
Piccolo also contains a C-terminally localized PDZ, C2A and C2B domains (Fenster, Chung 
et al. 2000; Garner, Kindler et al. 2000; Gundelfinger and tom Dieck 2000; Dresbach, 
Qualmann et al. 2001; Zhai, Vardinon-Friedman et al. 2001).  
Piccolo and Bassoon use their multidomain structure to interact with a large number of 
synaptic proteins.  For example, the central region of Piccolo and Bassoon, critical for their 
synaptic localization, interacts with Ribeye/CtBP1 (tom Dieck, Altrock et al. 2005), 
CAST/ELKS (Takao-Rikitsu, Mochida et al. 2004), RIM-BP1 (Davydova,	   Fejtova, 
Gundelfinger, in preparation), Dynein Light Chain (Fejtova, Davydova et al. 2009) and each 
other (Maas, Torres et al. in press). Piccolo also engages in a set of unique interactions that 
suggest a role in the regulation of F-actin. For example, its N-terminal Poly-Q domain 
interacts with Abp1(Fenster, Kessels et al. 2003), its central regions with GIT1 (Kim, Ko et 
al. 2003), Profilin1/2 (Wang, Kibschull et al. 1999) and Daam1 while it C-terminal domains 
with Trio and cAMP-GEFII (Personal communication). Intriguingly, the PDZ, C2A and C2B 
domains of Piccolo interact RIM2 and L-type VDCC, respectively (Fujimoto, Shibasaki et al. 
2002; Shibasaki, Sunaga et al. 2004). Not surprisingly, these interactions permit Piccolo and 
Bassoon to indirectly interact with a broader range of proteins that likely affects their 
common recruitment to Piccolo/Bassoon transport vesicles (PTVs) (Zhai, Vardinon-
Friedman et al. 2001) (Maas, Torres et al. in press). and/or differential localization, e.g. along 
photoreceptor ribbon synapses (tom Dieck, Altrock et al. 2005).  
Of the two, the functions of Bassoon have been characterized in the most detail. For 
example, in Bassoon knockout mice, the ribbons of photoreceptor cell are no longer tethered 
to the archiform density (Dick, tom Dieck et al. 2003). Morphological defects at central 
synapses have not been detected though a greater proportion of hippocampal synapses are 
silent implying a role for Bassoon in synaptic transmission (Altrock, tom Dieck et al. 2003). 
This concept is consistent with recent studies showing that short-term synaptic depression 
occurs during sustained high-frequency trains at hippocampal mossy fiber synapses 
(Hallermann, Fejtova et al. 2010) and abnormalities in the organization and function of 
calcium channels at photoreceptor ribbon synapses (Frank, Rutherford et al. 2010). 
Intriguingly, Bassoon and CAST have been found to direct interactions with beta1b or beta4 
subunits of the VGCC. Moreover, in double knock-out mice for P/Q- and N-type VGCCs, 
synapses are normal in size but have significantly reduced numbers of AZs and docked 
vesicles (Chen, Billings et al. 2011). At present, little is know concerning how each of the 
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fore-described interactions is regulated. Recent mass-spectrometry studies have shown that 
both Piccolo and Bassoon are extensively modified by post transduction modification like 
phosphorylation and O-GlcNAC (Skorobogatko, Deuso et al. 2011).   
Other than the growing number of binding partners, our understanding of Piccolo and its 
functions at synapses is rather limited. Conceptually, based on its structurally similarity with 
Bassoon, one would expect that many functions of Piccolo are redundant with Bassoon, yet 
the presents of domains unique in Piccolo indicate it provides novel functions to synapses as 
well (Fenster, Chung et al. 2000; Fenster and Garner 2002; Fenster, Kessels et al. 2003). 
Regions unique to Piccolo are scattered along its length, many of which appear to be 
modified by alternative splicing (Fenster, Chung et al. 2000; Fenster and Garner 2002; 
Fenster, Kessels et al. 2003). One such region is the C-terminus of the longest Piccolo 
isoforms, which contain the PDZ, C2A and C2B domains. This region has been found to 
interact with L-type VGCC, RIM2 and dopamine transporters (DAT) (Garcia, Gerber et al. 
2004; Cen, Nitta et al. 2008). The latter implies a novel function for Piccolo in dopaminergic 
neurons. Consistent with this concept, the expression of Piccolo was up regulated in the 
nucleus accumbens (NAc) in response to methamphetamine. Reducing Piccolo expression in 
the NAc augmented methamphetamine induced behavioral sensitization, as well as the 
accumulation of dopamine (Cen, Nitta et al. 2008). Studies in PC12 cells revealed that the 
C2A domain of Piccolo negatively regulates the surface expression of DAT indicating that 
Piccolo may regulate plasmalemmal DAT levels in dopaminergic presynaptic boutons (Cen, 
Nitta et al. 2008). Intriguingly, single nucleotide mutations in the C2A domain of Piccolo 
have been linked to major depressive disorders (Choi, Higgs et al. 2011), a behavior that can 
be elicited by the overexpression of the C2A domain of Piccolo in transgenic mice 
(Furukawa-Hibi, Nitta et al. 2010). 
Unfortunately, unraveling the role of Piccolo at synapses has been complicated by the 
size complexity of the Piccolo gene (Fenster, Chung et al. 2000; Fenster and Garner 2002; 
Fenster, Kessels et al. 2003). Initial studies aimed at removing exon14 (PcloΔEx14), had no 
effect on synaptic transmission or synapse formation (Mukherjee, Yang et al. 2010), yet only 
affected the expression of a subset of Piccolo isoforms (Waites, Leal-Ortiz et al. 2011). 
Injecting antisense oligonucleotides against Piccolo into the mouse hippocampus were found 
to affect both learning as well as the establishment of LTP (Ibi, Nitta et al. 2010). However, 
detailed electrophysiological studies were not performed. Finally, using neurons prepared 
from the PcloΔEx14 mice and a short-hairpin RNA (shRNA) that reduces Bassoon 
expression by ~60%, Mukherjee and colleagues have explored potential redundant function 
of Piccolo and Bassoon (Mukherjee, Yang et al. 2010). In these studies, no change in 
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electrophysiological characteristics of either GABAergic or glutamatergic synaptic 
transmission was detected, though a small but significant reduction in SV pool size by 
electron microscopy was observed (Mukherjee, Yang et al. 2010). Taken together, it remains 
unclear whether Piccolo and Bassoon have only minor roles in presynaptic function and/or 
whether the ongoing expression of alternative spliced isoforms perform redundant/masking 
function. 
 
1.11 Aims: 
Based on published studies, the most intriguing and yet enigmatic presynaptic AZ 
proteins are Piccolo and Bassoon. Their large size, early arrival at nascent synapses and 
capacity to interaction with a growing number of both structural and regulatory proteins 
suggest that they perform fundamental roles in the initial assembly and function of vertebrate 
peripheral and central nervous synapses. In this thesis, I have sought to address the core 
functions of Piccolo and Bassoon by developing alternative strategies and technologies to 
inactivate all Piccolo and Bassoon isoforms in a cell-autonomous and synapse specific 
manner. These strategies have allowed us to define not only Piccolo specific functions at 
hippocampal gluatmatergic synapses but also functions shared with Bassoon.  
The specific aims of this thesis are: 
1) Establish cell culture cryopreservation methodologies that allow genetically modified 
neurons to be stored and shared with collaborators.   
2) Develop plasmid and lentiviral based expression systems that support the 
simultaneous down regulation of multiple synaptic proteins, while co-express XFP-
tag reporter molecules at or near endogenous levels. 
3) Generate a set of shRNAs that efficiently eliminate the expression of Piccolo and/or 
Bassoon. 
4) Define the functions performed by Piccolo at excitatory hippocampal synapses.   
5) Define the synaptic functions shared by Piccolo and Bassoon.  
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2. Materials and methods 
 
2.1 Materials 
 
2.1.1 Chemicals 
All chemicals used were of analytical grade purchased from the described companies. 
Special chemicals and solutions utilized are detailed in the corresponding method 
descriptions. 
 
2.1.2 Bacterial cells 
Item Company 
NEB 10-beta Competent E. coli (High Efficiency) Genotype: 
araD139 ∆(ara-leu)7697 fhuA lacX74 galK (ϕ80 ∆(lacZ)M15) 
mcrA galU recA1 endA1 nupG rpsL (StrR) ∆(mrr-hsdRMS-mcrBC) 
New England BioLabs 
Table 2.1. Bacterial cells 
 
2.1.3 Bacterial culture media and antibiotics 
Bacterial culture media Composition  
LB Miller Media 5 g yeast extract, 10 g peptone from casein, 10 g sodium chloride 
per liter of H2O 
LB Miller Agar 5 g yeast extract, 10 g peptone from casein, 10 g sodium chloride, 
12 g agar-agar (??) per liter of H2O 
LB Lennox Media 5 g yeast extract, 10 g peptone from casein, 5 g sodium chloride 
per liter of H2O 
SOC 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 10 mM MgSO4, 20 mM glucose 
Kanamycin 50 mg/ml stock solution (1000x) 
Ampicillin 100 mg/ml stock solution (1000x) 
 Table 2.2. Bacterial culture media and antibiotics 
 
2.1.4. Molecular biology reagents, buffers and kits 
Items Composition or Company 
Agarose Invitrogen 
1X TAE 40 mM Tris-OH, 20 mM Acetic Acid, 
10mM EDTA pH 7.8 
Ethidium bromide Bio-Rad 
Endonucleases (restriction enzymes) New England Biolabs 
Taq DNA polymerase Invitrogen 
Ultra high-fidelity KOD Taq polymerase kit Novagen 
Alkaline Phosphatase, Calf Intestinal (CIP) New England Biolabs 
T4 DNA ligase New England Biolabs 
T4 Polynucleotide kinase (PNK) New England Biolabs 
EndoFree Plasmid Maxi kit Qiagen 
PureLink HiPure Maxi kit Invitrogen 
Gel extraction kit Qiagen 
1 kb DNA ladder New England Biolabs 
100 bp DNA ladder New England Biolabs 
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Annealing buffer 100 mM potassium acetate, 30 mM HEPES-
KOH, pH 7.4, 2 mM magnesium acetate 
 Table 2.3. Molecular biology reagents, buffers and kits 
 
2.1.5 Cells lines and medias 
 Table 2.4. Cells line and medias 
 
2.1.6 Primary antibodies  
Antibodies WB dilution ICC dilution Company 
rb Piccolo 44aII  1/500 Custom-made 
ms Bassoon 7f  1/500 Custom-made 
rb Map2a/b  1/500 Custom-made 
ms Map2a/b  1/500 Custom-made 
ms Beta-Actin 1/1000  Sigma 
ms GFAP 1/1000  Millipore 
ms vGlut1?  1/1000 Synaptic Systems 
rb Homer 1  1/500 Synaptic Systems 
ms Synaptophysin  1/1000 Synaptic Systems 
ms EGFP 1/5000  Roche 
ms Neomycin 1/1000  Millipore 
ms Tubulin 1/10000  Sigma 
rb Rim1  1/200 Synaptic Systems 
rb Munc13-1  1/200 Synaptic Systems 
Item  Composition and Companies 
HEK293T (Human Embryonic Kidney cells, 
SV40 large T antigen) 
ATCC 
COS-7 (CV-1 (simian) in Origin, and 
carrying the SV40) Kidney Fibroblast Cells 
from African green monkey 
ATCC 
HEK293T and COS-7 media DMEM, 1X GlutaMAX, 10% Fetal Bovine Serum 
(FBS), 1X Penicillin /Streptomycin. 
TrypLE™ Express (1x), phenol red 
All your text says that you use Trysin-EDTA 
Invitrogen 
Poly–L-Lysine 33 mg/l Poly-L-Lysine in 100 mM boric acid pH 8.5, 
sterile filtered 
HBSS pH 7.4 Hank’s balanced salt solution, Ca 2+ and Mg 2+ Free 
(Sigma), 10 mM HEPES pH 7.4 
Neuronal media Neurobasal media, B27, GlutaMAX (all from 
Invitrogen) 
Neuronal plating media Minimum Essential Media with Earle’s salts, 10% 
Donor horse serum, 100 mM Sodium pyruvate, 20 
mM glucose, 
Glia media Minimum Essential Media with Earle’s salts, 20 mM 
glucose; 10% FBS, Antibiotic-Antimycotic 
(Invitrogen) 
Glia-conditioned media Minimum Essential Media with Earle’s salts and 
glutamine-free, 10% FBS, 20 mM glucose, A/A 
conditioned with glial cultures 
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ms PSD95  1/200 Sigma 
ms NR1  1/500 Abcam 
ms HRP  1/500 Abcam 
ms Synapsin 1/5000  Synaptic Systems 
rb Synapsin site 4/5 1/1000  PhosphoSolution 
rb Synapsin site 3 1/1000  PhosphoSolution 
rb GluRI  
(S831-P) 
1/1000  PhosphoSolution 
rb Synaptotagmin 
(S309-P) 
1/1000  PhosphoSolution 
rb Rabphilin 
(S234-P) 
1/1000  PhosphoSolution 
rb GluRI  
(S831-P) 
1/1000  PhosphoSolution 
rb Munc18 
(S515-P) 
1/1000  PhosphoSolution 
rb Dynamin 
(S774-P) 
1/1000  PhosphoSolution 
rb Dynamin 1/1000  PhosphoSolution 
rb SV2 1/1000  Synaptic Systems 
rb Rab3 1/1000  Synaptic Systems 
rb Syntaxin 1/1000  Synaptic Systems 
rb SNAP25 1/1000  Synaptic Systems 
 Table 2.5. Primary antibodies 
 
2.1.7 Secondary antibodies 
Antibodies WB dilution ICC dilution Company 
rb Alexa 488  1/750 Invitrogen 
rb Alexa 568  1/750 Invitrogen 
rb Alexa 647  1/750 Invitrogen 
ms Alexa 488  1/750 Invitrogen 
ms Alexa 568  1/750 Invitrogen 
ms Alexa 647  1/750 Invitrogen 
ms HRP 1/10000  Roche 
mb HRP 1/10000  Roche 
 Table 2.6. Secondary antibodies 
 
2.1.8 Immunocytochemistry 
Item Composition 
Lorene’s fixative solution 60 mM PIPES pH7.0, 25 mM HEPES pH 7.0, 10 mM 
EGTA pH 8.0, 2 mM MgCl2, 0.12 M sucrose, 4% 
paraformaldehyde 
Permeabilization solution 0.25% Triton X-100 in 1X PBS 
Blocking solution (for immunostaining) 2% Bovine serum albumin (BSA), 2% glycine, 0.2% 
gelatin, 50 mM NH4Cl) 
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PBS pH 7.4 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.46 
mM KH2PO4  
 Table 2.7. Immunocytochemistry reagent  
 
2.1.9 Biochemistry 
Item Composition 
TBS 50 mM Tris-Cl pH 7.5, 150 mM NaCl pH 7.5 
TBS-T TBS plus 0.5% Tween-20 
Blocking solution (Western blot) 5% milk in TBS-T 
Homogenization buffer Ice-cold 1X-PBS supplemented with protease inhibitors and 
1% Tween-20 
2X Sample buffer 125 mM Tris–HCl pH 6.8, 20% Glycerol, 4% SDS, >0.02% 
Bromophenol Blue, 5% Beta-Mercaptoethanol 
 Table 2.8. Biochemistry reagent 
 
2.1.10 Animals 
Animal Notes Origin 
B6:129SF1/J Mus musculus (Wild type) Jackson Laboratory 
B6;129 S6-Pclotm1Sud/J Mus musculus (PcloΔEx14/Neo)  Jackson Laboratory 
Sprague-Dawley TIMED 
pregnant dams 
Rattus Norvegicus Charles River 
 Table 2.9. Animals 
 
2.1.11 Plasmid transfections 
Item  Composition or Company 
Lipofectamine 2000 Invitrogen 
Calfectin SignaGen 
Gene Pulser Electroporation BioRad 
 Table 2.10. Transfection reagents 
 
2.1.12 Live cell imaging reagents and solutions 
Item  Composition or Company 
Tyrode’s solution  
pH 7.4 
25 mM HEPES, 119 mM NaCl, 2.5 mM KCl, 30 mM glucose, 2 mM 
CaCl2, 2 mM MgCl2, 50 µM CNQX, 10 µM APV,  
High K+ Tyrode’s 
solution pH 7.4 
25 mM HEPES, 31.5 mM NaCl, 90 mM KCl, 30 mM glucose, 2 mM 
CaCl2, 2 mM MgCl2, 50µM CNQX, 10 µM APV,  
FM 5-95 Invitrogen 
FM 4-64 Invitrogen 
 Table 2.11. Live cell imaging reagents 
 
 
 
2.2 Methods 
 
2.2.1 Molecular biological methods 
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2.2.1.1Genotyping of Pclo mutant mice 
2.2.1.1a DNA extraction for genotyping Pclo mutant mice 
Neonate pups from PcloΔEx14/Neo mutant mice litters (P0-P1) were decapitated, and 
samples were taken for DNA extraction. Cortical samples from each pup were incubated with 
300 µl of 50 mM NaOH at 99 °C per 30 min. After this incubation, 30 µl of 10 mM Tris was 
added, and samples were maintained on ice for PCR. 
 
2.2.1.1b Polymerase chain reaction (PCR) for genotyping 
PCR was performed using 10 µl of master mix containing all components and primers for 
WT and KO samples plus 2 µl of DNA extract for genotyping. Final concentrations of the 
PCR reagents were: 1 µM forward primer WT, 1 µM reverse primer WT 1 µM forward 
primer KO, 1 µM reverse primer KO (see Table 12 for sequences), 2.0 mM MgCl2, 0.03 
units/µl Taq-polymerase, 0.2 mM dNTPs in 1x PCR buffer II.  
 
Primer 
Name 
5’ primer 3’ primer Product 
size 
wt 5’cgtagtcagactggaactcta 5’gctctggtacagaggtaaagcttgc 195 bp 
Pclo KO 5’ccttgaggtcaatgtgatca 5’gccaagttctaattccatcagaagctcgataccg 210 bp 
Table 2.12. Primer Sequence for PCR for genotyping wildtype and Pclo KO. 
 
Process Time and temperature Cycles 
Initial Denaturation 4 min, 94 °C 1 time 
Denaturation 
Annealing 
Extension 
30 sec, 94 °C 
1 min, 55 °C 
1 min, 72 °C 
 
35 time 
Final Extension 7 min, 72 °C 1 time 
Hold  ∞  4 °C  
Table 2.13: Thermocycling set up program for genotyping 
 
2.2.1.2 Bacterial transformations 
Transformations of chemically competent E. coli were accomplished as described by the 
manufacturer (New England Biolabs). Frozen aliquots of competent bacterial cells, stored at -
80 °C, were thawed for approximately 10 min on ice. The desired plasmid (0.2 µg) was 
added to the competent cell suspension, gently swirled with a pipet tip and placed on ice for 5 
min. Cells were then heat-shocked for 45 sec at 42 °C and placed back on ice for 5 min. SOC 
media (100 µl) was added to the cell suspension; the cells suspension was then placed in a 
37°C shaking incubator at speed of 200 rpm for 45 min. Cells were plated on LB agar plates 
with the appropriate antibiotics. Inoculated plates were placed at 37 °C overnight and 
removed after approximately 16 h. 
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2.2.1.3 Growing up bacterial colonies for plasmid minipreps 
Individual colonies were picked using sterile technique and used to seed a 4 ml Lennox 
Luria Broth (LB) culture with the appropriate antibiotics. Single colonies were grown in 15 
ml round-bottomed plastic tubes with adjustable caps to allow for oxygenation in a bacterial 
shaker overnight at 37 °C. 
 
2.2.1.4 Plasmid DNA minipreps 
Plasmid DNA was generally isolated from 2 ml overnight bacterial cultures using a 
modified Sambrook molecular cloning protocol. In brief, bacterial cultures were collected 
and centrifuged in a microcentrifuge at 14,000 rpm at room temperature for 5 min. The 
supernatant was carefully removed by vacuum suction without disturbing the cell pellet. Cell 
pellets were then resuspended in 200 µl Resuspension Buffer and then lysed in 200 µl Lysis 
Buffer. Tubes were then inverted 6-10 times for full lysis. Reactions were allowed to proceed 
for approximately 2 min but no longer than 5 min before the addition of 200 µl 
Neutralization Buffer. Tubes were inverted again 6-10 times until the formation of a white 
precipitate was seen. Tubes were then place for 5 min on ice. Cellular debris was then 
removed by centrifugation at 14,000 rpm for 5 min at 4 °C. Approximately 600 µl of 
supernatant from each tube was placed into a new 1.5 ml centrifuge tube and 900 µl of 
isopropanol was added and mixed well by continuously inverting the tube. Plasmid DNA was 
collected by centrifugation at 14,000 rpm for 15 min at 4 °C. The supernatant was carefully 
removed by vacuum suction, and the dried DNA pellet was resuspended in 50 µl nanopure 
water and stored at  -20 °C.  
 
2.2.1.5 Preparing endotoxin-free maxiprep plasmid DNA  
Plasmid DNA was prepared in large quantities (~1-2 mg) and high purity using a 
maxiprep kit [EndoFree Plasmid Maxi Kit (Qiagen) or PureLink HiPure Maxiprep Kit 
(Invitrogen)] according to the manufacturer’s instructions with the following modifications. 
In brief, LB (300 ml) was inoculated with 100 µl from a 3ml bacterial starter culture grown 
overnight for 14 to 18 hr at 37 °C in a bacterial shaker. DNA was purified as described by the 
manufacturer (Qiagen or Invitrogen). DNA pellets were resuspended in 500 µl of endotoxin-
free H2O. DNA concentrations were quantified using a spectrophotometer (BioSpec-nano) at 
260 nm.  
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2.2.1.6 Separating DNA fragments using agarose gel electrophoresis 
Separation of DNA fragments was accomplished using one-dimensional agarose gel 
electrophoresis. Analytic agarose gels (1% w/v) were prepared in 1X TAE buffer. This 
solution was heated in a microwave in 30 s intervals with swirling until the agarose solution 
began to bubble and then cooled in a cold-water bath. For visualization of the separated DNA 
fragments under UV light, ethidium bromide was added to a final concentration of 0.5 µg/ml. 
The agar solution was poured into a gel apparatus and allowed to solidify at room 
temperature in the hood for 20-30 min. For running gels, 1X TAE was added until the 
meniscus was approximately 1 cm above the agarose. Gels were run between 1 to 5 V/cm. 
Gels were visualized using a UV transilluminator and documented using the KODAK camera 
system.  
 
2.2.1.7 DNA purification from gel slices 
DNA fragments are isolated and purified from agarose gels as described by the 
manufacturer (Qiagen). In brief, DNA fragment(s) were excised from DNA agarose gels with 
a clean razor blade and solubilized with Buffer QG (using three times volume of the agarose 
mass). The mixture was heated at 42 to 50 °C until the agarose melted. The DNA fragments 
were purified using a QIAquick mini columns and eluted with 25 µl of nanopure water. 
Products were analyzed using a diagnostic 1% agarose gel to obtain a rough estimate of the 
concentration of each DNA fragment by comparing band intensities relative to 1.0 kb DNA 
ladder (NEB).  
 
2.2.1.8 DNA restriction enzyme digestions  
DNA plasmid digest were performed as described by the manufacturer (New England 
Biolabs). In brief, the reaction consisted of: 1 µl of 10X Buffer X, 0.1 µl of restriction 
enzyme X and 1 µg of plasmid or sample for a total reaction volume of 10 µl in nanopure 
H2O. The reactions were gently mixed by pipetting up and down and were incubated at 37 °C 
for more than 30 min. DNA fragments were separated on a 1% agarose gel (see above). 
 
2.2.1.9 Removal of phosphate from DNA using calf intestine alkaline phosphatase CIP 
Phosphatase DNA was performed as described by the manufacturer (New England 
Biolabs). In brief, reactions consisted of: 1 µl of 10X Buffer X, 3 µg of DNA, and 0.5 units 
CIP/µg vector DNA. Reactions were incubated for 60 min at 37 °C and then purified by 
agarose gel purification.   
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2.2.1.10 Ligation of DNA fragments 
Ligations are performed as described by the manufacturer (New England Biolabs). In 
brief, reactions were set up on ice in microcentrifuge tube and consisted of: 2 µl of 10X T4 
DNA ligase buffer (thawed and resuspended at RT), 50 ng of Vector DNA (3 kb), 50 ng 
insert DNA (1 kb), and 1 µl T4 DNA ligase (added last) in a total reaction volume with 
nanopure H2O of 20 µl. Reactions were mixed by pipetting up and down and incubated at 
room temperature for 10 min and then chilled on ice. Ligation reaction product (10 µl) was 
transformed into 50 µl chemically competent cells. 
 
2.2.1.11 Annealing oligonucleotides 
Annealing reactions consisted of 5 µl of the respective complementary oligonucleotides 
(100 pmol/µl) in a 50 µl, total volume of annealing buffer. The reaction was denatured at 
99°C for 4 min, annealed at 99°C for 10 sec with a decrease of 1°C every 10 sec until the 
reaction reached 4°C. The reactions were placed on ice until used. 
 
2.2.1.12 Phosphorylation of oligonucleotides 
Oligonucleotides were phosphorylated as described by the manufacturer (New England 
Biolabs). In brief, reactions consisted of: 1 µl T4 Polynucleotide Kinase (PNK) Buffer, 1 µl 
ATP (10 mM), 1 µl T4 PNK, 5 µl of H2O and 2 µl of annealed oligos (see above). Reactions 
were gently mixed by pipetting up and down, incubated at 37 °C for 30 min and then 
incubated at 70 °C for 10 min to heat inactivation PNK.  
 
2.2.1.13 PCR amplification 
Amplification of cDNA was done by PCR using specific primers. All primers were 
resuspended in ddH2O at 100 pmol/µl. The PCR reaction consisted of: 1X Buffer#1 For KOD 
HiFi DNA Polymerase, dNTPs (final concentration 0.2 mM), MgCl2 (final concentration 1 
mM), 10 to 90 ng/µl of Template DNA, 5' primer (final concentration 0.4 µM), 3' primer 
(final concentration 0.4 µM), 0.4 ul of KOD HiFi DNA Polymerase (2.5 U/µl) in 50 µl final 
volume.  
Process Time and temperature Cycles 
Initial Denaturation 1 min, 94 °C 1 
Denaturation 
Annealing 
Extension 
15-60 sec, 95 °C 
15-60 sec, 50-70 °C 
15-60 sec, 72 °C 
 
35 
Final Extension 10 min, 72 °C 1 
Hold ∞  4 °C  
Table 2.14: PCR amplification process time and temperature cycles 
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2.2.2 Design and generation of vectors  
2.2.2.1 Generation of the pZOff vector  
The pZOff vector was built on the backbone of the pEGFP-C1 vector (Clontech). The 
vector was modified to eliminate the resident multiple cloning site by digesting with BglII 
and BamHI followed by re-ligation (note that BglII and BamHI are compatible enzymes). 
Subsequently, a pair of synthesized oligonucleotides were inserted between the MluI and 
DraIII sites. (Note: the SalI, PvuI, and BamHI restriction sites in these oligos destroy the 
MluI and DraIII sites.) To create pZOff 1.0 H1 and pZOff 2.0 U6 vectors, the H1 or U6 
promoter from the pSuper plasmid (Oligoengine) was inserted into the SalI and BamHI sites, 
respectively, of this modified pEGFP vector. (Note: shRNA transcription is driven in the 
opposite direction from EGFP, which increases the chance of producing shRNAs without 
disrupting polymerase-II EGFP transcription.)  
 
2.2.2.2 Design and cloning of shRNAs 
Short hairpin RNAs (shRNAs) were designed corresponding to the 21mer target sites 
using Ambion’s criteria, which specifies oligo duplexes with 5’ AA overhangs. The target 
sequence for the two Piccolo shRNAs were: Pclo6  5’-AAGGGCGCAGGGGCTGCCCAA-
3’ based on nucleotides (332-353) and Pclo28 5’-AAGTGCTGTCTCCTCTGTTGT-3’ based 
on nucleotides 638-659 of the Rattus norvegicus Piccolo gene (GenBank accession no. 
NM_020098). For Bassoon, the Bsn16 shRNA 5’-AACACCTGCACCCAGTGTCAC-3’ was 
based on nucleotides 652-673 of Rattus norvegicus Bassoon gene (GenBank accession no. 
NM_0191416). Sense and antisense oligodeoxynucleotides were purchased from Sigma or 
Protein and Nucleic Acid (PAN) facility at Stanford University, containing looped overhangs 
for BglII and Hind III. The following oligos were used: Pclo28FW, Pclo28RV, Bsn16FW, 
Bsn16RV Pclo28SCFW, Pclo28SCRV, Bsn16SCFW, Bsn16SCRV (SC is for scramble). 
Corresponding complementary strands were annealed in annealing buffer, using a Thermo-
cycler, 2 µl of the annealed oligos were use for phosphorylation with T4-nucleotide kinase 
before being ligated with 0.2 µg of the pZOff 1.0 or 2.0 vectors open with BglII and HindIII 
endonucleases.  
 
2.2.2.3 Generation of FUGW H1 vector  
The lentiviral plasmid FUGW (Lois, Hong et al. 2002) was modified in several steps for 
expression of shRNAs, thus creating a new shRNA silencing vector FUGW H1. This was 
accomplished by first eliminating the EcoR1 site in the FUGW vector. Oligonucleotides 
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(FUGW PacI Oligo FW and FUGW PacI Oligo RV) were then used to introduce EcoRI and 
BstBI sites to create a new multi-cloning site. The final FUGW H1 vector was created by 
moving the H1 promoter and/or different shRNA sequences from the pZOff vector into the 
EcoRI and BstBI sites.  
 
2.2.2.4 Generation of EGFP::SynIa, EGFP::SV2 and VAMP2::HRP constructs as well as 
the Pclo28 and Bsn16 shRNAs 
EGFP SynapsinIa (EGFP::SynIa) was incorporated into the FUGW vector by first 
removing the EGFP cassette from the vector with XbaI and inserting the EGFP::Syn1a 
sequences taken from pEGFP::Syn1a with NheI and Xba1. EGFP::SV2 was incorporated into 
FUGW by removing the EGFP cassette from the vector with AgeI and XhoI and inserting 
EGFP::SV2 sequences taken from pEGFP::SV2 with AgeI and XhoI. The coding sequence of 
horseradish peroxidase (HRP) was fused to VAMP2 by initially amplifying the coding region 
of HRP with two oligonucleotides (HRP FW and HRP RV) using the polymerase chain 
reaction (PCR). This fragment was subcloned into the BamHI & BsrGI site in a VAMP2 
expressing vector (pVAMP2::EGFP) creating pVAMP2::HRP. Sequences encoding 
VAMP2::HRP flanked by NheI and MfeI restriction sites were then subcloned into the 
FUGW vector by removing the EGFP cassette with XbaI and EcoRI. 
The creation of bicistronic vectors expressing each of these reporter molecules as well as 
the shRNAs for Piccolo (Pclo28) or Bassoon (Bsn16) were created by subcloning the H1-
Pclo28 or H1-Bsn16 expression cassette into each of the aforementioned vectors using the 
corresponding NdeI or MluI and PacI sites in these vectors. 
 
2.2.2.5 Creation of tricistronic lentiviral vectors 
Double knock-down (DKD) of Piccolo and Bassoon was accomplished by creating 
tricistronic lentiviral vectors that expressed both a reporter gene and two shRNAs, one under 
the control of the H1 and the other U6 polymerase III promoter. Variants of these vectors are 
shown in Figure 3.19, and details are provided below for the creation of the DKD and 
scrambled control (SC) lentiviral vector (FUGW/DKD and FUGW/SC). The Bsn16/Pclo28 
DKD vector was created by modifying the FUGW Pclo28 vector (containing Pclo28 shRNA 
with H1 promoter) in two steps. First, a 750 nucleotide stuffer sequence containing 5’ BsiWI, 
EcoRI and BstBI and 3’ BsiWI sites were inserted into the FUGW/Pclo28 vector opened at 
the BsiWI site. Second, the sequence containing the U6 promoter and Bsn16 shRNA in 
pZOff 2.0 (pZoff2.0/Bsn16), flanked by EcoRI and AccI sites was subcloned at the EcoR1 
and BstB1 sites. The resulting FUGW vector drives expression of the Pclo28 shRNA via the 
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H1 promoter and the Bsn16 shRNA via the U6 promoter. These elements were separated by 
750 nucleotides, an arrangement that allows for efficient lentivirus production and 
simultaneous knockdown of both Piccolo and Bassoon using FUGW/DKD. An identical 
strategy was used to generate the FUGW SC expressing scrambled sequence of Pclo28 
(Pclo28SC) and Bsn16 (Bsn16SC). Note, the SC sequences retain the capacity to form 
hairpins yet are unable to bind Piccolo or Bassoon mRNA sequences. The final tricistronic 
vectors were created by opening each of the lentiviral vectors expressing EGFP-Syn1a, 
EGFP-SV2, or VAMP2-HRP with NdeI or MluI and PacI. The DKD or SC expression 
cassettes were moved into these vectors by isolating the NdeI or MluI and PacI inserts from 
the FUGW/DKD or FUGW/SC vectors, respectively. 
 
2.2.2.6 Creating an shRNA-resistant (Bsn16) full-length Bassoon 
A plasmid expressing EGFP 95-3938-Bassoon (Dresbach, Hempelmann et al. 2003) 
(NM_019146.) was used as a template for PCR. A two-step PCR was performed. The initial 
5’ and 3’ PCR products were generated with two primer pairs: a 5’ PCR fragment (Bsn 
AccIII FW/ Bsn 16 Silence mut RV) and 3’ PCR fragment (Bsn 16 Silence mut FW/ Bsn 
AflII RV). After purification of these fragments, they were used in a third PCR using the 
most 5’ and 3’ oligonucleotide primers (Bsn AccIII FW/ Bsn AflII RV). This new fragment 
was purified, digested with the restriction endonucleases AccIII and AflII before subcloning 
back in to the AccIII and AflII sites within pEGFP 95-3938-Bassoon. The new construct is 
referred to as pEGFP-Bsn/SM16 (SM = Silent Mutation).  
 
2.2.2.7 Construction of an adenoviral vector expressing mRFP-Bsn/SM16 
An adenoviral vector expressing mRFP-BsnSM16 was created from pEGFP-Bsn/SM16. 
As a first step, EGFP was replaced with mRFP creating pmRFP-Bsn/SM16. To facilitate 
cloning of mRFP-Bsn/SM16 into the adenoviral transfer plasmid pLPBL, the Ase1 site in 
pmRFP-BsnSM16 was replaced with a short nucleotide segment containing MfeI, BsiWI, 
PacI and AseI sites using the oligonucleotide pair AseI/MfeI FW and RV. This oligo 
inactivates the 5’ AseI site. Using the Mfe1 sites, the mRFP-Bsn/SM16 fragment from this 
vector was subcloned into the adenoviral shuttle vector pLPBL-1, which was opened with 
EcoRI. The new vector called pLPBL mRFP-Bsn/SM16 was sent to our collaborator Phillip 
Ng (Baylor College of Medicine, Houston, Texas, USA) for adenoviral production. At his 
adenoviral production facility, his team subcloned the mRFP-Bsn/SM16 fragment using 
flanking Asc1 sites into their final adenoviral vector, pHDAd. The new vector, pHDAd 
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mRFP-Bsn/SM16, was subsequently used to generate high titer adenovirus (Palmer and Ng 
2005; Brunetti-Pierri, Ng et al. 2006). Resulting virus had a 1x1013 µf/ml titer.   
 
2.2.2.8 Creating mCherry-tagged Piccolo and Bassoon zinc finger domains 
The zinc finger domains (ZF) from Piccolo and Bassoon were subcloned into the 
pmCherry-N2 expression vector using PCR to amplify each sub-region of these two 
molecules. pEGFP-Bsn/SM16 was used as a template for amplifying the first and second ZF 
domains from Bassoon (BsnZF1; BsnZF2), using the following oligonucleotide primers (Bsn 
HindIII ZF1 MutTS16 FW and Bsn BamH1 Zn1 MutTS16 RV to amplify ZnF domain 1; 
Bsn HindIII ZF2 FW and Bsn BamHI ZF2 RV to amplify ZF domain 2). Using a similar 
strategy the two ZF domains from Piccolo were amplified by PCR. Here, a plasmid encoding 
the N-terminus of Piccolo (p7f EGFP; Fenster et al., 2001) was used as a template. The first 
and second ZF domains from Piccolo (PcloZF1; PcloZF2) were amplified with the following 
oligonucleotide pairs (Pclo HindIII ZF1 FW and Pclo BamHI ZF1 RV for PcloZF1 and Pclo 
HindIII ZF2 FW and Pclo BamHI ZF2 RV for PcloZF2). All four fragments were purified, 
digested with the restriction endonucleases HindIII and BamHI and subcloned into the 
pmCherry-N2 opened with HindIII and BamHI, creating the following new plasmids: 
pmCh/BsnZF1, pmCh/BsnZF2, pmCh/PcloZF1, and pmCh/PcloZF2. 
To express these ZF in neurons, each mCherry tagged construct was placed into the 
lentiviral vector FUGW. This was accomplished by subcloning the NheI and MfeI fragments 
from each into the XbaI and EcoRI sites in FUGW. The new vectors are called: 
FUmCh/BsnZF1W, FUmCh/BsnZF2W, FUmCh/PcloZF1W and FUmCh/PcloZF2W. 
 
2.2.3 Biochemical methods 
 
2.2.3.1 Preparation of cellular lysates 
Cellular lysates were prepared from transfected HEK293. Cells were harvested into 
homogenization buffer [ice-cold 1X-PBS supplemented with a protease inhibitor cocktail 
(Complete Protease Inhibitor Tablet, EDTA-free; Roche Molecular Biochemicals)], and then 
placed directly into loading buffer. Cellular lysates from infected hippocampal neurons were 
harvested directly into loading buffer. 
 
2.2.3.2 Separating proteins via SDS-polyacrylamide electrophoresis 
Proteins from cellular lysates were separated on a one-dimensional 3-8% Tris-Acetate 
gels (NuPAGE; Invitrogen) as described by the manufacturer. This system provided excellent 
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separation of large molecular weight proteins (60-600 kD) with NuPAGE Tris-Acetate 
sodium dodecasulfate (SDS) running buffer (Invitrogen). Alternatively, proteins were 
separated using Mini-Protean TGX (Tris-Glycine extended; Biorad) precast gels with 
Tris/Glycine/SDS running buffer (Bio-Rad). This allowed for excellent separation of proteins 
in a lower range (10-200 kDa).  
 
2.2.3.3 Western blotting 
After separation by SDS gel electrophoresis, proteins were transferred onto 
polyvinylidene fluoride membrane (PVDF) as described by the manufacturer (Invitrogen or 
BioRad).  
 
2.2.3.4 Immunoblot detection of protein bands 
Specific proteins were detected on PVDF membranes using standard immunoblotting 
techniques. In brief, following transfer, PVDF membranes were rinse with distilled water and 
placed in blocking solution for 15 min at 30 °C. PVDF membranes were then incubated with 
primary antibody in blocking solution or Tris-buffered saline+0.5% Triton (TBS-T) for 1 hr 
at 30 °C or overnight at 4 °C. Membranes were then washed once for 15 min in TBS-T. After 
washing, secondary antibody coupled with horseradish peroxidase (HRP) in TBS-T was 
added to the membrane for 1 hr at 30 °C. Membranes were then washed with TBS-T three 
times, and immuno-detection was carried out with WesternBright ECL HRP substrate for 5 
min and visualized using high sensitivity x-ray film (LucentBluein) with an automatic 
developing machine (All Pro Imaging 100plus). 
 
2.2.4 Heterologous cell culture techniques 
2.2.4.1 Growth and passage of mammalian cell lines  
To passage both HEK293T and COS-7 cells, media was removed from the cells using a 
vacuum apparatus within a laminar flow hood. Cells were washed with sterile 1X phosphate-
buffered saline (PBS) and incubated with 2 ml 0.05% trypsin-EDTA at 37 °C for 5-10 min. 
Cells were dissociated by pipetting the solution up and down until a homogenous cell 
suspension was obtained. Cells were transferred to a 15 ml conical tube with media. Cells 
were centrifuged at 1000 g for 2 min, and the cell pellet was resuspended in the appropriate 
volume of media for plating or passing. 
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2.2.5 Hippocampal and glial primary cultures 
2.2.5.1 Coverslip preparation 
The coverslips for E18 hippocampal neuronal cultures were prepared as described 
previously (Banker and Goslin 1988; Tanaka 2002; Meberg and Miller 2003; Kaech and 
Banker 2006) with the following modifications. Specifically, square (22x22 mm) No.1 
coverslips were cleaned in ceramic holders in nitric acid for 2 h, washed with MilliQ water 
multiple time and air dried at room temperature for 2 h. Coverslips were then placed in a 100 
mm Petri dish, and a small drop of melted paraffin wax was added to each corner. Coverslips 
were sterilized by a germicidal ultraviolet lamp FG30T8 for 30 min and then treated with 
poly-L-Lysine (25 µg/ml, vendor) overnight at 37 °C in the cell culture incubator. Finally, 
coverslips were rinsed three times with sterile MilliQ water and maintained in plating media 
until use. 
 
2.2.5.2 Glial culture preparation 
Preparation, plating and growth of astrocytes from the cerebral cortex of P1-2 rats (type) 
was identical to that described previously (Banker and Goslin 1988; Tanaka 2002). 
Dissections for glial cell culture preparations were performed in a laminar flow hood. Several 
(2-4) postnatal rat pups (P1 or P2) were sacrificed using decapitation. Brains were removed 
and transferred to a dish containing HBSS plus 10 mM HEPES pH 7.4. Cortical hemispheres 
were isolated and the meninges carefully stripped away using fine forceps. The tissue was 
then minced into small pieces using scissors. The pieces of cortex were transferred into a 50 
ml centrifuge tube with 12 ml of HBSS with 1.5 ml each of 1% DNase and 2.5% Trypsin 
with EDTA and then incubated at 37 °C for 15 min. The trypsin reaction was stopped with 
5% Fetal Bovine Serum (FBS) and perform the trituration step, the tissue was centrifuged at 
1000xg for 5 min. Finally, the glial pellet was resuspended in glial medium and grown in a 
T75 flask for at least 14 days in vitro (DIV) before sub-culturing.  
 
2.2.5.3 Sub-culturing rat glial cells 
Glial cultures were harvested for replating once cells reach approximately 80-90% 
confluence. Microglia contaminating these cultures were removed by a quick smack of the 
flask on a tabletop. The media was then removed, and the cells were washed with 10 mL 
HBSS per flask before incubating the cells for 5-10 min at 37 °C in 10 ml of 0.05% Trypsin 
with EDTA. After the addition of glial media (10 ml) to stop the reaction, glia cells were 
detached from the flask by pipetting the media up and down several times. Cells were 
collected in a 15 ml conical tube, centrifuged at 1000 g for 5 min at room temperature and 
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resuspended in glial media. The cells from one flask were split and transferred into thirty 60 
mm plates five days before hippocampal neuron preparation. 
 
2.2.5.4 Hippocampal neuronal culture preparation 
Hippocampal cultures were prepared using a modified Banker culture protocol (Banker 
and Goslin 1988; Tanaka 2002; Meberg and Miller 2003). Primary cultures of hippocampal 
neurons were prepared from embryonic E18-19 Sprague Dawley rats (Charles River). 
Pregnant rats were euthanize with CO2 as approved by the Stanford Administrative Panel on 
Laboratory Animal Care (APLAC), the IACUC at Stanford University, and the uterus was 
removed and placed in a sterile 100 mm Petri dish. The remaining steps were performed in a 
laminar flow hood. Ideally, hippocampal neurons were prepared on embryonic day 18 when 
the fetus was approximately 25 mm from crown to rump. From the heads of decapitated 
fetuses, the brain was removed and placed in calcium- and magnesium-free HBSS. Each 
hippocampi was removed under a dissection microscope. Meninges were stripped away, and 
the isolated hippocampi were placed in a 60 mm Petri dish in HBSS. Hippocampi (16 to 20 
hippocampi) were then transferred to a 15 ml centrifuge tube (Falcon) with 5 ml of TrypLE 
and incubated at 37 °C for 30 min. The trypsin was then removed, and the hippocampi were 
washed three times with 14 ml of HBSS plus 10 mM HEPES pH 7.4 for 5 min per wash. The 
final volume was brought to 3 ml. Cells were then dissociated by pipetting up and down, first 
with a normal Pasteur pipette and then with a fire polished pipette with a tip of nearly half the 
normal diameter (~1mm). Continuous pipetting was done until there was a homogenous 
single cell suspension. Cells were counted using a hemocytometer. Approximately 800,000 
cells are then added to a 100 mm dish containing 6 poly-L-lysine-treated coverslips in 10 ml 
of plating media. After 1 hr, coverslips with neurons attached were flipped over and 
transferred to 60 mm dishes containing glial cells in 4 ml of Neurobasal media. Our standard 
plating density was ~130,000 cells per coverslip. Note: the coverslips were turn over so that 
the neurons were facing down, towards the glial cells. After three days, 3 ml of medium was 
removed and replaced with 3 ml of fresh Neurobasal media and weekly thereafter. 
 
2.2.6 Gene transfer into cells  
2.2.6.1 Cell transfections with Lipofectamine 2000 
HEK293T, COS-7 and neuronal cells were transfected with Lipofectamine 2000 
(Invitrogen) as described by the manufacturer. Briefly, 15 µl of Lipofectamine 2000 was 
combined with 0.5 ml OptiMEM (Invitrogen) (solution A), and 10 µg of plasmid DNA with 
0.5 ml OptiMEM media (solution B). Solutions were incubated for at least 5 min at room 
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temperature before combining the solutions together. For complete complex formation, this 
mixture was incubated for at least 20 min at room temperature. Finally, the 1.0 ml 
transfection mixture was added to cells in 10 cm Petri dish in a “spiral” pattern, starting from 
the periphery of the plate towards the center of it. Experiments were performed 24 to 60 hrs 
after transfection. 
 
2.2.6.2 Cell transfections by electroporation 
Plasmids were also introduced into neurons using electroporation. Here, electroporation 
of a cell/plasmid suspension was conducted in Gene Pulser Cuvettes (Bio Rad Laboratories; 
0.4 cm gap width) with approximately 4x106 cells in 500 µl of glia-conditioned media and 40 
µg of plasmid using a Gene Pulser (Bio-Rad Laboratories) with the following settings: 0.250 
kV with Set High Capacitance 0.975 (µF*1000).  
 
2.2.6.3 Lentivirus production 
Lentivirus was produced by transfecting a three-plasmid vector system, comprised of a 
shuttle plasmid (e.g. FUGW or FUSyn::EGFPW) and two packaging plasmids pCMV∆ R8.9 
and pHCMV VSVg into HEK293T cells as described previously (Lois, Hong et al. 2002). In 
brief, HEK293T transfections were conducted on confluent (60 to 80%) cell cultures with 
Lipofectamine 2000 (Invitrogen), using 10 µg of 10 kb of shuttle vector, 7.5 µg of pCMV∆ 
R8.9 and 5 µg of pHCMV VSVg and 50 µl of Lipofectamine 2000 per 10 cm Petri dish. The 
media was changed 16 to 24 hr after transfection with Neurobasal media supplemented with 
B-27 and Glutamax and maintained at 32°C and 5% CO2 in an incubator. The virus-
containing medium was collected 48 to 56 hr post-transfection, passed through a 0.45 µm 
filter to remove cell debris, and frozen at −80 °C in a cryogenic container. The viral titer was 
determined by fluorescence analysis of infected HEK293T cells, the total number of cells 
infected correspond to infectivity unit (I.U). 
 
2.2.6.4 Lentivirus infection of neurons 
Lentiviral infection of culture hippocampal neurons was conducted after transferring 
neuron/coverslips into 60 mm dishes. Under these conditions, we routinely use 10 µl of 
undiluted high titer virus/dish to infect 20-30% of cells (for imaging experiments) and 100 
µl/dish to super-infect approximately 100% of cells (for all biochemical experiments). 
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2.2.7 Immunocytochemistry and electron microscopy  
2.2.7.1 Lorene’s fixative solution 
Paraformaldehyde was dissolved in H2O to create a 4% solution. To adjust the pH for 
improved solubility, a few drops of 10N NaOH was added while stirring and heating in the 
fume hood. Once dissolved, the solution was allowed to cool at room temperature. PIPES, 
HEPES, EGTA, MgCl2 and sucrose were all added, and the final solution was adjusted to a 
pH of 7.3-7.4. The solution was adjusted to the appropriate final volume with H2O and was 
frozen in aliquots at -20°C. For use, the solution was thawed at 37°C and used (do not 
refreeze).  
 
2.2.7.2 Immunohistochemistry 
Hippocampal neuronal cultures, grown for 5-21 DIV, were fixed with either Lorene’s 
fixative solution for 10 min or 100% ice-cold methanol for 20 min. Cells were then 
permeabilized with 0.5% Triton X-100 in 1X PBS solution for 5 min, washed in 1X PBS, 
incubated in blocking solution for 15 min at room temperature, and incubated overnight at 
4°C with primary antibodies diluted in blocking solution or for 2 hr at RT. Afterwards, cells 
are rinsed 3-4 times in 1X PBS, incubated for 1 hr at RT or at 4°C overnight with secondary 
antibodies in blocking solution, rinsed again 3-4 times in 1X PBS followed by a final rinse in 
deionized water, dried, and mounted in mounting solution (Vectashield). 
 
2.2.7.3 Image acquisition for immunocytochemistry 
Fluorescent images were acquired using a Zeiss Axiovert 200M microscope equipped 
with oil immersion 100× Plan-Neofluar (NA 1.3) or 40× Plan-Neofluar (NA 1.3) objectives 
(Zeiss) and the following filter sets BFP, FITC and Texas Red (Chroma, VT). Fluorescence 
images were acquired using OpenLab software (Molecular Devices) and a CCD-camera 
(Hamamatsu ORCA-ER; 1344 x 1022 resolution, 12 bits/pixel). Some images were acquired 
using a spinning disk confocal microscope (Perkin Elmer) built on a Axiovert 200M 
microscope (Zeiss) equipped with an argon/krypton laser (Melles Griot 43 series), using a 
63x Plan-Apochromat objective (NA 1.4), Photometrics Cascade 512B digital camera (Roper 
Scientific) and MetaMorph software (Molecular Devices). 
 
2.2.7.4 Electron microscopy of VAMP2-HRP expressing neurons 
Ultrastructural analysis of glutamatergic asymmetric synapses was performed on 
dissociated cultures of hippocampal neurons transfected by electroporation at the time of 
plating (e.g. with pZOff-VAMP2-HRP). Samples were fixed with 2.5% glutaraldehyde or 4% 
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formaldehyde/0.5% glutaraldehyde in 0.15 M cacodylate buffer for 1 hr and processed as 
described previously (Micheva and Smith 2005) with a few modifications. Following 
fixation, neurons were incubated with 1 mg/mL diaminobenzodine (DAB) in 50 mM Tris, pH 
7.5 for 10 min. 0.01% H2O2 (Sigma) was added to the solution for 30 min at room 
temperature to stimulate HRP-mediated DAB precipitation. After extensive washing, neurons 
were prepared for electron microscopy by a microwave irradiation protocol described 
previously in detail (Micheva, Buchanan et al. 2003). Following infiltration in Embed 812 
(EMS), glass coverslips were removed by dissolution in hydrofluoric acid. Ultrathin 60 nm 
sections were cut with an ultramicrotome (Ultracut UCT; Leica) and placed on copper grids. 
Samples were post-stained with 5% uranyl acetate dissolved in ultrapure water for 15 min 
followed by 4 min of staining in 0.2% lead citrate. Grids were extensively rinsed in water 
during and after post-staining. Samples were imaged with a JEM-1230 transmission electron 
microscope (JEOL, Peabody, MA) at 80 kV accelerated voltage using a Gatan (Pleasanton, 
CA) 791 CCD camera. All sample processing and electron microscopy were done in the Cell 
Sciences Imaging Facility at Stanford University. 
 
2.2.8 Live cell microscopy and analysis  
2.2.8.1 Live imaging of XFP-tagged synaptic proteins  
All live cell imaging experiments were performed on a custom-built (S. Smith and N. 
Ziv) laser scanning confocal microscope built on an Axiovert 100TV microscope (Zeiss) 
equipped with a 40x Plan Neofluar oil immersion objective (1.3 NA; Zeiss), 488 nm and 514 
nm lasers (Coherent; Sapphire 488-20CDRH and Compass 215M-20) or a custom-built (C. 
Garner) laser scanning confocal microscope built on an Axiovert 200M (Zeiss) equipped with 
a 40x objective (1.3 NA; Zeiss Plan Neofluar), 488-514 nm laser (Spectra-Physics). Both 
systems were driven by a custom-written acquisition software, OpenView (N. Ziv, Technion 
Institute, Haifa, Israel). Neuronal coverslips were mounted in a custom-built chamber 
designed for perfusion and electrical stimulation, heated to 37 °C by a forced air blower and 
perfused with Tyrode’s saline solution. 
 
2.2.8.2 FM loading/destaining of neuronal synapses 
Functional presynaptic boutons were labeled with FM4-64 or FM5-95 dye (Molecular 
Probes) by incubation in high K+ Tyrode’s solution containing 1 µg/ml FM dye (1.64 M of 
FM4-64 or 1.76 M of FM5-95) for 60 sec followed by normal Tyrode’s + FM dye for 30 sec. 
Neurons were then washed for 5 min before imaging. Destaining was performed by electrical 
stimulation at the following frequencies (10 Hz, 5 Hz, 2 Hz) and time intervals (180 sec, 90 
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sec, 30 sec) specified for each experiment or by perfusion of high K+ Tyrode’s solution for 
60 sec.  
To measure % FM colocalization with EGFP::SynIa clusters, the number of FM-
containing clusters were divided by the total number of EGFP::SynIa clusters and multiplied 
by 100. To calculate relative FM intensities at boutons containing or lacking Piccolo, FM 
intensity values for infected neurons were normalized against those from neighboring 
uninfected neurons in the same field of view, enabling cross-coverslip comparisons.  
For FM destaining experiments at 5 and 10 Hz, the total number of action potentials 
elicited and images acquired were kept constant. Thus, at 10 Hz stimulation, images were 
acquired every 5 sec for a total of 90 sec, while at 5 Hz they were acquired every 10 sec for a 
total of 180 sec. In all cases, intensity values for a given FM punctum at each time point were 
expressed as a % of its initial fluorescence intensity prior to destaining using the following 
equation: (FM intensity at a given time point t/initial FM intensity) x 100. For each condition 
(e.g. EGFP::Syn), intensity curves that did not exhibit FM destaining (i.e. values >90% for all 
time points) were eliminated from the analysis. Remaining curves were pooled, averaged, 
and plotted using Excel (Microsoft).   
 
2.2.8.3 Calculating the size of the readily releasable pool (RRP) of SV as well as 
neurotransmitter release probability (Pr)  
Boutons were loaded using high K+ Tyrode’s solution to label the total recycling pool 
(TRP) of SV/bouton. RRP release was induced with either by adding 500 mM sucrose (60 
sec) or low frequency electrical stimulation (2 Hz for 30 sec; RRP release). Total FM 
destaining was induced with high K+ stimulation for 60 sec (background). To calculate the 
RRP size, puncta intensity values were put into the following equation to express the RRP as 
a % of the TRP: [[(TRP label – background) – (RRP release – background)]/ (TRP label – 
background)] x 100. To calculate Pr, the TRP was loaded with FM5-95 using high K+ 
Tyrode’s solution, and release of the RRP was induced using 2 Hz for 30 sec electrical 
stimulation. During stimulation, images were acquired every 5 sec. Intensity values were 
expressed as % initial fluorescence intensity; those exhibiting minimal destaining (values 
>95% for all time points) were eliminated from the analysis, and remaining curves averaged 
and plotted as described above. 
 
2.2.8.4 Fluorescent recovery after photobleaching (FRAP) acquisition and analysis 
EGFP::SynIa or EGFP::SV2 puncta were bleached to approximately 20% of their initial 
fluorescence by a high intensity laser beam (488 nm wavelength). Images were taken 15 x 1 
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minute to monitor fluorescence recovery for EGFP::Syn1a, and 4 x 1 minute followed by 6 x 
5 min for EGFP::SV2. For each time point, intensity values were expressed as % starting 
fluorescence prior to bleaching. To control for non-specific photobleaching during image 
acquisition, intensity of bleached puncta were normalized against those of unbleached puncta 
for each time point, as described (Tsuriel, Geva et al. 2006), with the following equation: 
[(intensity of bleached Synapsin punctum at time t)/(average intensity of all unbleached 
puncta in field of view at time t)] x 100. To control for variability in the extent of bleaching 
for each puncta, values were further normalized, making zero the default value for bleached 
puncta and enabling us to pool and average all recovery curves for a given condition. Tau 
values were calculated using a custom macro written in Excel (N. Ziv; see (Tsuriel, Geva et 
al. 2006)).  
 
2.2.8.5 Defining EGFP::SynIa dispersion kinetics 
Dispersion of EGFP::Syn1a was induced by electrical stimulation (10 Hz, 90 sec), as 
previously described (Chi, Greengard et al. 2001). Puncta intensity values were expressed as 
% initial fluorescence intensity prior to stimulation. Curves for all EGFP::Syn1a puncta were 
combined for a given condition, averaged, and plotted. For this analysis, puncta that did not 
exhibit dispersion (% initial fluorescence values > 90 for all time points) were excluded. 
To compare extent of Synapsin dispersion to that of FM destaining, EGFP::Syn1a 
intensity was monitored during the 5 Hz destaining experiment (see FM destaining protocol 
above). 
To assess the role of CaMKIIα in Synapsin dispersion, coverslips were perfused with 
normal Tyrode’s solution containing 10 µM KN-62 (IC50= 0.9 µM)(Tocris) and incubated in 
the drug for 20 min prior to eliciting dispersion. EGFP::Syn1a intensity was monitored either 
prior to stimulation and every 5 sec during stimulation (for dispersion curves) or prior to 
stimulation and at the last time point (t=90 sec) (for bar graphs).  
FM5-95 destaining was also monitored after incubation with 10 µM KN-62. For this 
experiment, boutons were first loaded with FM5-95 using high K+ stimulation as described 
above. After waiting 15 min to allow for some recovery of EGFP::Syn1a after stimulation, 
cells were incubated for an additional 20 min in 10 µM KN-62. SV exocytosis was then 
elicited by 5 Hz stimulation for 180 sec, and both FM intensity and EGFP::Syn1a intensity 
were monitored over this time period (images taken every 10 sec). Destaining curves were 
then plotted as described above and compared with destaining curves from untreated 
coverslips of cultures infected with LV/EGFP::Syn1a or LV/EGFP::Syn1a/Pclo28. 
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2.2.8.6 Quantification of EGFP::SynIa dispersion and FM destaining kinetics 
As described previously (Chi et al., 2001), dispersion or destaining curves for 
EGFP::Syn1a or FM4-64 puncta were obtained using the equation: (F0-Ft)/Fo where Fo = 
initial fluorescence intensity prior to stimulation (obtained by averaging puncta intensities 
from 2 images taken 5 sec apart) and Ft = fluorescence intensity at each of the 18 time points 
t during stimulation, from t=5 to t=90 sec. Curves for each puncta in a field of view were 
pooled and averaged to give a single destaining curve per coverslip. Curves for individual 
puncta containing values > 0 for time points > 20 sec were eliminated from the analysis (to 
correct for imperfections in the puncta-tracking software).  
To calculate the average extent of EGFP::SynIa dispersion or FM4-64 destaining for each 
coverslip, the ΔF/Fo intensity values for the last five time points (t = 70-90 sec) were 
averaged to give avg Ft=70-90 (see Fig. S2). To express % increase in EGFP::SynIa 
dispersion or FM destaining for condition B (i.e. Pclo28 knockdown) vs. condition A (i.e. 
wild-type), both imaged on a given day, the following equation was used: [(avg Ft=70-90 (B) 
/ avg Ft=70-90 (A)) -1] x 100. Resulting data points were then plotted on a column graph, 
enabling comparisons between experiments performed in different batches of neurons. This 
measurement was used to compare phenotypes induced by pharmacological or genetic 
manipulation to the typical conditions observed in wild-type neurons.  
To express % decrease in dispersion or destaining for a coverslip of condition A (i.e. 
wild-type neurons) vs. condition B (i.e. Pclo28-expressing neurons), the same general 
strategy was used with the following equation: [1- (avg Ft=70-90 (A) / avg Ft=70-90 (B))] x 
100.  
 
2.2.8.7 Image analysis of live cell experiments  
Image analysis and quantification were performed with custom-written OpenView 
software (Noam Ziv) and Excel (Microsoft). GraphPad Prism (GraphPad software, Inc.) was 
used for curve fitting, graph plotting, and statistical analyses. 
                                                                                                                                          Results 
 48 
3. Results 
 
3.1 Optimization and characterization of cryopreserved astrocyte cultures 
and hippocampal neuronal cultures  
Dissociated hippocampal neuronal cultures remain the workhorse of many molecular and 
cellular neuroscience laboratories due to the fact that they are well characterized and 
currently serve as the best system for experimentation in living neurons. Low-density 
embryonic hippocampal neurons in the “Banker” style (Banker and Goslin 1988; Tanaka 
2002; Meberg and Miller 2003; Kaech and Banker 2006) offer a culture system that is 
amenable to cells manipulation, gene transfer, electrophysiology and biochemistry, for 
example. However, these types of cultures can be labor intensive and time consuming. 
Strategies that would allow both the expansion and preservation of astrocytes would reduced 
the need for extra animals and the weekly time commitment to dissect, dissociate, and culture 
these cells. Hovever, there are concerns that repeated passaging of astroglia led to alterations 
in cellular phenotypes, the overgrowth of macrophages and microglia and the inability of 
astroglia to support the growth and differentiation of hippocampal neurons. In an attempt to 
streamline this process, detailed optimization and characterization of both cryopreserved 
astrocytes and hippocampal neuronal cultures were done.  
 
3.1.1 Cryopreservation of glial cells 
For an initial characterization, astroglial cultures were frozen and thawed three times and 
then examined for their basic morphological features, including a large flat cell appearance, 
immunoreactivity for Glial Fibrilliary Acidic Protein (GFAP) and robust β-actin staining. No 
differences were seen in morphology, GFAP or β-actin staining between any of these cells 
even after the third freeze/thaw (Figure 3.1A). 
Contamination of astrocyte cultures with macrophages and microglia is a major concern 
that can adversely affect the growth of cultured hippocampal neurons. As previously reported 
(Banker and Goslin 1988), macrophage and microglia were found to increased in number in 
our cultures, as determined by morphology and appearance. Microglia were seen as round 
phase bright, loosely attached cells resting on top of the astroglial monolayer, while 
macrophages were identified by morphology. Intriguingly, these cells were readily removed 
or reduced by a quick smack of the flask on a flat surface prior to washing and replating. 
Only very few microglia were found in astroglial cultures after the second passage.  
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Fig. 3.1 Cryopreserved glia support the growth and differentiation of rat hippocampal 
neurons 
(A) Glia prepared from P1 rat cerebral cortex were frozen and then thawed 1-3 times before replating. 
Glial cells were grown on coverslips for 1 week prior to fixation in 4% PFA and immunostained with 
antibodies against β-actin (upper images; green; Alexa 488) or GFAP (lower images; green; Alexa 
488) and DAPI (blue). (B) Freshly prepared hippocampal neurons from E18 rats were plated on 
coverslips and grown in the presence of glia that had been frozen and thawed 1-3 times. Neurons were 
then fixed after 21 DIV and immunostained with antibodies against Piccolo (upper images; green; 
Alexa 488) or vGluT1 (lower images; green; Alexa 488) and MAP2a/b (red; Alexa 568).  Scale bars = 
10 µm. 
 
Next, cryopreserved astrocytes that had undergone three cycles of growth and 
cryopreservation were evaluated if they could support the growth and maturation of 
hippocampal neurons. Hippocampal neurons from E18 rats cultured in the presence of freshly 
prepared astrocytes grew and differentiated into mature cells with elaborate axon and 
dendritic arbors and extensive synaptic contacts (Figure 3.1B). Moreover, astroglia, grown 
and refrozen three times, also supported the survival of the neurons for 3-4 weeks with no 
visible differences in morphology and number of synapse per dendrite from freshly prepared 
glia (Figure 3.1B). 
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These results indicate that repeated freezing and passaging of astroglia prepared from the 
rat cortex does not adversely affect their ability to support the long-term survival (three 
week) and differentiation of co-cultures of dissociated rat hippocampal neurons. This 
suggests that cryopreservation can provide a significant savings in time and costs with 
respect to resources, animals, and glial cell production when taking these simple measures. 
 
3.1.2 Viability of cryopreserved dissociated hippocampal neurons 
A further improvement to streamline Banker style cultures would be the ability to 
cryopreserve dissociated hippocampal neurons. Although cryopreservation of hippocampal 
tissue has been achieved previously (Jensen, Sorensen et al. 1984; Sorensen, Jensen et al. 
1986), cryopreservation of dissociated hippocampal neurons has not yet been described. To 
this end, focus was placed on the type of cryomedia to improve neuronal viability. 
Traditional cryopreservation of cells and brain tissue typically uses a cryomedia of 
growth media and 10% dimethyl sulfoxide (DMSO) (Paynter 2008). Slow freezing of freshly 
prepared and dissociated neuron in Neurobasal media supplemented with B-27 and 
GlutaMAX failed to yield a significant number of viable cells that differentiated into neurons 
when cultured with fresh astroglia (Figure 3.2A). To improve hippocampal neuron viability, 
a cryopreservation media typically used for sensitive cell lines [recommended by AMB at 
UMBC (Applied Molecular Biology at University of Maryland, Baltimore County) and 
Atlanta Biologicals] consisting of 90% Fetal Bovine Serum (FBS) and 10% DMSO was 
tested. Greater than 60% of the neurons survived after being previously frozen in 90% 
FBS/10% DMSO and stored in liquid N2 for 9 months (Figure 3.2A).  
As neurons are generally vulnerable to glutamate toxicity, blockers of NMDA and 
AMPA receptors (10 µM APV and 50 µM CNQX, respectively) were added to the freezing 
media in an attempt to enhance the viability of frozen neurons. This manipulation failed to 
further improve viability of neurons frozen in 90% FBS/10% DMSO. Furthermore, 
hippocampal neurons frozen in a defined optimized serum substitute used in the culture 
neuronal culture media (B-27) with 10% DMSO with and without 10 µM APV and 50 µM 
CNQX both failed to significantly support the survival of frozen neuron (< 10% survival; 
Figure 3.2A). 
 
3.1.3 Morphological characterization of cryopreserved neurons 
In addition to cell viability, morphology and synapse formation are other important 
characteristics for experimental use of these cultures. In an initial set of experiments, 
hippocampal neurons frozen in 90% FBS/10% DMSO were studied for the number of 
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dendrites. Neurons were fixed after 5 to 6 DIV with 4% paraformaldehyde (PFA) and stained 
with antibodies against the dendritic microtubule protein MAP2a/b. Images revealed that 
freshly prepared and frozen neurons exhibited nearly identical neuronal morphologies (Figure 
3.2B). To confirm this conclusion, the total number of MAP2a/b positive primary dendritic 
process were quantified (Figure 3.2C) as well as the number of dendritic branches per cell 
(Figure 3.2D). No significant difference between neurons prepared freshly or frozen could be 
found for any of these parameters. 
             
Fig. 3.2 Viability of cryopreserved neurons and normal differentiation 
(A) The viability of fresh or cryopreserved neurons was analyzed by determining the number of 
cells/field of view with a 10x objective. Equal numbers of freshly prepared hippocampal neurons 
were either plated 1) directly or first frozen in 2) Neurobasal media supplemented with B27, 1X 
GlutaMAX and 10% DMSO, 3) 90% FBS and 10% DMSO; 4) 90% FBS and 10% DMSO plus 
CNQX/APV; 5) B27 media or 6) B27 media with CNQX/APV before plating.  After 14 DIV, the 
cells were fixed and the number of neurons/field of view was determined. (p < 0.0001, ANOVA; n = 
total number from 3 separate experiments, each experiment with 8 different coverslips and ~30 
different fields of view per coverslip. (B) Freshly prepared neurons and cryopreserved neurons plated 
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in the presence of glia, after 6 DIV cells were fixed and immunostained with antibodies against 
MAP2a/b. (C) Quantification of the number primary neurites of freshly plated and cryopreserved 
neurons. p < 0.0001, t-test; n=?. (D) Analysis of the number of branch points per neuron of freshly 
prepared and cryopreserved neurons. p < 0.0001, t-test, n = 5 separate experiments, each consisting of 
4 different coverslips with approximately 20 different cells per coverslip. Scale bars = 10 mm. Error 
bars are SEM. 
 
In a second set of experiments, cryopreserved neurons were examined for their ability to 
form synapses. Here neurons were grown for 14 DIV before fixing and staining with 
antibodies against MAP2a/b, the synaptic vesicle protein Synaptophysin and postsynaptic 
density protein Homer 1 (Figure 3.3A). Once again, neurons were observed to exhibit 
complex MAP2a/b positive dendritic arbors that resembled those from freshly plated 
neurons. Moreover, numerous Synaptophysin and Homer 1 positive puncta were found to 
colocalize and decorate these dendritic profiles (Figure 3.3A). Image analysis revealed that 
pre and postsynaptic markers colocalize to similar extents between freshly plated and 
cryopreserved neurons. These data indicate that neuronal cells that survive freezing in 90% 
FBS/10% DMSO are able to differentiate normally. 
 
3.1.4 Characterization of lentiviral use in cryopreserved neurons 
Since delivering recombinant molecules and/or short hairpin RNAs (shRNAs) into 
neurons with lentivirus is a critical method for studying the function of specific neuronal 
proteins at or near endogenous levels (Leal-Ortiz, Waites et al. 2008; Waites, Specht et al. 
2009; Torres, Barra et al. 2010; Hua, Leal-Ortiz et al. 2011; Waites, Leal-Ortiz et al. 2011) 
(see also section 3.2 below), particularly for this work, cryopreserved neurons frozen in 90% 
FBS/10% DMSO were infected with lentivirus pre and post thawing to determine whether 
this altered their viability and/or ability to differentiate. For comparison, neurons were 
infected with a lentivirus for EGFP expression in the following conditions: 1) freshly 
prepared neurons infected one day after plating; 2) frozen and thawed neurons infected one 
day after plating; and 3) neurons infected prior to freezing that were frozen and thawed. 
Neurons were fixed and analyzed after 6 DIV (Figure 3.3C). EGFP-positive neurons were 
detected in both axons and dendrites irrespective of the conditions (Figure 3.3C). 
In a second set of experiments, synapses formed between neurons that were infected 
either before or after being cryopreserved were analyzed. For these experiments, neurons 
were infected with an EGFP-tagged Synapsin1a (EGFP::Syn1a) to mark the presynaptic 
boutons of infected neurons. Neurons were maintained in culture for 16 DIV before fixation 
and were stained with antibodies against MAP2a/b to identify dendritic arbors and 
Synaptophysin to visualize synaptic vesicle clusters (Figure 3.3D). EGFP::Syn1a positive 
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puncta were detected situated on the spines of MAP2a/b-positive dendrites that also 
colocalized with Synaptophysin positive puncta. This pattern was observed irrespective of 
whether neurons were freshly prepared and infected one day after plating, frozen and infected 
one day after plating or infected before freezing (Figure 3.3D). 
           
Fig. 3.3 Synaptic contacts and lentiviral infections of cryopreserved hippocampal 
neurons 
Images of freshly prepared or cryopreserved neurons grown for 14 DIV before fixing in 4% PFA and 
immunostaining with antibodies against MAP2a/b (red; Alexa 568) and (A) Homer 1 (green; Alexa 
488) or (B) Synaptophysin (green; Alexa 488). Images reveal the presence of synapses along 
MAP2a/b-positive dendrites. (C) Freshly prepared or cryopreserved neurons infected with FUGW 
either on the day of plating or before freezing. After 6 DIV cells were fixed and immunostained with 
antibodies against MAP2a/b (red; Alexa 568). Soluble expressed EGFP (green) fills both axonal and 
dendritic processes. (D) Fluorescent images of freshly prepared or cryopreserved neurons infected 
with FU-EGFP::Syn1a-W either on the day of plating or before freezing. After 16 DIV, neurons were 
fixed and immunostained with antibodies against MAP2a/b (blue; Alexa 350) and Synaptophysin 
(red; Alexa 568). EGFP/Syn1a positive puncta (green) are seen to colocalize with Synaoptophysin 
puncta (red) along MAP2a/b positive dendrites (blue). Scale bars = 10 µm. 
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The identification of these EGFP-Syn1a puncta as synaptic was confirmed by 
immunostaining each of these cultures with antibodies against MAP2a/b and the postsynaptic 
dendritic spine protein Homer1 or the presynaptic active zone protein Piccolo (Figure 3.4A 
and 3.4C). Together, these data demonstrate that freezing freshly dissociated hippocampal 
neurons in 90% FBS/10% DMSO does not adversely affect their ability to be infected with 
lentivirus either before or after freezing, nor their ability to survive for more than 2 weeks in 
culture and differentiate into mature neurons (Figure 3.4B & D). 
               
Fig. 3.4 Infected cryopreserved neurons form normal numbers and functional synapses 
Fluorescent images of freshly prepared or cryopreserved neurons infected with FU-EGFP::Syn1a-W 
(green) on the day of plating. After 16 DIV, neurons were fixed and immunostained with antibodies 
against MAP2a/b (blue; Alexa 647) and (A) Homer 1 (red; Alexa 568) or (C) Piccolo (red; Alexa 
568).  Quantification reveals that over 80% of the EGFP::Syn1a puncta colocalize with (B) Homer1 
or (D) Piccolo (Pclo) puncta. (E) Fluorescent images of freshly prepared or cryopreserved 
hippocampal neurons infected with FU-EGFP::SV2-W (green) on the day of plating. After 14 DIV, 
infected neurons were mounted in an imaging chamber and stimulated with 90 mM KCl in the 
presence of FM4-64 (red). (F) Quantication of colocalization of EGFP::SV2 puncta (green) with 
FM4-64 (red) puncta. (p < 0.0001, t-test) n= 3 different experiments, each experiment 4 different 
coverslip and each coverslip ~10 different cells. Scale bars = 10 µm. Error bars are SEM. 
 
In a third set of experiments, cryogenic neurons infected with lentivirus were assessed for 
their functional properties by examining whether frozen neurons retained their capacity to 
recycle their SVs in an activity-dependent manner. Here, a 10 Hz 1 min stimulation protocol 
was used to load functional presynaptic boutons with the styryl dye FM4-64 (Leal-Ortiz, 
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Waites et al. 2008) of fresh or frozen neurons infected with EGFP::SV2 grown for 14 DIV. A 
high percentage of EGFP::SV2 puncta (>90) was found to colocalize with FM4-64 recycling 
sites (Figure 3.4E). Quantification of these data revealed that the fraction of EGFP::SV2 sites 
capable of recycling FM4-64 was nearly identical whether fresh neurons were infected one 
day after plating, frozen and infected one day after plating or infected before freezing (Figure 
3.4F). No statistical difference was found between the different two conditions. 
 
3.1.5 Electrophysiological characterization of cryopreserved neurons 
Finally, intrinsic and synaptic electrophysiological properties, including excitatory 
postsynaptic current (EPSC) amplitude and frequency, were assessed for both fresh and 
cryopreserved neurons in collaboration with Julia Brill at Stanford University. Fresh and 
cryopreserved neurons showed no difference in input resistance (fresh: 242 =/- 40 MΩ, n=8; 
frozen: 215 +/- 27 MΩ, n=17) and resting membrane potential (fresh: -56.0 +/- 1.6 mV, n=8; 
frozen: -54.8 +/- 1.1 mV, n=16). However, cryopreserved neurons showed a significantly 
smaller capacitance (fresh: 40.6 +/- 4.1 pF, n=8; frozen: 29.5 +/- 2.3 pF, n=17;  p < 0.05) 
than control freshly prepared neurons. Fresh and cryopreserved neurons had similar 
responses to hyperpolarizing and depolarizing current injections (-100 to +250 pA in 25 pA 
increments), as seen in representative traces from a control (black trace) and a cryopreserved 
(red trace) neuron (Figure 3.5A). No significant differences in input/output curves, i.e the 
number of action potentials generated in response to depolarizing current steps, were found 
between 5 control and 15 cryopreserved neurons (Figure 3.5B). This shows that 
cryopreserved neurons do not differ from control neurons in terms of expression of ion 
channels (mainly sodium and potassium). 
To confirm whether cryopreserved neurons formed functional synapses onto each other, 
we recorded spontaneous excitatory postsynaptic potentials (EPSCs) in voltage clamp mode. 
Representative recordings of spontaneous activity in a control and a previously frozen neuron 
held at a membrane potential of -60 mV it is shown in Figure 3.5C.  Spontaneous EPSC 
parameters amplitude, rise time, half width and frequency were analyzed in 4 control and 7 
cryopreserve neurons, no significant differences in amplitude, kinetics and frequency of 
events were found (Figure 3.5D). This indicates that cryopreserved and control neurons form 
similar numbers of functional excitatory synapses and that those synapses have 
indistinguishable properties. In summary, we found no different between fresh and 
cryopreserve cells, which demonstrated that our cryopreservation methodology do not affect 
the electrical properties of neurons. 
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Fig. 3.5 Cryopreserved hippocampal neurons exhibit normal electrophysiological 
properties 
Intrinsic and synaptic properties of fresh and frozen neurons grown for 14DIV. Data is shown as 
average +/- standard error (number of cells). (A) Current clamp recordings show similar responses of 
fresh (black trace) and cryopreserved neurons (red trace) to hyperpolarizing and depolarizing current 
injections (-100 pA, +200 pA). (B) Input/output curves. Number of action potentials generated in 
response to hyperpolarizing and depolarizing current injections. No significant differences between 
control (n=5) and previously frozen neurons (n=15) were detected. (C) Representative voltage clamp 
recordings of spontaneous activity in a control and a previously frozen neuron held at -60 mV. 
Downward deflections are spontaneous EPSCs, demonstrating the presence of functional synapses 
between the cultured neurons. Expanded traces at bottom show individual EPSCs. (D) Summary of 
spontaneous EPSC parameters in 4 control and 7 previously frozen neurons. There were no significant 
differences in amplitude, kinetics and frequency of events. (Data collected by Julia Brill) All the 
data is shown as average +/- standard error (number of cells). 
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3.2 Development of vectors for the effective expression of recombinant 
protein and shRNA in cultured hippocampal neurons 
The true strength of cellular science is the ability to monitor changes in the dynamics and 
function of individual molecules in real time. Challenges associated with the delivery of 
recombinant molecules, near endogenous levels, to neuronal cells have greatly hampered our 
understanding of the cellular mechanisms underlying synapse formation and synaptic 
transmission. To overcome these limitations, I have developed both plasmid and viral system 
that allow for the efficient delivery and expression of recombinant XFP-tagged proteins 
and/or shRNAs into neurons. The results presented below describe the evolution of these 
vectors and their utility as tools to study the cellular dynamics of proteins as well as the 
contribution of individual molecules to neuronal function. 
 
3.2.1 Custom design of a short hairpin RNA expression vector for the efficient 
knockdown of multiple synaptic proteins 
The study of presynaptic boutons is an exceptionally challenging problem for cell-
biologist as they can form 100um away from the cell soma. To overcome this limitation and 
allow investigators to the assessment the impact of shRNA mediated knockdown on 
presynaptic function, a set of vectors were developed to assess the effectiveness of both 
plasmids and lentiviral vectors to deliver both presynaptic reporter molecules and multiple 
shRNA expression cassettes in one vector. To this end, a plasmid-based vector was initially 
created that contains an shRNA expression system, an shRNA target mRNA/protein reporter, 
as well as a reporter that is insensitive to shRNA-mediated knockdown. Elements from 
different plasmids were combined to form a new plasmid named “pZoff” (Figure 3.6A-C). 
This new vector contains an EGFP expression cassette including the CMV promoter, EGFP 
and multicloning site (MCS) (CMV-EGFP-MCS) from the “Clontech” vector pEGFP-C1. 
The neomycin/kanamycin-resistant gene was also included to allow for antibiotic selection in 
both prokaryotic and eukaryotic cells. Antibodies against the neomycin resistance gene 
product in eukaryotic cells provide a constitutively active reporter that can be used to 
normalize transfection efficiency in cellular lysates. Moreover, by creating a fusion protein 
between a target gene sequence (X) and EGFP (EGFP-X), one can use antibodies to EGFP to 
monitor changes of target protein expression levels. Finally, the polymerase III H1 or U6 
cassettes from pSuper plasmid with multicloning sequence were introduced into this plasmid 
allowing any target shRNA to be cloned via a pair of oligonucleotides into the BglII and 
HindIII sites (Figure 3.6D, E). 
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3.2.2 Design of shRNAs for selective and efficient knockdown of Piccolo and Bassoon 
The utility of the PZoff vector was initially explored in experiments to assess the 
effectiveness of shRNAs to efficiently knockdown the expression of Bassoon and Piccolo 
isoforms in cultured hippocampal neurons. This was accomplished by generating several 
shRNAs against sequences situated in the N-terminus of Bassoon and Piccolo (Figure 3.7A) 
(tom Dieck, Sanmarti-Vila et al. 1998; Fenster and Garner 2002). This region has been 
shown to encode segments of both high (Figure 3.7A) and low molecular weight isoforms of 
Bassoon and Piccolo (Cases-Langhoff, Voss et al. 1996; Fenster, Chung et al. 2000; Zhai, 
Olias et al. 2000; Fenster and Garner 2002)(see also Figure 3.28D). 
    
Fig. 3.6 Schematic flow diagram used to create the pZoff shRNA expression vector 
(A) Plasmid map of pSuper (Addgene) revealing relative position of the Polymerase III promoter H1, 
the multicloning site (MCS) for shRNA as well as Ampicillin resistant gene. (B) Graphical 
representation of how short hairpin RNAs (shRNAs) were synthesized and processed following 
transcription. (C) Schematic diagram of the pEGFP-C1 vector (Clontech), which expresses EGFP and 
a Kanamycin resistant gene. (D) Schematic diagram of the pZOff-1.0 H1 plasmid, which contains the 
H1-shRNA expression cassette and the CMV-EGFP minigene. (E) Schematic diagram of pZoff-2.0, 
which is identical to pZOff-1.0 except the H1-shRNA expression cassette was replaced with an 
alternative polymerase III promoter U6.  
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Each target sequence was selected using a program called “super RNAi” 
(Mekentosj.com). This program determines shRNAs that contain approximately 50% GC 
content and a low ΔG at the 3’ and/or 5’ end of each oligo. It also allows the inclusion of 
BglII and HindIII linker sequences at the 5’ and 3’ of these oligos, respectively, and a loop 
linking the two complementary 21 nucleotide segments as well as a 3’ polymerase III 
termination signal comprised of five thymidines (T5) (Figure 3.7B). For these N-terminal 
sequences, the program selected two shRNA for Piccolo (called Pclo6 & Pclo28) and one for 
Bassoon (Bsn16). Each was subcloned into the pZoff 1.0 H1 vector with BglII and HindIII 
thereby generating three new plasmids called pZoff-Pclo6, pZoff-Pclo28 and pZoff-Bsn16 
(Figure 3.7A). 
         
Fig. 3.7 shRNA mediated knock down of EGFP-Piccolo 
 (A) Schematic diagram of Piccolo and Bassoon, illustrating their multidomain structure. Highlighted 
are the polyglutamate (pQ) region, two double zinc finger domains (Zn1/2), three coiled-coil domains 
(CC1-3), PDZ domain, and two C-terminal C2 domains (C2A/B) in these proteins. Also shown are 
the locations and sequences of shRNAs generated against Piccolo and Bassoon. These include Pclo6, 
Pclo28, Bsn16 and a scrambled control Pclo28SC and Bsn16SC. (B) Schematic diagram of the 
pZOff-plasmid expressing an N-terminal segment of Piccolo (nucleotides 1-700) fused to EGFP 
(EGFP::Pclo) and the shRNA against Piccolo (Pclo28) (pZoff/EGFP::Pclo/H1-Pclo28). (C) Western 
blots of cellular extracts from COS7 cells transfected with pZoff plasmids expressing a 700 bp N-
terminal fragment of Piccolo (pZoff/EGFP::Pclo) and shRNAs against either Piccolo (Pclo28 or 
Pclo28SC) checking the efficiency of Pclo28 using EGFP antibody. (D) Western blots of cellular 
extracts from COS7 cells transfected with pZOff plasmids expressing a 900 bp N-terminal fragment 
of Bassoon (pZoff/EGFP::Bsn) and shRNAs against either Piccolo (Pclo28 or Pclo28SC) checking 
the specificity of Pclo28 using EGFP antibody. (E) Western blots of cellular extracts from COS7 cells 
transfected with pZoff/EGFP::Bsn or pZoff/EGFP:: Pclo and shRNAs against either Piccolo (Pclo28 
or Pclo28SC) checking the normalization of protein using Neomycin antibody. 
 
3.2.3 Assessment of shRNAs for selective and efficient knockdown of Piccolo and 
Bassoon 
To assess the effectiveness of these shRNAs, a reporter system was designed in which the 
N-terminal segment of Piccolo, containing the Pclo28 target sequence, was fused in-frame 
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with the C-terminal end of EGFP in the pZoff-Pclo28 vector, creating pZoff/EGFP-N-
Pclo/H1-Pclo28. As a control, the Pclo28 shRNA sequence was scrambled, such that it would 
no longer hybridize with the Piccolo mRNA (Pclo28SC), yet would still form a stable 
hairpin, creating pZoff/EGFP-N-Pclo/H1-Pclo28SC. As an initial evaluation of specificity, 
two additional pZoff vectors were created that expressed an N-terminal segment of Bassoon 
fused to EGFP and either Pclo28 (pZoff/EGFP-N-Bsn/H1-Pclo28) or Pclo28SC 
(pZoff/EGFP-N-Bsn/H1-Pclo28SC). Each of these vectors were then used to transfect 
HEK293 cells and the cellular lysates were run out on an SDS-PAGE gel, transferred to 
nitrocellulose and probed with antibodies against EGFP and neomycin (Figure 3.7C-E). 
[Note: the pZoff vector also expresses the neomycin resistance gene. These levels were used 
to normalize expression levels between experiments (Figure 3.7E)]. As shown in Figure 7C, 
Pclo28 caused the selective down-regulation of EGFP-N-Pclo but not EGFP-N-Bsn (Figure 
3.7D). Pclo28SC had no effect on the expression of either EGFP-fusion protein (Figure 
3.7C). These data suggest that Pclo28 could be an effective reagent to selectively down-
regulate the expression of Piccolo. They also nicely illustrate the utility of the pZoff vector 
system for exploring the potential utility of different shRNAs. 
Next, we evaluated whether shRNAs generated against Piccolo and Bassoon could also 
knockdown the expression of endogenous Piccolo and Bassoon. As discussed in the 
introduction, Piccolo and Bassoon are large structural proteins of presynaptic active zones 
accumulating at nascent synapses as they form. In cultured hippocampal neurons, both are 
expressed at the earliest stages of neuronal differentiation and begin to accumulate at nascent 
presynaptic boutons around 7 days in vitro (DIV). Both are also present at mature synapses in 
vivo and in vitro (Cases-Langhoff, Voss et al. 1996; tom Dieck, Sanmarti-Vila et al. 1998; 
Fenster, Chung et al. 2000; Garner, Kindler et al. 2000; Gundelfinger and tom Dieck 2000; 
Dresbach, Qualmann et al. 2001; Zhai, Vardinon-Friedman et al. 2001; Fenster and Garner 
2002). 
A major challenge with studying the expression and function of these presynaptic 
proteins is that axons extend hundreds of microns from the cell soma forming synapses on 
hundreds of target neurons. Thus, identifying the boutons of a small subset of transfected 
neurons even in dissociated cultures is a daunting task. To address this problem, pZoff vector 
was modified to express a recombinant EGFP-tagged presynaptic protein. In initial 
experiments, utility of Synapsin1a, a presynaptic vesicle-associated protein, as such a 
reporter was examined. Here, EGFP in the pZoff vector was replaced with EGFP-tagged 
Synapsin1a (EGFP–SynIa). As reported previously (Chi, Greengard et al. 2001; Chi, 
Greengard et al. 2003), presynaptic boutons of neurons transfected with pZoff-EGFP-SynIa 
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were easily identifiable, exhibiting a punctate pattern along the dendrites of fixed and 
immunostained untransfected cells that colocalized with other pre- and postsynaptic markers 
(Figure 3.8A). 
                 
Fig. 3.8 shRNA-mediated knockdown of Piccolo and Bassoon with the pZoff vector in 
cultured hippocampal neurons 
(A) Fluorescent images of hippocampal neurons transfected with either pZOff/EGFP::Syn1a, 
pZOff/EGFP::Syn1a/Pclo6, pZOff/EGFP::Syn1a/Pclo28 or pZOff/EGFP::Syn1a/Bsn16 plasmids. 
After 14DIV, neurons were fixed and immunostained with antibodies against MAP2a/b (blue) and 
Piccolo (top panels; red) or Bassoon (bottom panels; red). Note Piccolo immunofluorescence is absent 
at EGFP::Syn1a (green) puncta in neurons expressing Pclo6 and Pclo28 but not Bsn16. Conversely, 
Bassoon immunoreactivity is only lacking from Bsn16-expressing presynaptic boutons. (B) 
Quantification of % colocalization of Piccolo immunoreactive puncta and EGFP::Syn1a puncta along 
dendritic profiles. (C) Quantification of % colocalization of Bassoon immunoreactive puncta and 
EGFP::Syn1a puncta along dendritic profiles. 
 
To explore whether shRNAs against Piccolo and Bassoon efficiently knockdown the 
expression of these AZ proteins, cultured hippocampal neurons were transfect by 
electroporation at the day of plating with vectors expressing EGFP::SynIa and each of the 
Piccolo/Bassoon shRNAs (pZoff-EGFP::SynIa/Pclo6, pZoff-EGFP::SynIa/Pclo28 or pZoff-
EGFP::SynIa/Bsn16). Neuronal cultures were then fixed in 4% PFA at 14 to 18 DIV, and 
immunostained with antibodies against MAP2a/b and Piccolo or Bassoon. As seen in Figure 
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3.8A, selective loss of Piccolo immunoreactivity was observed in EGFP::SynIa positive 
boutons from cells expressing Pclo6 or Pclo28 and Bassoon immunoreactivity in neurons 
expressing Bsn16. Quantifying these data revealed that nearly 95% of all EGFP::SynIa 
positive puncta lacked either Piccolo or Bassoon immunoreactivity, respectively (Figure 
3.8B, C). No change in the expression of these AZ proteins was seen in neurons only 
expressing EGFP::SynIa. 
In summary, these pZoff vectors not only allow for the efficient knockdown of neuronal 
proteins, e.g. the presynaptic AZ proteins Piccolo and Bassoon, but also permits the 
quantification of knockdown efficiency in heterologous cells or within neuronal 
microdomains, such as presynaptic boutons. Utilizing these vectors, specific shRNA were 
developed that efficiently knockdown the expression of two structurally related presynaptic 
active zone proteins, Piccolo and Bassoon.  
 
3.2.4 Harnessing viruses for the efficient expression of shRNAs and recombinant 
proteins in cultured neuronal cells 
Although the pZoff vector system readily supports the cell-autonomous elimination of 
proteins, in general the poor efficiency of plasmid-based transfection systems limits the 
utility of this strategy to explore more global changes in protein or mRNA expression. 
Moreover, plasmid-based systems are prone to overexpression artifacts and often create pools 
of soluble recombinant proteins that mask the normal distribution and/or drives these 
molecules into inappropriate membrane compartments protein complexes. To overcome these 
problems, alternatives like lentivirus were explored that allowed for lower expression and 
higher efficiency of gene transfer into neurons. 
 
3.2.5 Expressing recombinant proteins at endogenous levels with lentivirus 
In general for the expression of a single recombinant protein, a lentiviral backbone was 
used that was based on a self-inactivating vector FUGW (Figure 3.9A, D & F). This 
lentivirus vector was engineered to contain a human ubiquitin-C promoter driving the GFP 
reporter gene (Schmidt, Christoph et al. 1990; Niwa, Yamamura et al. 1991; Schorpp, Jager 
et al. 1996). To increase transcription levels, the woodchuck hepatitis virus 
posttranscriptional regulatory element (WRE) was inserted downstream of GFP (Zufferey, 
Donello et al. 1999). To increase viral titers, the human immunodeficiency virus–1 (HIV-1) 
flap element (Zennou, Petit et al. 2000) was inserted between the 5’ long terminal repeat 
(LTR) to generate the viral vector called FUGW (Lois, Hong et al. 2002) (Figure 3.9A, D & 
F). To test this, one of the first vectors created was for the expression of EGFP-SynIa (FU 
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EGFP::Syn1a-W)(Figure 3.9A). High-titer lentiviruses were made and found to infect over 
50% of the 80,000 cells with only 25 to 50 µl of virus harvested from the supernatant. Cells 
were infected the same day after plating, grown for 14 DIV, fixed and stained with the 
Synapsin antibodies (Figure 3.9B). No significant overexpression of Synapsin1a per bouton 
was found, indicating that the FU-EGFP::SynIa-W vector resulted in EGFP-Syn1a 
expression at levels that allowed neurons to maintain expression near the endogenous level of 
Synapsin within a presynaptic bouton (Figure 3.9C).  
             
Fig. 3.9 Lentiviral expression of EGFP::SynIa at endogenous levels and schematic 
diagram of the lentiviral vector (FUGW) used to express XFP-tagged proteins and 
shRNA 
(A) Schematic diagram of EGFP-Synapsin1a in a lentiviral expression vector. (B) Fluorescent images 
of hippocampal neurons infected with FU-EGFP::Syn1a-W (green) on the day of plating. After 14 
DIV, neurons were fixed and immunostained with an antibody to Synapsin1a (red). (C) Quantitation 
of the intensity of Synapsin1a immunoreactivity at boutons with or without EGFP::Syn1a. Total 
Synapsin1a levels were similar for infected and uninfected neurons, indicating that lentiviruses 
express recombinant proteins does not drive Synapsin1 expression above endogenous levels. SEM 
bars plotted (n > 100 puncta/condition). (D) Schematic diagram of the FUGW vector which contains a 
CMV enhancer, 5’ and 3’ LTR’s, HIV RRE, Flap, UbiquitinC promoter, EGFP coding sequence, 
WRE element and the ampicillin resistant gene. (E) Schematic diagram of the shRNA expression 
cassette and insertion of this element between the Flap and Ubiquitin promoter in FUGW. (F) The 
resulting FUGW-H1 expression vector, which can be used to express both shRNAs and different XFP 
tagged proteins such as EGFP::Syn1a or EGFP-SV2 under the Ubiquitin-C promoter.  
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3.2.6 Development of bicistronic lentiviral vectors for the down-regulation of 
presynaptic proteins 
For expression of interference RNAs in a lentiviral vector, the H1 promoter cassette was 
introduced upstream of the Ubiquitin C promoter in the FUGW vector. This new vector, 
called FUGW H1 (Figure 3.9F), was further modified to allow for the insertion of different 
shRNAs by subcloning the shRNA fragments from the pZoff plasmids, such as Pclo28, Pclo6 
and Bsn16. These new plasmids (called FUGW Pclo28, FUGW Pclo6 and FUGW Bsn16, 
respectively) contained a specific shRNA of interest and EGFP to identify infected cells. To 
monitor the effects of Piccolo and Bassoon down-regulation on presynaptic bouton function, 
EGFP was replaced with different XFP-tagged presynaptic proteins. For example, in one set 
of vectors, EGFP::SynIa (Figure 3.9A)(Chi, Greengard et al. 2001; Chi, Greengard et al. 
2003) was inserted into each of these vectors, creating LV/EGFP::SynIa, 
LV/EGFP::SynIa/Pclo6 LV/EGFP::SynIa/Pclo28 LV/EGFP::SynIa/Bsn16 (Figure 3.10A) 
(LV for lentivirus vector FU(tag)W).  
         
Fig. 3.10 Lentivirus-mediated knockdown of Piccolo with interference RNAs 
Schematic diagram of LV/EGFP::Syn1a/Pclo28 lentiviral expression vector. (B) Fluorescent images 
of hippocampal neurons infected with LV/EGFP::SynIa, LV/EGFP-SynIa/Pclo6, 
LV/EGF::SynIa/Pclo28 LV/EGFP::SynIa/Bsn16 on the day of plating. After 14 DIV, neurons were 
fixed and immunostained with antibodies against MAP2 (blue, merged) and Piccolo (red). Only a 
fraction of presynaptic boutons express EGFP::SynIa; the remaining Piccolo immunoreactivity seen is 
from the boutons of uninfected neurons (merged). Scale bars = 10 µm. (C) Quantification of the 
percent colocalization of EGFP-SynIa puncta with Piccolo immunoreactive puncta situated along 
MAP2 positive dendritic profiles (n>2000 puncta/condition, 5 expts). Error bars show SEM.  
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Virus prepared from these plasmids were used to infect neurons on the day of plating (0 
DIV). After 14 DIV, neurons were fixed with 4% PFA and immunostained with antibodies 
against MAP2a/b and Piccolo or Bassoon. In neurons expressing shRNAs for Pclo28, Pclo6 
or Bsn16, over 95% of EGFP::SynIa positive puncta lacked Piccolo or Bassoon, respectively 
(Figure 3.10B, C). As Pclo28 produced a slightly better down-regulation of Piccolo 
compared of Pclo6, the majority of the subsequent experiments used the Pclo28 shRNA 
(Figure 3.11A, B). To assess the specificity of these shRNA, we evaluated whether Piccolo or 
Bassoon levels were altered in neurons expressing Bsn16 or Pclo28, respectively. Synaptic 
levels of Piccolo and Bassoon were identical to control (e.g. the boutons of uninfected 
neurons), suggesting that our shRNA are highly specific for their corresponding proteins 
(Figure 3.10B,C & 3.11A,B) 
             
Fig. 3.11 Lentivirus-mediated knockdown of Piccolo and Bassoon 
(A) Fluorescent images of hippocampal neurons infected with LV/EGFP::SynIa, 
LV/EGFP::SynIa/Pclo28, LV/EGFP::SynIa/Bsn16 on the day of plating. After 14 DIV, neurons were 
fixed and immunostained with antibodies against MAP2a/b (blue, merged) and Bassoon (red). Only a 
fraction of presynaptic boutons expressed EGFP::Syn. The remaining Bassoon immunoreactivity seen 
in LV/EGFP::SynIa/Bsn16 (lower panel) was from the boutons of uninfected neurons. Scale bars = 10 
µm. (B) Quantification of colocalization of EGFP::Syn1a puncta with Bassoon puncta along MAP2 
positive dendritic profiles (n > 2000 puncta/condition, 5 expts). Error bars show SEM. (C) Western 
blots of cellular lysates from hippocampal neurons uninfected or infected with LV/EGFP::SynIa 
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LV/EGFP::SynIa/Pclo28 or LV/EGFP::SynIa/Bsn16 on the day of plating. Lysates were harvested at 
14 DIV, and blots were probed with antibodies against Piccolo, Bassoon, Tubulin, Synaptophysin 
(Syph), and EGFP for EGFP::Syn. Protein molecular weights are indicated (right).  
 
To directly monitor changes in proteins levels over time, neurons were grown in flasks 
(T-25) and infected to near 100% with one of three viruses (LV/EGFP::SynIa, 
LV/EGFP::SynIa/Pclo28 and LV/EGFP::SynIa/Bsn16) on the day of plating (0 DIV). After 
14 DIV cellular lysates were collected, Western blotted and probed with antibodies against 
Piccolo, Bassoon and Tubulin. The latter was used as a loading control. These data revealed 
that Pclo28 or Bsn16 caused a greater than 90% down-regulation Piccolo and Bassoon levels, 
respectively. Importantly, neither shRNA affected the expression of synaptic vesicle proteins, 
Synaptophysin or Tubulin, (Figure 3.11C). 
 
3.2.7 Design of a tricistronic lentiviral vector for the down-regulation of multiple 
synaptic proteins 
Due to potential redundancies in Piccolo and Bassoon function, the elimination of both 
proteins in the same cell would be particularly advantageous. While this can be achieved by 
infecting two different bicistronic lentiviral vectors expressing different XFP-reporters and 
shRNAs, technical challenges associated with co-infection, the used of multiple fluorophores 
and/or identifying co-expressing cells limits the utility of this strategy. Therefore, a new 
tricistronic lentiviral vector was developed to place multiple shRNAs within the same 
reporter vector. Starting with the bicistronic vector expressing FUGW/Pclo28, a new cassette 
expressing the shRNA for Bassoon (Bsn16) driven by the H1 polymerase III promoter was 
inserted in different positions and orientations (Figure 3.12A). 
These custom-designed lentiviral expression vectors allow for high rates of gene transfer 
to a population of neurons for expression of recombinant protein encoded by cDNAs up to 
4000 base pairs. Moreover, by introducing the H1 polymerase III cassette, shRNAs can be 
co-expressed in these vectors leading to the efficient and specific down-regulation of 
neuronal proteins, such as Piccolo or Bassoon. Down-regulation of both Piccolo and Bassoon 
expression was seen when plasmid versions were electroporated into hippocampal neurons 
on the day of plating. However, it was not possible to generate lentiviruses from these vectors 
(Figure 3.12A, B). 
One likely explanation was that virus production is adversely affected by the presence of 
repetitive sequence elements (e.g. two H1 promoter sequences) between the LTRs. To 
explore this possibility, we created a second-generation FUGW/DKD vector 
(LV/EGFP/DKD) in which the Bsn16 shRNA was driven by the U6 polymerase III promoter 
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(Figure 3.12C). In parallel, a control vector FUGW/SC (LV/EGFP/SC) was created with the 
same structural organization as FUGW/DKD 2.0 yet expressed scrambled versions of the 
Pclo28 (Pclo28SC) and Bsn16 (Bsn16SC) that retain their ability to form shRNAs (Figure 
3.12D). High-titer lentivirus production was successful from these new constructs (e.g., 50 to 
75 µl of virus infected more than 90% of the 80,000 neurons plated on one coverslip). 
 
Fig. 3.12 Schematic diagrams of double knockdown vectors 
A) Schematic diagram of a vector contain two different shRNA expression cassette which includes 
the polymerase III promoter H1 and U6 and different spacer size in between of two pol. III promoter 
(B) Table showing which vector can produce down-regulation of Piccolo and Bassoon. (C) 
LV/EGFP/DKD vector. (D) LV/EGFP/SC.  
 
To study the potential for these lentiviruses for biochemical experiments, high titer 
LV/EGFP/DKD or LV/EGFP/SC lentivirus was used to infect a population of (~500,000 
neurons) near 100%. Protein lysates from neurons 14 DIV were then probed for Piccolo, 
Bassoon or Tubulin (Figure 3.13A). Quantification and normalization to Tubulin revealed 
that the levels of Piccolo and Bassoon in LV/EGFP/SC versus uninfected cells lysates were 
not different. In contrast, there was a greater than 90% knockdown of Piccolo and Bassoon 
expression in neurons infected with LV/EGFP/DKD (Figure 3.13B). This level of down-
regulation was similar to neurons infected with single knockdown vectors (FUGW/Bsn16 or 
FUGW/Pclo28). 
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Fig. 3.13 Western analysis of Piccolo and Bassoon double knockdown (DKD). 
(A) Western blots of cellular lysates prepared from rat hippocampal neurons infected on the day of 
plating with lentiviruses expressing soluble EGFP together with shRNAs against Piccolo and Bassoon 
(LV/EGFP/DKD) (H1 Pclo28 and U6 Bsn16 or scrambled controls for each shRNA (LV/EGFP/SC) 
(H1 Pclo28SC and U6 Bsn16SC). After 14 DIV, lysates from uninfected cells or those infected with 
LV/EGFP/SC or LV/EGFP/DKD were harvested and probed with antibodies against Piccolo, 
Bassoon, or Tubulin as indicated. Note that immunoreactivity for Piccolo and Bassoon is nearly 
absent from EGFP/DKD-infected lysates. (B) Quantification of Piccolo or Bassoon normalized to 
tubulin (n=3 expts.). Error bars show SEM. 
 
Taken together, these data reveal that lentiviruses hold a great deal of utility not only to 
express various recombinant proteins but also shRNAs. They should allow molecules to be 
expressed near endogenous levels and support the expression of multiple shRNA, as long as 
repeat sequence elements, which can cause recombination events, are not included between 
the two LTRs. Furthermore, a tricistronic vector was developed that not only supported the 
double knockdown (DKD) of Piccolo and Bassoon but also included reporter proteins that 
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permitted the identification of boutons from neurons lacking these proteins in a cell 
autonomous and synapse-specific manner. 
 
3.2.8 Expressing full-length Bassoon for rescue experiments using a helper-dependent 
adenoviral vector (HDAd) 
Due to the packaging limit of lentiviruses, gene transfer of large molecules, such as 
Bassoon (~12,000 bp), is not viable using this type of approach. Therefore, for rescue 
experiments with full-length Bassoon, helper-dependent adenoviral vectors (HDAd) were 
utilized that permit a cloning capacity of up to 37 kb (Palmer and Ng, 2008; Palmer and Ng, 
2011). Thus with the goal of rescuing of the Piccolo/Bassoon double knockdown (DKD) 
phenotypes, we designed and built an HDAd vector that expressed full-length mRFP-tagged 
Bassoon (HDAd mRFP-Bsn SM16) (Figure 3.14A). To allow this recombinant Bassoon to be 
resistant to our shRNA Bsn16, silent point mutations were placed in the sequence of Bassoon 
to prevent Bsn16 targeted destruction. A helper-dependent, non-replicating adenovirus was 
produced by the Ng Lab (Department of Molecular and Human Genetics, Baylor College of 
Medicine, Houston, Texas), which enabled the efficient (>40%) infection of hippocampal 
neurons with this ~14 kb cDNA. 
The HDAd mRFP-Bsn SM16 adenovirus was initially characterized in HEK293T cells to 
assess whether full-length Bassoon was expressed. Western blotting performed with cellular 
lysates prepared 48 hrs post-infection revealed the presence of a prominent band of ~450 kD 
that is similar in size to endogenous Bassoon (Figure 3.14B), To functionally characterize the 
recombinant Bassoon expressed from HDAd mRFP-Bsn SM16 virus was then used to infect 
neurons grown for 5 to 7 DIV and imaged 48 to 72 hr later. In live imaging experiments, 
highly mobile mRFP-Bsn puncta were observed along axonal processes consistent with 
previous studies showing that Bassoon was transported in association with vesicular transport 
intermediates along axons (Dresbach, Torres et al. 2006; Cai, Pan et al. 2007; Fejtova, 
Davydova et al. 2009)(Figure 3.14C). To examine if this Bassoon reached the synapse, 
HDAd mRFP-Bsn/SM16 infected neurons at 7 DIV were fix at 14 DIV with 4% PFA and 
immunostained with antibodies against Synaptophysin and MAP2a/b. Here, mRFP-Bsn 
SM16 positive puncta were observed that colocalize with Synaptophysin along MAP2a/b 
positive dendrites consistent with it appropriate presynaptic localization (Figure 14D). Based 
on this characterization, adenovirus technology allows us to express a full-length 
fluorescently tagged Bassoon for rescue experiments that shows proper expression and 
localization of our fusion protein of interest. 
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Fig. 3.14 Expression of full-length mRFP-tagged Bassoon using Adenovirus 
(A) Schematic diagram of high capacity adenovirus (HDad) developed for the expression of full-
length Bassoon. The N-terminus of Bassoon was tagged with mRFP, and nucleotides involved in 
shRNA-mediated knockdown by Bsn16 were mutated (SM16). (B) Western blots of lysates from 
uninfected neurons or HEK293T with and without infection with HDad-mRFP/Bsn-SM16 and then 
immunostained with Bassoon antibodies. (C) Live imaging of mRFP;;Bsn-SM16 positive puncta in 
the axons of hippocampal neurons 5DIV. These puncta represent transport vesicles for active zone 
proteins. (D) Spatial distribution of mRFP/Bsn-SM16 expressed in cultured hippocampal neurons. 
Neurons were infected on the day of plating and immunostained at 14 DIV with antibodies against 
MAP2a/b (Alexa 647; blue) or synaptophysin (Alexa 488; green).  
                                                                                                                                      Results 
 71 
3.3 Assessing the role of Piccolo in presynaptic assembly and function 
Piccolo is structurally related to a second active zone protein, Bassoon. As both proteins 
are co-expressed at a variety of synaptic types (glutamatergic, GABAergic, glycinergic, 
dopaminergic, and cholinergic, among others), it appears that many functions performed by 
Piccolo may be shared or redundant to those of Bassoon. However, each has their own 
distinct sequence are hypothesized to also have unique functions in the presynaptic bouton. In 
a set of studies described below, shRNA-mediated knockdown of Piccolo was used to assess 
its contribution to synapse assembly and function. Studies presented in the next section are 
designed to identify functions shared with Bassoon.  
 
3.3.1 Loss of Piccolo does not affect synapse formation or morphology 
As discussed in section 3.2, bicistronic lentiviral vectors were generated that express not 
only shRNAs against Piccolo (Pclo6 and Pclo28) but also have a presynaptic marker, EGFP-
tagged SV protein Synapsin1a (e.g LV/EGFP::Syn1a/Pclo28). In neurons infected with 
LV/EGFP::Syn1a or LV/EGFP::Syn1a/Pclo28, clusters of EGFP::Syn1a along the dendritic 
arbors of uninfected cells were seen. Immunostaining of these cultures revealed that Bassoon 
clusters were found to colocalize with the EGFP-Syn1a clusters along dendritic that 
contained or lacked Piccolo, respectively (Figure 3.11). These data suggest that Piccolo may 
not be required for synapse formation.  
To further test this hypothesis, cultured hippocampal neurons infected with either 
LV/EGFP::SynIa or LV/EGFP::SynIa/Pclo28 were also immunostained with antibodies 
against several key presynaptic (Synaptophysin, RIM1α, Munc13-1) and postsynaptic (PSD-
95, NR1) proteins (Figure 3.15A & B). As shown, each exhibited a punctate pattern that 
reliably colocalized with EGFP-Syn1a clusters along dendritic profiles, regardless of whether 
Piccolo was present (Figure 3.15A) or absent (Figure 3.15B). These data indicate that the loss 
of Piccolo does not disrupt the synaptic targeting of multiple key pre and postsynaptic 
proteins. 
To assess whether the loss of Piccolo affected synapse ultrastructure, a strategy was 
developed for visualizing the boutons of neurons expressing Pclo28 by electron microscopy 
(EM). This was achieved by replacing EGFP::SynIa in the pZOff vector with a second SV 
protein VAMP2 tagged at its C terminus with horseradish peroxidase (HRP) (VAMP2::HRP) 
(Figure 3.16A). VAMP2 is an essential transmembrane component of SVs (Elferink, Trimble 
et al. 1989; Sudhof, Baumert et al. 1989), and in VAMP2::HRP, the C-terminal HRP is 
situated within the vesicle lumen. Upon reaction with hydrogen peroxide and 
diaminobenzodine (DAB), HRP forms an electron-dense precipitate, enabling visualization of 
                                                                                                                                      Results 
 72 
vesicles within boutons of neurons expressing pZOff/VAMP2::HRP (Figure 3.16B). To 
verify that VAMP2::HRP did not affect Piccolo down regulation, cultures expressing 
pZOff/VAMP2::HRP or pZOff/VAMP2::HRP/Pclo28 were immunostained with antibodies 
against Piccolo and HRP at 6 DIV (Figure 3.17A). Under these conditions, Piccolo 
immunoreactivity was detected in the axons of untransfected neurons or those expressing 
VAMP2::HRP alone but not in axons of neurons expressing Pclo28. These data indicate that 
the down regulation of Piccolo by Pclo28 shRNA was not hampered by coexpression of 
VAMP2::HRP. 
 
Fig. 3.15 Piccolo is not essential for the clustering of key pre and postsynaptic proteins 
(A) Hippocampal neurons infected with LV/EGFP::SynIa or (B) LV/EGFP::SynIa/Pclo28 and 
immunostained with antibodies against Synaptophysin (Syph), RIM1α, Munc13-1, PSD-95, or NR1 
subunits of the NMDA receptor after 14 DIV. Shown are EGFP::Syn1a (green) puncta along MAP2 
positive dendrites (not depicted) that colocalize (Merged) with each pre- or postsynaptic protein (red). 
Scale bars = 10 µm. 
 
To visualize synapses, hippocampal neurons electroporated at the time of plating with 
pZOff/VAMP2::HRP or pZOff/VAMP2::HRP/Pclo28 were fixed and processed for EM at 14 
DIV. In both cases, presynaptic boutons expressing VAMP2::HRP were readily identified 
based on the presence of electron-dense SVs (Figure 3.16B and 3.17B). 
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Fig. 3.16 Ultrastructural characterization of excitatory synapses with Horseradish 
peroxidase (HRP) tagged VAMP2 
(A) Schematic diagram of the pZOff/VAMP2::HRP and pZOff/VAMP2::HRP/Pclo28 vectors used to 
express the shRNA against Piccolo (Pclo28). With HRP placed within the luminin of synaptic 
vesicles, VAMP2::HRP can be used to unambiguously label subsets of synaptic vesicles within 
presynaptic boutons of transfected neurons, without obscuring the synaptic junction or other synaptic 
structures when observed by electron microscopy. (B) Low (upper panels) and higher (lower panels) 
magnification electron micrographs of VAMP2::HRP positive axonal varicosities post-stained with 
either 3.5% uranyl acetate in 50% acetone (Post Stain #1) or 15 minutes of 5% uranyl acetate in 
aqueous solution (Post Stain #2). The latter stain, used for a majority of the studies, allows for a 
clearer visualization of the PSD in these preparations. In both conditions, the general bouton structure 
and other cellular organelles were appropriately stained and labeled SVs were clearly visible (top 
panels). In all samples with VAMP2::HRP, some darkening of the plasma membrane occurs, likely 
due to the presence of some protein on the plasma membrane. In the post-stain #1 condition, despite 
bouton proximity to adjacent neuronal plasma membranes, electron dense synaptic junctions were 
virtually absent (bottom left panel, for example). However, post-stain #2 adequately labeled synaptic 
junctions and post-synaptic densities (arrowheads in bottom right panel).  These experiments 
demonstrate that the presence of labeled VAMP2-HRP on the synaptic plasma membrane was distinct 
from the electron-dense synaptic junction, which could be discerned and further analyzed. 
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Fig. 3.17 Ultrastructural characterization of excitatory synapses lacking Piccolo 
(A) Hippocampal neurons electroporated at the time of plating with pZOff/VAMP2-HRP or 
pZOff/VAMP2::HRP/Pclo28 and immunostained at 6 DIV with HRP (488/Alexa; green) and Piccolo 
(568/Alexa; red) antibodies. Note the lack of Piccolo immunoreactivity in Pclo28-expressing axons. 
(B) Transmission EM micrograph of a VAMP2::HRP positive bouton containing both clear-centered 
(unlabeled SV) and dark-centered SVs (labeled SV). HRP-labeled vesicles are easily distinguished 
from 80-nm DCVs and other labeled structures. Synaptic boutons from VAMP2::HRP expressing 
(labeled bouton) and untransfected (unlabeled bouton) neurons. Arrowheads denote synaptic 
junctions, identified based on electron-dense PSDs. An excitatory synapse formed between a 
pZOff/VAMP2::HRP/Pclo28 transfected presynaptic bouton and a postsynaptic spine. An excitatory 
synapse formed between a pZOff/VAMP2-HRP (control) transfected presynaptic bouton and a 
postsynaptic spine. 
 
These labeled SVs were easily distinguishable from both unlabeled SVs and the 80 nm 
dense core vesicles hypothesized to carry Piccolo and Bassoon to nascent synapses (Figure 
3.17B)(Zhai, Vardinon-Friedman et al. 2001). Qualitatively, no gross morphological 
differences were detected between unlabeled synapses, those expressing only VAMP2::HRP, 
and those expressing VAMP2::HRP/Pclo28 (Figure 3.17B). Furthermore, when synapses 
were carefully quantified for bouton area, AZ/PSD length, docked SVs/AZ length, and SV 
density (# vesicles/bouton area), no morphological differences were found (Table 3.1). These 
data strongly suggest that Piccolo is not essential for the structural assembly of excitatory 
asymmetric synapses. 
                                                                                                                                      Results 
 75 
Parameter VAMP2 HRP VAMP2 HRP Pclo28 
AZ Length (nm) 0.258 ± 0.142 0.229 ± 0.102 
Docked SVs/AV Length (n/um) 13.87 ± 6.26 14.29 ± 5.30 
SV Density (n/um) 163.8 ± 58.36 169.0 ± 49.02 
Percentage of SVs Labeled 20.4 ± 12.5% 24.5 ± 14.8% 
 
Table 3.1 Quantitative ultrastructural analysis of synapses with or without Pclo28 
All data are from boutons with at least two clearly labeled synaptic vesicles opposed to a distinct 
synaptic junction. All parameters were measured by an observer blind to phenotype. n= 64 boutons 
with 66 active zones for control and 53 boutons with 55 active zones for +Pclo28. Data are shown ± 
standard deviation. t tests revealed no significant differences, with no P < 0.05. 
 
3.3.2 Synapses lacking Piccolo exhibit faster rates of SV exocytosis 
Although synapses still form in the absence of Piccolo, its large size and multiple binding 
partners suggest that it may be functionally important for SV recycling. To test this 
hypothesis, styryl FM dyes (Cochilla, Angleson et al. 1999) were used to analyze presynaptic 
function. To examine whether boutons lacking Piccolo were presynaptically active, the total 
recycling pool (TRP) of vesicles was labeled with FM4-64 (90 mM KCl, 60 sec) (Pyle, 
Kavalali et al. 2000) in neuronal cultures infected with either LV/EGFP::SynIa, 
LV/EGFP::SynIa/Pclo28, LV/EGFP::SV2, or LV/EGFP::SV2/Pclo28. At boutons with 
(EGFP::SynIa or EGFP::SV2) or without (EGFP::SynIa/Pclo28 or EGFP::SV2/Pclo28) 
Piccolo, more than 80% of EGFP::SynIa or EGFP::SV2 clusters co-localized with FM4-64 
puncta (Figure 3.18A, B, C & D). These data indicated that synapses lacking Piccolo are 
presynaptically functional and no more likely to be silent than control boutons.  
To determine the relative sizes of the total recycling pool (TRP) of SVs, the total FM 
fluorescence intensity at boutons containing or lacking Piccolo was examined. No difference 
was observed in the average intensity of FM4-64 fluorescence (Figure 3.19A), indicating that 
TRP size was unaffected by the absence of Piccolo. To evaluate whether the loss of Piccolo 
led to changes in SV exocytosis, the destaining kinetics of the TRP using both 10 and 5Hz 
electrical stimulation was compared (Figure 3.19B, C). Intriguingly, boutons lacking Piccolo 
destained more quickly than those expressing only EGFP-Syn1a (two-way ANOVA; 
p<0.0001 for both conditions)(Figure 3.19B, C), indicating that Piccolo is a negative 
regulator of SV exocytosis.  
Piccolo could regulate SV exocytosis by influencing vesicle docking and/or fusion with 
the AZ plasma membrane, or by controlling SV translocation from the reserve to readily 
releasable pools. To explore possible changes in SV docking and/or fusion, the size of the 
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Fig. 3.18 Synapses lacking Piccolo have functional boutons 
(A) Fluorescent images of 14 DIV hyppocampal neurons infected with LV/EGFP::Syn1a or 
LV/EGFP::Syn1a/Pclo28 and loaded with FM4-64 (red) with 90mM K+. Note the high degree of 
match between EGFP-Syn1a and FM4-64 in both merged images. (B) Bar graphs quantifying the % 
colocalization between EGFP::Syn1a and FM4-64 puncta in control cultures (EGFP::Syn) or those 
lacking Piccolo (EGFP::Syn1a/Pclo28) (n >800 puncta/condition, 2 expts) are over 80%.. (C) Images 
of 14 DIV hyppocampal neurons infected with LV/EGFP::SV2-W or LV/EGFP::SV2-W/Pclo28  
were loaded with FM4-64 (red) using high K+ Tyrodes solution. (D) Bar graph quantifying the % 
colocalization of EGFP::SV2 puncta with FM4-64 in the presence or absence (Pclo28) of Piccolo. 
FM4-64 has over 80% of colocalization with EGFP-SV2 puncta. Like EGFP::Syn1a, EGFP::SV2 is a 
reliable marker of presynaptic boutons. Scale bars = 10 µm. Error bars are SEM. 
 
readily releasable pool (RRP) of SVs or release probability (Pr) was monitiored in the 
absence of Piccolo (Figure 3.19D & E). RRP represents the subpopulation of SVs that are 
docked at the active zone plasma membrane and poised to undergo fusion with the arrival of 
an action potential, while Pr is a measure of the probability that SVs in the RRP will undergo 
fusion. Two methods were used to estimate RRP size, one utilizing hypertonic sucrose (500 
mM; ~800 mOsm) and the other a weak electrical stimulus (2Hz, 30 sec)(Pyle, Kavalali et al. 
2000). Under both conditions, no significant difference in RRP size between wild type 
synapses and those lacking Piccolo was found (t test; p>0.5)(Figure 3.19D). 
To determine Pr, the destaining kinetics of boutons under conditions that stimulate RRP 
release was measured, as previously reported (Ryan, Reuter et al. 1993; Pyle, Kavalali et al. 
2000; Mozhayeva, Sara et al. 2002; Sankaranarayanan, Atluri et al. 2003). Again, no 
significant difference in release probability between wild-type boutons and those lacking 
Piccolo was found (t test; p>0.5)(Figure 3.19E). Taken together, these data indicated that the 
increased SV exocytosis rates observed at 5 and 10 Hz are not due to increased RRP size or 
Pr.  
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Fig. 3.19 Loss of Piccolo enhances the rate and does not affect the size of the readily 
releasable pool of synaptic vesicles 
(A) Graphs bar of FM4-64 fluorescence intensity at EGFP::Syn1a puncta, comparing the relative sizes 
of the Total Recycling Pool (TRP) of SVs at control synapses (EGFP::Syn1a) and those lacking 
Piccolo (EGFP::Syn/Pclo28). FM4-64 intensity values at EGFP::Syn1a-expressing boutons were 
normalized against those from neighboring uninfected cells to enable cross-coverslip comparison. 
Average normalized FM4-64 intensity from control boutons was set to 100; that from Pclo28 boutons 
was ratio against this value (n>800 puncta, 2 expts). (B & C) Destaining kinetics of the TRP at 10Hz 
B and 5Hz C, comparing synapses with EGFP::Syn1a and EGFP::Syn1a/Pclo28. (D) Graphs Bar 
comparing the size of the readily releasable pool (RRP) of synaptic vesicles in boutons expressing 
EGFP::Syn1a or EGFP::Syn1a/Pclo28, as determined by either the application of 500mM sucrose 
(left) or 2 Hz, 30sec stimulation (right). No significant differences were found (t test; p>0.5). Sucrose 
experiments were performed twice for each condition, stimulation experiments 3 times, shown no 
difference on control versus shRNA of Piccolo. (E) Destaining kinetics of the RRP during 2 Hz, 
30sec stimulation for control (EGFP::Syn1a) boutons and those lacking Piccolo 
(EGFP::Syn1a/Pclo28) (n =5 expts/condition). SEM bars plotted.  
 
3.3.3 Piccolo modulates the dispersion kinetics of Synapsin1a 
From the above results, it would appear that Piccolo’s negative regulation of SV 
exocytosis was unlikely to occur at the level of SV priming or fusion, as described for 
RIM1α and Munc13 (Augustin, Rosenmund et al. 1999; Schoch, Castillo et al. 2002; Weimer 
and Richmond 2005; Gracheva, Burdina et al. 2006; Weimer, Gracheva et al. 2006), but 
rather at an earlier step, such as translocation of SVs from the reserve pool to the RRP. 
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To date, the only protein that has been implicated in regulating SV translocation is the 
SV-associated phosphoprotein Synapsin (De Camilli, Benfenati et al. 1990; Greengard, 
Valtorta et al. 1993; Ryan, Li et al. 1996; Chi, Greengard et al. 2003).  Synapsin is 
hypothesized to mediate the clustering and retention of SVs within boutons (Greengard, 
Valtorta et al. 1993; Ceccaldi, Grohovaz et al. 1995). Activity-dependent 
phosphorylation/dephosphorylation of Synapsin by CaMKII, protein kinase A (PKA), 
MAPK, and protein phosphatases 2A and 2B (PP2A and PP2B) appears to regulate the 
exocytosis kinetics of SVs, presumably by regulating Synapsin binding to SVs and/or the 
actin cytoskeleton (Greengard, Valtorta et al. 1993; Ryan, Reuter et al. 1993; Jovanovic, 
Czernik et al. 2000; Pyle, Kavalali et al. 2000; Jovanovic, Sihra et al. 2001; Mozhayeva, Sara 
et al. 2002; Chi, Greengard et al. 2003; Sankaranarayanan, Atluri et al. 2003). Importantly, 
Synapsin has also been shown to undergo an activity-dependent dispersion away from 
presynaptic boutons (Chi, Greengard et al. 2001), and the rate of dispersion is linked to its 
phosphorylation state (Chi, Greengard et al. 2001; Chi, Greengard et al. 2003). 
To explore whether the loss of Piccolo impacts SV translocation via alterations in the 
properties of Synapsin, the association and/or dispersion kinetics of Synapsin1a within 
presynaptic boutons were examined. For these experiments, the shRNA expression vector 
containing EGFP::SynIa was used. Similar to experiments using LV/EGFP::Syn1a, no 
increase in Synapsin immunostaining at boutons expressing EGFP::SynIa was found (Figure 
3.9B,C), indicating that endogenous Synapsin expression is down-regulated in the presence 
of EGFP-Syn1a to maintain similar total levels/bouton. These levels were quantified and 
compared to the synaptic levels of EGFP::SynIa in boutons of control neurons and those 
expressing Pclo28. No discernable differences in fluorescence intensity were observed when 
cultures were fixed with 4% paraformaldehyde (Figure 3.20A). However, when cultures were 
fixed with methanol, which extracts soluble proteins, a significant decrease (t-test; p<0.0001) 
in the intensity of EGFP::SynIa at boutons lacking Piccolo was detected (Figure 3.20A). This 
suggested that EGFP::SynIa was not as tightly associated with SVs and/or actin-related 
structures in the absence of Piccolo but rather was shifted into a more soluble fraction. 
To test this concept, Fluorescence Recovery After Photobleaching (FRAP) was used to 
monitor the steady-state exchange kinetics of EGFP::SynIa fluorescence at individual 
boutons (Figure 3.20B, C). EGFP::SynIa fluorescence recovered more quickly at boutons 
lacking Piccolo (Figure 3.28D) (tfast = 1.2 min, tslow = 11.9 min vs. tfast = 2.2 min, tslow = 33.7 
min for control boutons; two-way ANOVA, p<0.0001), indicating that mechanisms 
regulating the association of Synapsin1a with SVs and/or the actin/spectrin cytoskeleton were 
altered in the absence of Piccolo. 
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To assess whether the faster exchange kinetics of EGFP::SynIa in the absence of Piccolo 
were due to decreased presynaptic stability and/or decreased association of SVs with 
synapses, the turnover rates of SV2, a SV integral membrane protein, in the presence and 
absence of Piccolo was examined.  Here, an N-terminally EGFP-tagged SV2 was subcloned 
into our lentiviral vectors in place of EGFP::SynIa. Similar to EGFP::SynIa, EGFP::SV2 
reliably labeled presynaptic boutons, exhibiting a high degree of colocalization with FM4-64 
(Figure 3.18C, D). However, in contrast to EGFP::Syn1a, the exchange kinetics of 
EGFP::SV2 was not altered in the absence of Piccolo (Figure 3.20D, E), indicating that 
general presynaptic stability and SV retention were not significantly altered in the absence of 
Piccolo. 
                  
Fig. 3.20 Loss of Piccolo increases the solubility and exchange kinetics of Synapsin1a 
within presynaptic boutons 
(A) Bar graphs of EGFP::Syn1a fluorescence intensity at presynaptic boutons from neurons 
expressing EGFP::Syn1a or EGFP::Syn1a/Pclo28. Data compare the effect of methanol versus 4% 
paraformaldehyde fixation (n>800 puncta, 7 fields of view/condition). (B) Time-lapse images of 
EGFP::Syn1a puncta. Single fluorescent puncta (indicated by arrows) were photobleached and their 
recovery monitored over time. (C) Fluorescence recovery curves for puncta at boutons with 
EGFP::SynIa, n=20 or without Piccolo EGFP::SynIa/Pclo28, n=17. (D) Images of puncta at boutons 
with EGFP::SV2 or without Piccolo EGFP::SV2/Pclo28. (E) Fluorescence recovery curves for 
EGFP::SV2 puncta at synapses with EGFP::SV2, n=8 or without Piccolo EGFP::SV2/Pclo28, n=12 
SEM bars plotted.  
 
Differences in steady-state exchange kinetics could translate into activity-dependent 
differences in the dispersion kinetics of EGFP::SynIa. Therefore, an electrical stimulation 
protocol (10 Hz, 90 sec) shown to promote the dispersion of EGFP::SynIa was employed 
                                                                                                                                      Results 
 80 
(Chi, Greengard et al. 2001; Chi, Greengard et al. 2003). Changes in the fluorescence 
intensity of EGFP::SynIa at individual boutons were monitored both during stimulation and 
for the subsequent 10 min recovery period. In contrast to wild-type boutons, a more complete 
dispersion of EGFP::SynIa and a slower rate of recovery in boutons lacking Piccolo were 
observed (two-way ANOVA; p<0.0001)(Figure 3.21A, B). A previously unreported 
heterogeneity in the extent of EGFP::SynIa dispersion at individual boutons under both 
conditions was observed. 
To evaluate whether the extent of EGFP::SynIa dispersion was coupled to the rate of SV 
exocytosis, the loss of EGFP::SynIa and FM5-95 fluorescence from boutons during 5 Hz 
stimulation was simultaneously monitored for 3 min. The analysis revealed a tight correlation 
between the two events. At boutons with minimal EGFP::SynIa dispersion (<10% for all time 
points), very little FM5-95 destaining occurred (Figure 3.21 C, D). In contrast, synapses with 
more complete EGFP::SynIa dispersion (>40% after 30 sec stimulation) exhibited dramatic 
FM5-95 destaining (Figure 3.21C, D). This feature was present both at control synapses 
(Figure 3.21C) and those lacking Piccolo (Figure 3.21D). A statistical analysis of the final 
fluorescence intensity values for EGFP::SynIa and FM5-95 after the 3 min stimulation 
revealed a strong correlation between the extent of EGFP::SynIa dispersion and that of FM5-
95 destaining at both control boutons and those lacking Piccolo (r = 0.58, p<0.0001 for 
control; r = 0.59, p<0.0001 for Pclo28)(Figure 3.21E, F). Although this tight correlation was 
observed for all synapses, the average degree of EGFP::SynIa dispersion and FM5-95 
destaining was greater at boutons lacking Piccolo, significantly shifting these correlation 
values to the lower right (Figure 3.21E, F). These data strongly indicate that the accelerated 
SV exocytosis rates observed at synapses lacking Piccolo are coupled to concomitant 
increases in the dispersion kinetics of SynIa.  
 
3.3.4 Changes in SV exocytosis and Synapsin dynamics are not observed at synapses 
lacking Bassoon 
Boutons lacking Bassoon were tested to determine if phenotypes seen at boutons lacking 
Piccolo were similarly observed. To this end, sets of shRNAs against Bassoon were 
generated and subcloned into the LV/EGFP::SynIa vector under the control of the H1 
promoter (Figure 3.9 & 3.11). This Bsn16-shRNA was found to efficiently and specifically 
reduce the expression of Bassoon in lysates of cultures infected with LV/EGFP::SynIa/Bsn16 
on the day of plating and then harvested after 14 DIV (Figure 3.11). 
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Fig. 3.21 Loss of Piccolo increases Synapsin1a dispersion and FM5-95 destaining 
kinetics 
(A) Time lapse images of EGFP::Syn1a puncta. Images were acquired before, during, and after 
EGFP::Syn1a dispersion was elicited with 10Hz, 90 sec stimulation. Shown here are sample images 
taken before (pre) and immediately following stimulation (90 sec, 10Hz), as well as after 10 min of 
recovery. (B) Graphical representation of data from A, plotting the average change in fluorescence 
intensity over time at boutons with or without Piccolo (n>100 puncta/condition). Bar in upper left 
indicates time during which stimulation (10Hz) was applied. Synapsin1a dispersion and FM 
destaining are tightly correlated. (C & D) FM5-95 destaining curves for individual EGFP::Syn1a 
puncta at boutons with C or without Piccolo D. Shown in black are examples of FM5-95 destaining 
curves for which there was either dramatic (>40%; triangles) or minimal (<10%; squares) dispersion 
of EGFP::Syn1a. Shown in light gray are EGFP::Syn1a intensities for these boutons. Correlation 
analysis of EGFP::SynIa dispersion and FM5-95 destaining at synapses with E or without Piccolo F. 
Plotted are EGFP::SynIa and FM5-95 intensity values (expressed as % initial fluorescence) at the 
final timepoint (t=180 seconds) of 5 Hz stimulation (control = 709 puncta, Pclo28 = 855 puncta). 
Dashed lines and circles indicate average intensity values for EGFP::Syn1a and FM5-95 at control 
boutons (blue; 90.8 +/- 1.0% and 75.6 +/- 0.9%, respectively) and those lacking Piccolo (red; 79.2 +/- 
0.9% and 65.5 +/- 0.8%, respectively). Note that values for boutons lacking Piccolo are significantly 
shifted toward the lower right. SEM bars plotted 
 
Similarly, at the synaptic level, a dramatic decrease (>95%) in the percent co-localization 
of Bassoon and EGFP::SynIa in axons along dendritic profiles was observed (Figure 3.11). 
This decrease was not observed for Piccolo (Figure 3.10), indicating that the Bsn16 shRNA is 
specific for Bassoon.  
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Using dynamic imaging, the dispersion and reclustering rates of EGFP::SynIa was 
examined in boutons lacking Bassoon. As shown in Figure 3.11, synapses lacking Bassoon 
exhibited no detectable defects in EGFP::SynIa dispersal or reclustering (Figure 3.22A), and 
no change in the destaining kinetics of FM5-95 (Figure 3.22B). Together, these observations 
strongly argue that the phenotypes observed for Piccolo are real and not artifacts of long-term 
shRNA expression. Moreover, they indicate that sequence elements unique to Piccolo play a 
fundamental role in negatively regulating SV exocytosis, apparently by influencing the 
activity-dependent dispersion of SynapsinIa. 
     
Fig. 3.22 Loss of Piccolo but not Bassoon from presynaptic boutons alters the dispersion 
kinetics of Synapsin1a and the destaining kinetics of FM5-95 
(A) Dispersion and reclustering kinetics of EGFP::Syn1a in control boutons (EGFP::Syn1a) and those 
lacking Piccolo (EGFP::Syn1a/Pclo28) or Bassoon (EGFP::Syn1a/Bsn16). (B) EGFP::Syn1a and 
EGFP::Syn1a/Pclo28 curves are from Fig. 3.21 (n~100 puncta/condition). Destaining kinetics of 
FM5-95 during 5Hz stim for control boutons (EGFP::Syn1a) and those lacking Piccolo 
(EGFP::Syn1a/Pclo28) or Bassoon (EGFP::Syn1a/Bsn16). (n>200 puncta, 2 expts/condition). SEM 
bars plotted.  
 
3.3.5 Loss of Piccolo enhances the CaMKII sensitivity of Synapsin 1a 
The association of Synapsin1a with SVs and the Actin cytoskeleton in nerve terminals is 
thought to be regulated by CaMKII phosphorylation (Schiebler, Jahn et al. 1986; Benfenati, 
Valtorta et al. 1992; Greengard, Valtorta et al. 1993; Stefani, Onofri et al. 1997; Chi, 
Greengard et al. 2001; Chi, Greengard et al. 2003). Thus, the altered dynamics of 
EGFP::Syn1a dispersion in the absence of Piccolo was hypothesized to be due to changes in 
its CaMKII-dependent phosphorylation. This was examined by blocking CaMKII activity 
with 10 µM KN62 prior to and during a 10 Hz stimulation for 90 sec. KN62 had no 
significant effect on the dispersion kinetics or total amount of dispersion observed for 
EGFP::Syn1a in wild-type boutons (two-way ANOVA; p = 0.15)(Figure 3.23A, B). 
However, this treatment caused a dramatic reduction in EGFP::Syn1a dispersion at Pclo28 
boutons, “rescuing” dispersion to levels seen at wild-type boutons (two-way ANOVA; p < 
.0001)(Figure 3.23B, C). To determine whether this decrease in dispersion was accompanied 
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by a decrease in SV exocytosis rate, the impact of KN62 on the destaining kinetics of FM5-
95 at Pclo28 boutons was examined. Again, KN62 attenuated the Pclo28 phenotype, slowing 
the accelerated exocytosis of SVs seen in the absence of Piccolo (two-way ANOVA; 
p<0.0001)(Figure 3.23D). These results indicate that the effects of Piccolo loss of function 
(LOF) are mediated in part by CaMKII. Moreover, they provide further evidence that the 
Synapsin dispersion and SV exocytosis phenotypes are mechanistically linked. 
                
Fig. 3.23 CaMKII inhibition rescues Pclo28 phenotypes and synapsin1a is hypo-
phosphorylated in the absence of Piccolo 
(A) Dispersion kinetics of EGFP::Syn1a in wild-type neurons incubated with (KN62) or without 
(control) 10 uM KN62 during a 90 sec, 10 Hz stim. Yellow line indicates maximal amount of 
dispersion (expressed as % of initial fluorescence intensity prior to stimulation) seen in these neurons 
without KN62 (n>100 puncta/condition). (B) Bar graphs summarizing the % dispersion of 
EGFP::Syn1a puncta at synapses with EGFP::Syn1a or without Piccolo EGFP::Syn1a/Pclo28 in the 
presence (black) or absence (white) of KN62. % dispersion =(100- % initial fluorescence) was 
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measured at 90 sec following a 10Hz, 90sec stim (n=2 expts, 905 puncta for control w/o KN62; 3 
expts, 1070 puncta for control +KN62; 7 expts, 2195 puncta for Pclo28 w/o KN62; 8 expts, 2341 
puncta for Pclo28 +KN62). SEM bars plotted. (C) Dispersion kinetics of Synapsin1a in neurons 
lacking Piccolo and incubated with (KN62) or without (control) KN62 during a 90 sec, 10 Hz 
stimulation. For comparison, yellow line indicating maximal amount of dispersion observed in wild-
type neurons is included (n>100 puncta/condition). (D) Destaining kinetics of FM5-95 at boutons 
lacking Piccolo in the presence (triangles) or absence (squares) of KN62, during a 5Hz, 180sec (900 
pulse) stimulation (n=5 expts, 1134 puncta for Pclo28 w/o KN62; 2 expts, 437 puncta for Pclo28 
+KN62). SEM bars plotted. (E) Schematic diagram of Synapsin1a, illustrating the names and 
positions of each of its seven characterized phospho-sites. (F) Western blot of hippocampal lysates 
from 14 DIV control cells EGFP::SynIa and those lacking Piccolo EGFP::SynIa/Pclo28, untreated or 
treated with high K+ (2min, 90mM KCl) and probed with phospho-Synapsin1a antibodies 
recognizing Site 3 or Sites 4/5, as well as antibodies against total Synapsin1a and EGFP. Upper panels 
are EGFP::SynIa, lower panels are endogenous Synapsin. This experiment was repeated 3 times to 
verify the results. (G) Western blot of lysates from unstimulated control cells EGFP::SynIa and those 
lacking Piccolo EGFP::SynIa/Pclo28, probed with antibodies against Piccolo, Tubulin, 
Synaptophysin, and Dynamin, as well as phospho-antibodies against GluR1, Synaptotagmin, 
Rabphilin, Munc18, and Dynamin. This experiment was performed twice to verify the results.  
 
3.3.6 Synapsin1a is hypophosphorylated in the absence of Piccolo 
The ability of KN62 to rescue the Pclo28 phenotypes suggested that Synapsin might be 
hyperphosphorylated by CaMKII in the absence of Piccolo. To test this idea, Western blots of 
hippocampal lysates containing (EGFP::Syn1a) or lacking (EGFP::Syn1a/Pclo28) Piccolo 
were probed with two phospho-Synapsin1a antibodies that recognize sites phosphorylated by 
CaMKII or MAPK (Figure 3.23E) (Chi, Greengard et al. 2003). In these experiments, lysates 
from 14 DIV cultures were analyzed either directly (untreated) or after high K+ treatment (90 
mM KCl, 2 min) to stimulate Synapsin phosphorylation. As expected, the levels of both 
endogenous and EGFP::SynIa phosphorylation at sites 3, 4 and 5 increased in all lysates after 
high K+ stimulation (Figure 3.23F). However, in lysates from Pclo28 neurons, the levels of 
phosphorylation at these sites under both basal and high K+ conditions were dramatically 
reduced (Figure 3.23F). This unexpected finding suggested that the kinase/phosphatase 
balance at boutons lacking Piccolo was altered and that perhaps these boutons exhibited 
enhanced phosphatase activity. To test this hypothesis, a panel of phospho-specific antibodies 
against a number of pre and postsynaptic proteins, including GluR1, Synaptotagmin, 
Rabphilin, Munc18, and Dynamin were screened. The phosphorylation levels of these 
proteins as assessed by Western blot were not altered in the absence of Piccolo (Figure 
3.23G), indicating that the effect could be specific to Synapsin. 
 
3.3.7 Altered Synapsin phosphorylation does not mediate the Piccolo LOF phenotypes 
Activity-dependent phosphorylation of Synapsin1a by multiple kinases (Figure 3.23E) 
has been shown to regulate its association with SVs and the actin cytoskeleton (Schiebler, 
Jahn et al. 1986; Benfenati, Valtorta et al. 1992; Ceccaldi, Grohovaz et al. 1995; Hosaka, 
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Hammer et al. 1999; Chi, Greengard et al. 2001; Jovanovic, Sihra et al. 2001; Chi, Greengard 
et al. 2003). For instance, serine to alanine (S/A) phospho-mutants that prevent PKA and/or 
CaMKII phosphorylation of EGFP-Syn exhibit decreased t values of activity-dependent 
dispersion and FM destaining, suggesting that they dissociated more slowly from SVs and/or 
the actin cytoskeleton within presynaptic boutons (Chi, Greengard et al. 2001; Chi, 
Greengard et al. 2003). This raised the question of whether Pclo28 phenotypes are mediated 
via the altered phosphorylation of Synapsin. 
This was examined by exploring whether the Synapsin S23A phospho-mutant, which 
prevents CaMKII phosphorylation and slows both dispersion and FM destaining kinetics in 
wild-type neurons (Chi, Greengard et al. 2001; Chi, Greengard et al. 2003), could suppress 
synapsin dispersion kinetics in synapses lacking Piccolo. Surprisingly, this mutation did not 
decrease the extent of Synapsin dispersion (Figure 3.24A, B). Moreover, treating neurons 
with KN62 to inhibit CaMKII activity only partially rescued the extent of wild-type Synapsin 
dispersion or that of the S23A mutant in boutons lacking Piccolo, (Figure 3.24A, B). These 
data indicate that CaMKII phosphorylation of Synapsin does not mediate its enhanced 
dispersion in the absence of Piccolo. To further investigate whether other Synapsin 
phosphorylation sites could contribute to the Pclo28 phenotypes, additional phospho-mutants 
were examined. Specifically, mutations that disrupted the PKA phosphorylation site (S1A) or 
nearly all Synapsin phosphorylation sites (S12346A) were generated and their dispersion 
kinetics measured in neurons lacking Piccolo. As with S23A, neither of these mutants 
rescued the Pclo28 phenotypes (Figure 3.24C, D). For example, S12346A partially rescued 
Synapsin dispersion but had no effect on FM destaining (Figure 3.24D, E, F), while S1A, like 
S23A, had no effect on Synapsin dispersion but completely rescued the extent of FM 
destaining (Figure 3.24D, E, F). Similarly, the addition of PKA and/or MAPK inhibitors 
(KT5720 & PD98, respectively) had no effect on EGFP::SynIa dispersion (Figure 3.24G, H), 
suggesting that of the kinases examined, only CaMKII is linked to the Pclo28 phenotypes. 
Taken together, these data indicate that while Synapsin phosphorylation and exchange 
kinetics are altered in the absence of Piccolo, the alteration in the properties of Synapsin 
cannot account for the Pclo28 phenotypes. 
 
3.3.8 Activity-dependent F-actin assembly is disrupted in the absence of Piccolo 
An alternative explanation for the observed phenotypes in neurons lacking Piccolo is that 
they are due to altered presynaptic actin dynamics. Supporting this concept, actin 
depolymerization has been shown to enhance EGFP-SynIa dispersion and FM4-64  
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Fig. 3.24 Aberrant Synapsin1a phosphorylation does not cause the Pclo28 phenotypes 
(A) Timecourse of dispersion for wild-type and S23A mutant Synapsin1a in neurons lacking Piccolo, 
in the presence or absence of KN62. KN62 attenuates the dispersion of both wild-type and S23A 
SynapsinIa. (B) Average extent of EGFP::SynIa dispersion +/- KN62, expressed as % decrease in 
EGFP::Syn1a dispersion for S23A vs. wild-type EGFP::SynIa in the Pclo28 background (n=2 
coverslips for EGFP::Syn1a + KN62, 3 for S23A, 3 for S23A + KN62; 2 batches of neurons). Yellow 
line denotes “complete rescue” of Pclo28 phenotype, defined as the % decrease in EGFP::Syn1a 
dispersion observed in wild-type neurons vs. Pclo28 neurons (=33%). (A) Timecourse of dispersion 
for wild-type (wt), S1A, S23A, and S12346A EGFP::SynIa mutant constructs in neurons expressing 
Pclo28. S12346A partially rescues the EGFP::SynIa dispersion phenotype, with 8.4% less dispersion 
than wt EGFP::SynIa in Pclo28 boutons (*= p<0.05, t-test). (D) Average extent of EGFP::Syn1a 
dispersion, expressed as % decrease in EGFP::SynIa dispersion for phospho-mutants vs. wt 
EGFP::SynIa in neurons expressing Pclo28. Yellow line denotes complete rescue of the Pclo28 
phenotype. (E) Timecourse of FM4-64 destaining at boutons expressing wild-type (wt), S1A, S23A, 
and S12346A EGFP::SynIa mutant constructs in neurons expressing Pclo28.. (F) Average extent of 
FM destaining, expressed as % decrease in FM destaining for phospho-mutants vs. wild-type 
EGFP::SynIa in neurons expressing Pclo28 (n=5 coverslips for S1A, 7 for S23A and S12346A; 3 
batches of neurons). Yellow line denotes complete rescue of Pclo28 phenotype, defined as the % 
decrease in FM4-64 destaining observed in wt neurons vs. Pclo28 neurons (=11.6%). S1A and S23A 
both rescue the enhanced FM4.64 destaining (by 17.6% and 17.9%, respectively), but S12346A does 
not (*= p<0.05; ** = p<0.005, t-test). (G) Timecourse of EGFP::Syn1a dispersion in neurons 
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expressing Pclo28, in the presence of PKA (KT5720) and MAP kinase (PD98) blockers. SEM values 
shown (n> 3 experiments/condition). SEM bars plotted. (H) Average extent of Synapsin dispersion in 
the presence of PKA and MAPK inhibitors. Neither has a significant effect on EGFP::SynIa 
dispersion. 
 
destaining in cultured hippocampal neurons (Sankaranarayanan, Atluri et al. 2003), similar to 
Piccolo knockdown. As an initial test of this hypothesis, Pclo28-expressing neurons were 
treated with the F-actin stabilizing drug jasplakinolide, which largely normalized the 
enhanced EGFP::Syn1a dispersion and FM4-64 destaining (Figure 3.25A, B C, D, & E). 
                
Fig. 3.25 Inhibiting F-actin assembly with Jasplakinolide rescues the Pclo28 phenotypes 
(A) EGFP-SynIa dispersion and FM4-64 destaining in boutons of neurons infected with 
LV/EGFP::SynIa/Pclo28 and treated with +/- 5 mM jasplakinolide. Arrows denote colocalized 
EGFP::SynIa and FM4-64 puncta. 15µm size bars. (B) Timecourse of EGFP::Syn1a dispersion at 
boutons lacking Piccolo, in the absence (black) or presence (gray) of jasplakinolide. SEM bars shown 
(n=2 experiments/condition). (C) Average extent of EGFP::Syn1a dispersion in the boutons of 
neurons expressing Pclo28 and treated with jasplakinolide (n=10 coverslips). Complete rescue 
(Yellow line). Jasplakinolide decreases the extent of dispersion by 24.1% (***= p<0.0001, t-test). (D) 
Timecourse of FM4-64 destaining at boutons lacking Piccolo, in the absence (black) or presence 
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(gray) of jasplakinolide. SEM values shown (n=2 expts/condition). (E) Average extent of FM 
destaining at Pclo28 boutons treated with jasplakinolide (n=6). Complete rescue (dashed line). 
Jasplakinolide decreases the extent of FM4-64 destaining by 23.3% (**= p<0.005, t-test).  
 
To directly assess F-actin polymerization in neurons lacking Piccolo, the dynamic 
behavior of EGFP::β-actin was monitored in these neurons. Previous studies showed that 
EGFP::β-actin clusters at presynaptic boutons in response to synaptic depolarization, and that 
this phenomenon represented F-actin polymerization (Colicos, Collins et al. 2001; 
Sankaranarayanan, Atluri et al. 2003). In our experiments, EGFP::β-actin clustering was 
induced by stimulating neurons for 30-45 sec with high K+ (90 mM KCl) Tyrodes solution 
containing FM4-64 to allow for simultaneous label of functional presynaptic boutons. Here, 
the high K+ treatment caused a robust recruitment of EGFP::β-actin to presynaptic sites in 
wild-type neurons, as indicated by approximately 60% colocalization of EGFP::β-actin 
clusters with FM4-64 as well as with Piccolo and synaptophysin immunostaining (Figure 
3.26A, B). Together these data indicate that changes in presynaptic function observed in the 
absence of Piccolo are largely accountable through a role of Piccolo in regulating the 
dynamic assembly presynaptic F-actin.  
             
Fig. 3.26 Presynaptic localization of EGFP::Actin markers 
(A) Fluorescent images of hippocampal neurons 14DIV expressing EGFP::β-actin. Following either a 
high K+ stimulation (90mM KCl) or the addition of 5 mM jasplakinolide, axonal EGFP::β-actin is 
found to coalesce into puncta that, colocalize with synaptophysin immunoreactive puncta (indicated 
by arrows), indicating that synaptic activity directs the presynaptic recruitment/assembly of F::Actin. 
Size bar is 10 um. (B) Quantification of the fraction of EGFP::β-actin puncta that colocalize with 
Piccolo or synaptophysin immunoreactive puncta. Also quantified is the % colocalization of 
EGFP::β-actin puncta with sites of synaptic vesicle recycling as measured by FM4-64 uptake 
following a High K+ stimulation. Note, approximately 60% of EGFP::β-actin puncta (induced by high 
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K+ stimulation for these experiments) are presynaptic based on colocalization with all three markers 
(n=6 fields of view for Piccolo, 5 for synaptophysin, 9 for FM4-64).  
 
3.3.9 CaMKII dynamics are altered in axons lacking Piccolo 
Like Actin, the signaling molecule CaMKII, implicated in pre and postsynaptic plasticity 
mechanisms, has been shown to undergo activity-dependent clustering at presynaptic boutons 
(Tao-Cheng, Dosemeci et al. 2006). These findings suggest that presynaptic CaMKII 
dynamics could depend upon F-actin assembly and might be altered in the absence of 
Piccolo. To test this idea, the activity-dependent clustering of YFP::CaMKIIα in control 
boutons was compared to neurons treated with latrunculin A. As in the EGFP::β-actin 
experiments, high K+ induced strong clustering of YFP::CaMKIIα at presynaptic boutons. 
However, pre-treatment with latrunculin A blocked this effect (Figure 3.27A-C). Moreover, 
in neurons lacking Piccolo, YFP::CaMKIIα clustering was significantly reduced (Figure 
3.27A-C), indicating that Piccolo indeed facilitates the activity-dependent recruitment of 
CaMKII into presynaptic boutons via its regulation of F-actin assembly. This defect in 
presynaptic CaMKII clustering could explain the lower levels of activity-dependent, 
CaMKII-mediated Synapsin phosphorylation observed in neurons lacking Piccolo described 
previously (see 3.3.8). 
 
3.3.10 PcloΔEx14 -/- mice exhibit normal F-actin assembly 
A recent study described mice with a targeted deletion of exon 14 in the PCLO gene 
(PcloΔEx14), encoding 125 nucleotides of the C2A domain (Mukherjee, Yang et al. 2010) 
(Figure 3.41). The authors reported a >95% reduction in Piccolo protein levels based on 
Western blots using a C-terminal antibody, yet no defects in neurotransmission or synaptic 
plasticity (Mukherjee, Yang et al. 2010). These data suggest clear difference with our 
experiments using Pclo28 shRNA. To reconcile these differences, the protein expression 
patterns and primary synaptic phenotype of Pclo28-expressing neurons with those prepared 
from PcloΔEx14 mice were compared. 
To reassess the impact of deleting this C-terminal exon on the expression of the 560 kDa 
Piccolo, the expression pattern of Piccolo isoforms in total brain homogenates from wild-
type, heterozygous, and PcloΔEx14 littermates were examined by Western blot using our 
well-characterized 44aII antibody (Cases-Langhoff, Voss et al. 1996; Fenster, Chung et al. 
2000; Fenster and Garner 2002); (Figure 3.28A). 
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Fig. 3.27 CaMKIIα   recruitment to presynaptic boutons is impaired in Piccolo 
knockdown neurons 
(A) Fluorescent images of YFP::CaMKIIα expressing rat hippocampal neurons grown for 14DIV. 
Initial YFP::CaMKIIα fluorescent is evenly distributed within axons and then becomes concentrated 
within presynaptic boutons following a High K+ stimulation. Boutons in these live experiments are 
identified by labeling recycling pools of synaptic vesicles with FM4-64 during the High K+ 
stimulation. Shown is the redistribution of YFP::CaMKIIα in control, latrunculin A-treated, and 
Pclo28-expressing axons, before (pre) and after (post) stimulation with 90 mM KCl Tyrodes buffer + 
FM4-64. Arrows indicate presynaptic sites based on FM4-64 labeling. In wild-type axons, 
YFP::CaMKIIα becomes more punctuate after stimulation; latrunculin A and Pclo28 shRNA block 
this effect. 15µm size bar. (B) Bar graphs quantifying the percent increase in YFP-CaMKIIα 
fluorescence intensity at presynaptic boutons following high K+ stimulation. Fluorescence increases 
45% in wild-type neurons, but only 17% in the Piccolo knockdown and 7% in the presence of 
latrunculin (n=8 for wt, 6 for Pclo28, 3 for latA; **= p<0.005, t-test) SEM bars plotted. (C) Number 
of YFP-CaMKIIα puncta/unit axon length before (pre-treat) and after (post-treat) high K+ stimulation 
or latrunculin treatment (same n values as B). Pclo28-expressing axons have fewer YFP-CaMKIIα 
puncta prior to stimulation than wild-type axons (0.12 vs. 0.20 puncta/pixel, respectively). High K+ 
induces new puncta in wild-type neurons (from 0.20 to 0.36 puncta/pixel; **= p<0.005, paired t-test), 
but not those treated with latrunculin A or lacking Piccolo. 
 
This antibody was raised against a ~1,686 amino acid region of Piccolo that contains 
binding sites for two Actin regulators, GIT1 and Profilin (Figure 3.28A) (Wang, Kibschull et 
al. 1999; Kim, Ko et al. 2003). In wild-type lysates, we observed a typical pattern of Piccolo 
immunoreactive bands at ~560, 500, 400, 350, 300 and 200 kD (Figure 3.28B), thought to 
arise by alternative splicing of the 350 kb, 26 exon PCLO gene (Fenster and Garner, 2002) 
and BioGPS.org web page (Figure 3.28D). In PcloΔEx14 lysates, a selective reduction of the 
560, 500, and 400 kDa bands was observed (Figure 3.28 B), supporting the concept that 
alternative splicing and not protein degradation of the 560 kD protein gave rise to this 
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pattern. In contrast, neurons expressing Pclo28, targeting a sequence in exon 1 (Figure 
3.28A), lost all immunoreactive bands (Figure 3.28C). These data demonstrate that 
PcloΔEx14 mice were not complete Piccolo nulls and suggest that the absence of synaptic 
phenotypes in PcloΔEx14 mice is not due to an inconsequential role for Piccolo in 
neurotransmitter release but rather to the continued expression of multiple isoforms 
containing the central region of Piccolo. 
         
Fig. 3.28 Piccolo isoform expression in PcloΔEx14 mice and rat hippocampal neurons 
expressing Pclo28 shRNA 
(A) Schematic diagram of Piccolo depicting its multiple domains (Q, two Zinc finger (Zn), three 
coiled-coil (CC), PDZ, C2A and C2B), regions targeted by Pclo28 shRNA, exon 14 deletion, 44aII 
antibody and binding partner PRAI, CtBPI, ERC/CAST/ELKs and Rims. (B) Western blot of brain 
homogenates from wild-type (+/+), heterozygous (+/-), and PcloΔEx14 (-/-) mice, probed with the 
44aII antibody. Black arrowheads indicate major immunoreactive bands (~560, 500, and 400 kD) that 
are absent in -/- mice. (C) Western blot of lysates from rat hippocampal neurons infected with EGFP-
Synapsin1a +/- Pclo28, probed with 44aII antibodies. Note the disappearance of all immunoreactive 
bands in lysates expressing Pclo28. Data indicate that eliminating exon 14 from the mouse Piccolo 
gene only affects the expression of a subset of Piccolo isoforms. (D) Schematic diagram of Piccolo 
isoforms predicted from BioGPS.org web page. 
 
To directly test this hypothesis, the most prominent Pclo28 phenotype, impaired F-Actin 
assembly, was examined in hippocampal neurons cultured from PcloDEx14 mice. As in the 
rat experiments, neurons were infected with EGFP::β-actin or EGFP::β-actin Pclo28 
constructs at the time of plating, grown for 10 days, and then depolarized with high K+ for 1 
minute prior to fixation and immunostaining with 44aII antibody. Intriguingly, high K+-
induced EGFP::β-actin clustering was robust in both wildtype and PcloDEx14 axons (Figure 
3.29A). No significant differences in presynaptic cluster intensity or number of clusters per 
unit length of axon were detected between the two genotypes (Figure 3.29B, C). Moreover, 
while Piccolo levels were ~75% lower in PcloDEx14 neurons, remaining immunoreactivity 
was presynaptic and >70% colocalized with EGFP::β-actin clusters, similar to wild-type 
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neurons (Figure 3.29A-D). In contrast, Pclo28 expression eliminated both high K+-induced 
EGFP::β-actin clustering and Piccolo immunoreactivity from axons of both genotypes 
(Figure 3.29A-D). These results clearly demonstrate that Piccolo isoforms containing the 
central domain are synaptically localized in PcloDEx14 neurons and can support activity-
dependent F-actin assembly. Since Piccolo regulates neurotransmitter release via F-actin 
assembly, these data further illustrate the need for transgenic animals with a more complete 
genetic knockout of Piccolo with which to study the synaptic and behavioral consequences of 
its loss-of-function. 
       
Fig. 3.29 PcloΔEx14 mice exhibit normal presynaptic F-Actin assembly 
(A) Fluorescent images of EGFP::β-actin in axons of 10 DIV +/+ and -/- hippocampal neurons, + or - 
Pclo28 shRNA, treated with high K+ (1 min) and immunostained with 44aII antibodies. For both 
genotypes, extensive axonal EGFP::β-actin clustering is induced by high K+, and clusters colocalize 
with presynaptic Piccolo immunoreactivity (arrows). Pclo28 eliminates EGFP::β-actin clustering and 
Piccolo immunoreactivity for both genotypes (arrowheads). Image gain is set ~5X higher for 
EGFP::β-actin (but not Piccolo) in Pclo28-infected axons to enable its visualization, as it is largely 
diffuse. 10um size bar. (B) Bar graphs quantifying the intensity of high K+-induced EGFP::β-actin 
puncta at presynaptic boutons, expressed as % increase in bouton/axon fluorescence (+/+ n=5 images 
from 2 animals; -/- n=14 images, 2 animals; +/+ /Pclo28 n=8, 2 animals; -/- /Pclo28 n=14, 2 animals). 
For both genotypes, presynaptic EGFP::β-actin fluorescence is >40% increased vs. axon fluorescence, 
but only ~20% increased in the presence of Pclo28 (***= p<0.0001, t-test). (C) Number of EGFP::β-
actin puncta/unit axon length (n values same as B). For both genotypes, high K+ stimulation induces 
EGFP::β-actin puncta densities of ~0.6/pixel axon length, and Pclo28 reduces this value three-fold 
(***= p<0.0001, t-test). (D) Fraction colocalization of EGFP::β-actin puncta with Piccolo 
immunostaining (n values same as B). For both genotypes, EGFP::β-actin puncta exhibit a similar 
degree of colocalization with Piccolo (~0.65). Although Piccolo immunoreactivity is substantially 
weaker in -/- neurons, it is still readily detectable with 44aII antibodies. Pclo28 significantly reduces 
Piccolo immunoreactivity, and hence colocalization with axonal EGFP::β-actin clusters, in both 
genotypes (to <0.11; ***= p<0.0001, t-test). 
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3.4 Assessing the role of Bassoon and Piccolo on the maintenance Synaptic 
Vesicle Pools. 
Studies of synapses lacking either Piccolo or Bassoon reveal that neither protein alone is 
essential for nascent synapse formation (Altrock, tom Dieck et al. 2003; Hallermann, Fejtova 
et al. 2010), though each contributes to the regulated release of neurotransmitters (Leal-Ortiz, 
Waites et al. 2008; Ibi, Nitta et al. 2010; Waites, Leal-Ortiz et al. 2011). One potential 
explanation for these relatively mild phenotypes is that these molecules are functionally 
redundant. Given that the shRNAs are capable of eliminating over 90% of all Piccolo and 
Bassoon isoforms (Figure 3.11), it was of interest to explore whether an RNA-interference 
based strategy could provide clues to the redundant functions of these active zone proteins. 
 
3.4.1 Characterization of synapses lacking Bassoon and Piccolo 
For these studies, a tricistronic lentiviral vector was created containing the Bassoon 
(Bsn16) and Piccolo (Pclo28) shRNAs or a scrambled version of Bassoon (Bsn16SC) and 
Piccolo (Pclo28SC) driven by separate polymerase III promoters (U6 and H1, respectively), 
as well as a reporter protein (i.e. EGFP) driven by the Ubiquitin C promoter (Figure 3.12C, 
D). To test the efficacy of this DKD vector (LV/EGFP/DKD), hippocampal cultures were 
infected at high titers with lentivirus at the time of plating (ensuring approximately 90% 
infection) and harvested at 14 days in vitro (DIV), a time at which the neurons were mature 
and still appeared healthy. Western blot analysis revealed that LV/EGFP/DKD (Figure 
3.12C) eliminated expression of all Bassoon and Piccolo isoforms from neurons, while the 
control vector containing scrambled versions of both shRNAs (LV/EGFP/SC) (Figure 
3.12D), did not have this effect (Figure 3.13). The levels of other presynaptic proteins, 
including the SV-associated proteins SV2, Synaptophysin, Rab3a, Syntaxin, and SNAP25, 
were also significantly reduced in lysates from DKD neurons (Figure 3.30A).  
Although DKD-infected cultures appeared healthy, it seemed reasonable that the dramatic 
reduction of SV-associated proteins could be due to abnormal neuronal development and/or 
poor cell health in the absence of Bassoon and Piccolo. An examination of dendritic 
morphology, using antibodies against MAP2a/b, revealed that LV/EGFP/DKD infected 
neurons at 14DIV had similar dendritic morphologies as those infected with LV/EGFP/SC 
(Figure 3.30B, C). Furthermore, no beading of MAP2a/b was observed (Park, Bateman et al. 
1996; Hoskison, Yanagawa et al. 2007), suggesting that overall cell health and development 
were unaffected by Bassoon/Piccolo DKD. LV/EGFP/SC and LV/EGFP/DKD-infected 
neurons were also morphologically similar to uninfected neurons and to those infected with 
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EGFP alone (data not shown), indicating that there were no significant off-target effects 
resulting from expression of two shRNAs from a single vector. 
             
Fig. 3.30 Double knockdown of Bassoon and Piccolo reduces the expression of synaptic 
vesicle proteins but not hippocampal neuronal differentiation, made smaller synapses 
but does not affect synapse density.  
(A) Western blots of cellular lysates from hippocampal neurons infected with the following lentivirus 
LV/EGFP/Pclo28; LV/EGFP/Bsn16; LV/EGFP/SC; or LV/EGFP/DKD at the time of plating. 
Samples collected after 14DIV were probed with antibodies against a series of SV-associated proteins 
(SV2, Synaptophysin, Rab3a, Syntaxin, and SNAP25). All of these proteins are dramatically reduced 
in the DKD condition. Similar results were obtained in 3 independent experiments. (B) Images of cell 
bodies and dendrites from 14 DIV neurons infected with LV/EGFP/SC or LV/EGFP/DKD(green) at 0 
DIV and immunostained with antibodies against MAP2a/b (red). Size bar is 25 mm. (C) 
Quantification of primary dendrite number in uninfected cells and those infected with LV/EGFP/SC 
or /DKD. No difference was observed between the 3 conditions (n=22 cells/condition). (D) 
Fluorescent images of 14 DIV neurons expressing EGFP::SynIa together with scrambled shRNAs 
(SC) or Bsn16/Pclo28 (DKD), immunostained with PSD-95 antibodies. Note that a majority of 
EGFP::SynIa puncta colocalize with PSD-95 in both SC and DKD conditions, yet are visually 
smaller. Size bar is 10 mm. (E) Quantification of the fraction of EGFP::Syn1a puncta that colocalize 
with PSD-95 puncta under SC and DKD conditions. No significant difference in the fraction of 
colocalization was observed (n>6 fields of view/condition, >100 puncta/field, unpaired t-test). (F) 
Fluorescent images of 14 DIV neurons infected on 0 DIV with LV/EGFP::SynIa/SC or /DKD, and 
immunostained with antibodies against PSD-95 to label postsynaptic densities. Arrows indicate a 
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subset of the LV/EGFP::SynIa puncta that colocalize with PSD-95. (G) Quantification of synapse 
density in LV/EGFP::Syn1a/SC and DKD-expressing axons. Synapses are defined as sites with 
colocalized EGFP::SynIa and PSD-95 puncta (white arrows). Values are depicted as # of 
synapses/unit length axon. There is no significant difference between the SC and DKD conditions, 
indicating that synapse formation is not altered in axons lacking Bassoon/Piccolo. 
 
One potential consequence of decreased levels of SV-associated proteins in DKD lysates 
might be an inability of DKD-infected neurons to form presynaptic boutons. This outcome 
seemed possible, especially given the early appearance of Bassoon and Piccolo at nascent 
presynaptic sites (Zhai, Olias et al. 2000) and their hypothesized roles in scaffolding a series 
of proteins to define the CAZ (Ziv and Garner, 2004). Therefore, to visualize presynaptic 
boutons in DKD-infected neurons, soluble EGFP in the SC and DKD vectors was replaced 
with EGFP::SynIa (pEGFP::SynIa/SC or /DKD), a SV-associated protein whose localization 
is almost exclusively presynaptic (Chi, Greengard et al. 2001). Neurons were electroporated 
with vectors at the time of plating and examined at 14 DIV. EGFP::SynIa was found to be 
still clustered in the axons of DKD-expressing neurons with these clusters colocalizing with 
the postsynaptic protein PSD-95, indicating that they were synaptic (Figure 3.30D, E). 
Furthermore, EGFP::SynIa colocalized with PSD-95 to a similar extent in SC and DKD-
expressing neurons, and the density of EGFP::SynIa with PSD-95 clusters along axons was 
similar for both conditions (Figure 3.30F, G). These data indicated that synapse formation 
was not directly affected by Bassoon/Piccolo DKD (Figure 3.30D, E, F, G). However, the 
size and intensity of EGFP::SynIa puncta were significantly reduced in the DKD background, 
suggesting that SV pool size maybe reduced (Figure 3.30D). 
 
3.4.2 Decreased SV pool size in the absence of Bassoon and Piccolo 
Immunostaining on EGFP::Syn/SC and EGFP::Syn/DKD-expressing neurons was 
performed using antibodies to a series of SV-associated proteins to examine SV pool size in 
presynaptic boutons lacking Bassoon and Piccolo. The intensities of all proteins examined by 
immunofluorescence confocal microscopy (Synaptophysin, SV2, VGLUT1 (not shown), 
VAMP2 (not shown)) were reduced by ~50% in the bouton of EGFP::SynIa/DKD expressing 
neurons compared to SC controls (Figure 3.31A-G). Moreover, their degrees of 
colocalization with EGFP::SynIa were reduced by ~40% compared to control boutons 
(shown for Synaptophysin; Figure 3.31A, B), reflecting the fact that SV proteins at many 
DKD expressing boutons were below the threshold of detection for our puncta analysis 
software. In contrast, the intensities of postsynaptic proteins (Homer1b and PSD-95) 
juxtaposed to EGFP::SynIa/DKD boutons were not significantly decreased (Figure 3.31E, I, 
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J). These findings indicated that loss of Bassoon and Piccolo from presynaptic boutons leads 
primarily to a dramatic reduction in SV pool size. 
       
Fig. 3.31 Loss of Piccolo and Bassoon reduces SV pool size in presynaptic boutons 
(A) Fluorescent image of 14 DIV neurons expressing EGFP::SynIa/SC or EGFP::SynIa/DKD, 
immunostained with synaptophysin antibodies. Size bar is 10 mm. (B) Quantification of EGFP::SynIa 
colocalization with Synaptophysin for SC and DKD conditions. Significantly fewer EGFP::SynIa 
puncta colocalize with Synaptophysin in the DKD (~30% vs. 70%; n> 3 fields of view/condition, with 
>50 puncta/field; * = p<0.05, unpaired t-test). (C) Images of 14 DIV neurons expressing 
EGFP::SynIa/SC and /DKD, loaded with FM4-64 using 10Hz stimulation for 60 sec. Size bar is 10 
mm. (D) Quantification of EGFP::SynIa colocalization with FM4-64 for SC and DKD conditions. 
Significantly fewer EGFP::Syn1a puncta colocalize with FM4-64 in DKD boutons (~80% vs. ~40%; 
n>5 fields of view/condition, >50 puncta/field; ***= p<0.0001, unpaired t-test. (E) Quantification of 
fluorescence intensities for a series of synaptic markers at EGFP::SynIa/DKD boutons, expressed as 
fractions of fluorescence intensity for the same marker at EGFP::SynIa/SC boutons. Dotted line at 1.0 
indicates the average fractional intensity for all markers at SC control boutons (ie. SC/SC). Note that 
presynaptic markers (SV2, Synaptophysin, FM4-64) are reduced by ~50% at DKD boutons, while 
postsynaptic markers (PSD-95, Homer1b) remain unchanged (n>4 fields of view/condition, >30 
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boutons/field; ** = p<0.005, ***= p<0.0001, unpaired t-test). (F) Cumulative frequency distribution 
of SV2 immunofluorescence intensity at EGFP::SynIa/SC (black line) or /DKD (green line) 
expressing boutons. Note that the distribution is shifted to the left for DKD boutons, indicating 
smaller SV pool size. SV2 intensity values are from (n=332 DKD and 360 SC boutons from 5 fields 
of view). (G) Similar to F, but for Synaptophysin (n=635 DKD and 369 SC boutons, 7 fields of 
view). (H) Similar to F, but for FM4-64 (n=254 DKD and 177 SC boutons, 8 fields of view). (I) 
Cumulative frequency distribution of PSD-95 immunofluorescence intensity at postsynaptic sites 
juxtaposed to EGFP-Syn-expressing boutons. The distribution of PSD-95 intensity is slightly left-
shifted for DKD boutons, but not to the extent of the presynaptic markers (n=144 DKD and 251 SC 
boutons, 4 fields of view. (J) Similar to E, but for Homer1b. The Homer1b puncta intensity 
distribution is nearly identical for SC and DKD-expressing boutons (n=119 DKD and 221 SC 
boutons, 4 fields of view). 
 
FM4-64 dye uptake at EGFP::SynIa/DKD boutons during a train of 600 action potentials was 
examined (10 Hz, 60 sec) to determine whether this reduction translated into a defect in SV 
recycling. As observed for other SV markers, both the intensity and colocalization of FM4-64 
with EGFP::SynIa were significantly reduced in DKD versus SC boutons (Figure 3.31C, D, 
E, H), suggesting that SV cycling was also likely perturbed in the absence of Bassoon and 
Piccolo. 
 
3.4.3 SV pool size is rescued by the expression of full-length, shRNA-resistant, Bassoon 
To rule out off-target effects of the shRNA DKD-induced SV loss, we examined whether 
this phenotype could be rescued by expressing full-length Bassoon in the DKD background. 
For this experiment, we created SC and DKD vectors that express the EGFP-tagged SV 
integral membrane protein SV2 as a reporter (pEGFP::SV2/SC; pEGFP::SV2/DKD). 
Endogenous SV2 was dramatically reduced in the DKD background (Figure 3.30A), and 
EGFP::SV2 (Figure 3.32A) was less prone to overexpression than EGFP-tagged Synapsin1a, 
making it a more reliable readout of SV pool size. Neurons were electroporated with 
pEGFP::SV2/SC or pEGFP::SV2/DKD vectors prior to plating, then infected with an 
adenoviral vector (HDAd) expressing an shRNA-resistant, mRFP-tagged Bassoon (HDAd-
mRFP::Bsn/SM16) (see section 3.2.8) at 5 DIV (Figure 3.32A). The ability of 
mRFP::Bsn/SM16 to rescue DKD-induced SV loss was assessed at 14 DIV. Reassuringly, 
mRFP::Bsn/SM16 expression prevented the dramatic loss of EGFP::SV2 fluorescence 
normally seen in DKD expressing boutons (Figure 3.32A, B, D). The intensity of 
Synaptophysin immunostaining within these boutons was also similar to wildtype levels, 
indicating that the effect was not specific for SV2 (Figure 3.32A, C, E). These findings 
indicated that off-target effects of my shRNAs are not responsible for the loss of SVs, as 
Bassoon expression alone rescued this phenotype.  
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Fig. 3.32 Expression of mRFP::Bsn-SM16 rescues SV pool size at DKD boutons 
(A) Fluorescent image of 14 DIV neurons expressing pEGFP::SV2/SC alone, pEGFP::SV2/DKD 
alone, or pEGFP::SV2/DKD together with shRNA-resistant mRFP::Bsn/SM16, and immunostaining 
with Synaptophysin antibodies. mRFP::Bsn/SM16 (mRFP::Bsn*) expression rescues the dramatic 
loss of EGFP-SV2 and Synaptophysin immunofluorescence from DKD boutons. Size bar is 10 mm. 
(B) Quantification of EGFP::SV2 fluorescence intensity at boutons expressing SC, DKD, and 
DKD/mRFP::Bsn/SM16 vectors. Values are expressed as fraction of EGFP-SV2 intensity at SC 
boutons. EGFP-SV2 intensity is reduced by ~80% in the DKD background, but rescued to control 
levels in the presence of mRFP::Bsn-SM16 (n>4 fields of view/condition, >100 boutons/field; 
***=p<0.0005, ****=p<0.0001, unpaired t-test). (C) Quantification of Synaptophysin 
immunofluorescence intensity at SC, DKD, and DKD/mRFP::Bsn-SM16 boutons. Synaptophysin 
intensity is reduced by ~50% in the DKD background, but like EGFP::SV2 is rescued to control 
levels by mRFP::Bsn-SM16 (n>3 fields of view/condition, >50 boutons/field; **= p=0.005, 
***=p=0.0001, unpaired t-test). (D) Cumulative frequency distribution of EGFP::SV2 fluorescence 
intensity at SC, DKD, or DKD/mRFP::Bsn/SM16 (mRFP::Bsn*) expressing boutons. This curve is 
left-shifted in the DKD condition, indicating dramatically smaller SV pool size, but is similar to the 
SC control in the presence of mRFP::Bsn/SM16 (n=673 SC, 541 DKD, and 101 
DKD/mRFP::Bsn/SM16 boutons, ≥4 fields of view/condition). (E) Cumulative frequency distribution 
of Synaptophysin immunofluorescence intensity at SC, DKD, and DKD/mRFP::Bsn/SM16 boutons. 
Again, the curve is left-shifted in the DKD condition, but similar to SC control in the presence of 
mRFP::Bsn/SM16 (n=261 SC, 236 DKD, and 70 DKD/mRFP-Bsn/SM16 boutons, ≥3 fields of 
view/condition). 
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3.4.4 Ultrastructure of boutons lacking Bassoon and Piccolo 
Our fluorescence imaging studies described thus far indicated that Bassoon and Piccolo 
are important for maintaining SV pool size but not necessarily for synapse formation. To 
confirm this conclusion, the ultrastructural properties of boutons lacking both proteins were 
examined. Similar to ultrastructural studies on synapses lacking Piccolo (Figure 3.16 & 3.17), 
SC and DKD vectors expressing the SV integral membrane protein VAMP2 conjugated to 
horseradish peroxidase (VAMP2::HRP) was used to identify the boutons and axon of 
transfected neurons by electron microscopy (EM). Again, neurons were electroporated with 
pVAMP2::HRP/SC and pVAMP2::HRP/DKD constructs prior to plating, then fixed and 
processed for EM analysis on 14 DIV. 
As anticipated, presynaptic boutons expressing the pVAMP2::HRP/SC control vector 
were morphologically normal, containing many ~40 nm diameter SVs of uniform density 
juxtaposed to prominent postsynaptic densities (PSDs) (Figure 3.33A). In contrast, boutons 
from pVAMP2::HRP/DKD expressing neurons had highly variable and abnormal 
morphologies (Figure 3.33B) with few 40 nm SVs but instead a variety of pleiomorphic 
vesicles greater than 80 nm in diameter. Some of these were tubulovesicular structures 
resembling early endosomes (Parton, Simons et al. 1992), while others were spherical and 
reminiscent of late endosomes/multi-vesicular bodies (MVBs) that transport organelles and 
proteins to lysosomes (Almeida, Takahashi et al. 2006; Altick, Baryshnikova et al. 2009; Lee, 
Sato et al. 2011) (Figure 3.33B). Moreover, juxtaposed PSDs were noticeably less electron-
dense, suggesting that postsynaptic structures were also affected by the presynaptic loss of 
Bassoon and Piccolo. This implies that more general facets of synapse structural integrity are 
being impaired in the absence of Piccolo and Bassoon. 
As it was often difficult to readily visualize synapses (e.g. with both pre and postsynaptic 
specialization) in these samples, pVAMP2::HRP/DKD neurons from an earlier timepoint (9 
DIV) were examined to obtain more quantitative measurements of their features. Indeed, 
boutons pVAMP2::HRP/DKD transfected neurons at 9 DIV typically had multiple 40 nm 
SVs juxtaposed to an identifiable postsynaptic structure (Figure 3.33B). However, these 
boutons also displayed significantly more pleiomorphic vesicles than their 
pVAMP2::HRP/SC counterparts (Figure 3.33A-D), and juxtaposed PSDs were often less 
electron-dense. In addition, SV morphology was altered at many of these boutons, with 
abnormally elongated or enlarged vesicles (Figure 3.33B, E). These data illustrate that 
Bassoon/Piccolo loss dramatically alters synaptic integrity and that many of these changes 
can be detected at a relatively early timepoint (9 DIV). 
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Fig. 3.33 Quantification of synaptic ultrastructure in boutons lacking Bassoon and 
Piccolo 
(A) Electron micrographs of boutons from neurons electroporated with pVAMP2::HRP/SC at 9 (left) 
or 14 (right) DIV. Red arrows indicate SVs labeled with VAMP2::HRP, which forms an electron-
dense precipitate within the vesicle lumen. PSD = postsynaptic density. (B) Micrographs of boutons 
from neurons electroporated with pVAMP2::HRP/DKD at 9 (left) or 14 (right) DIV. Red arrows 
indicate labeled SVs, red asterisks (placed immediately above vesicles) indicate abnormally-shaped 
SVs, blue arrowheads indicate tubulovesicular structures, and red arrowheads indicate multi-vesicular 
bodies. Note the increase in tubulovesicular structures and MVBs, and concomitant decrease in SVs, 
at 14 vs. 9 DIV. Size bars are 200 nm. (C) Quantification of HRP-labeled pleiomorphic vesicles (>80 
nm diameter)/bouton for boutons from neurons electroporated with pVAMP2-HRP/SC or /DKD. 
DKD boutons have significantly more pleiomorphic vesicles than SC control boutons (n=22 boutons 
for SC, 45 boutons for DKD; **=p<0.005, unpaired t-test). (D) Quantification of the ratio of 
pleiomorphic vesicles (>80 nm diameter) to SVs (50 nm diameter) per bouton for SC and DKD-
expressing boutons. DKD boutons have a significantly greater average ratio, reflecting their increased 
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number of pleiomorphic vesicles and decreased number of SVs (n= 22 SC and 45 DKD boutons; 
***=p<0.0005, unpaired t-test). (E) Relative frequency histogram of SV diameters in boutons from 
neurons expressing pVAMP2::HRP/SC vs. /DKD at 9 DIV. Values are shifted to the right for DKD 
boutons, indicating larger SV diameters (n=114 SVs from 5 boutons for SC, 146 SVs from 10 
boutons for DKD).  
 
3.4.5 SV degradation is enhanced in the absence of Bassoon and Piccolo 
A fundamental question raised by the analysis of DKD neurons is what causes the 
decrease in the number of SV per bouton. One likely possibility is that DKD-induced SV loss 
involves the activation of lysosomes and/or proteasomes, the two major cellular organelles 
responsible for protein degradation (Waites and Garner 2011). EGFP::SV2/SC and 
EGFP::SV2/DKD expressing neurons cultured for 12 DIV were incubated for 16 hr with 200 
mM chloroquine/100 mM leupeptin (chloro/leu) or 0.1 mM epoxomicin (epoxo) to inhibit 
lysosomal or proteasomal activity, respectively (Ehlers 2000; Lee, Tee et al. 2004; 
Willeumier, Pulst et al. 2006). EGFP::SV2 fluorescence intensity was then compared in 
treated vs. untreated neurons. Chloro/leu treatment was found to completely prevent the loss 
of EGFP::SV2 fluorescence in DKD boutons but had no effect on the fluorescence intensities 
of these molecules in SC control boutons (Figure 3.34A, B, C). Similarly, epoxo treatment 
significantly increased EGFP::SV2 fluorescence in the DKD but not the SC background 
(Figure 3.34A, C, F). These data demonstrate that protein degradation is responsible for the 
loss of SVs in boutons lacking Bassoon and Piccolo. 
Proteins are targeted for lysosomal or proteasomal degradation through ubiquitination, a 
posttranslational modification wherein ubiquitin molecules are attached to specific lysine 
residues of the target protein (Varshavsky 2005; Yi and Ehlers 2005; Waites and Garner 
2011). Ubiquitination requires the coordinated activity of a series of enzymes, including an 
E1 ubiquitin activating enzyme, E2 ubiquitin conjugating enzymes, and E3 ubiquitin ligases 
(Ding and Shen 2008; Lehman 2009). To test whether DKD-mediated SV degradation 
required protein ubiquitination, neurons expressing the pEGFP::SV2/SC or 
pEGFP::SV2/DKD constructs were treated for 16 hr (from 12-13 DIV) with 1 mM ziram, a 
drug that blocks the E1 ubiquitin activating enzyme (Chou, Maidment et al. 2008; Rinetti and 
Schweizer 2010). As with chloro/leu and epoxo, ziram treatment significantly increased 
EGFP::SV2 fluorescence intensity at DKD boutons without affecting SC control boutons 
(Figure 3.34A, D, G), suggesting that SV protein ubiquitination was enhanced at boutons 
lacking Bassoon and Piccolo. 
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Fig. 3.34 Protein degradation drives SV loss in the DKD background 
(A) Fluorescent image of 13 DIV neurons expressing pEGFP::SV2/SC or /DKD constructs, at 
baseline (control) or treated for 16 hrs with 200 mM chloroquine/100 mM leupeptin to block 
lysosomal degradation, 0.1 mM epoxomicin to block the proteasome, or 1 mM ziram to block protein 
ubiquitination. Note that all treatments increase EGFP::SV2 fluorescence in the DKD background. 
Size bar is 10 µm. (B) Quantification of EGFP::SV2 fluorescence intensity in the boutons of 
pEGFP::SV2/SC or /DKD expressing neurons treated with chloro/leu. Values are expressed as 
fraction of EGFP::SV2 intensity at untreated SC boutons. EGFP::SV2 fluorescence is reduced by 
~50% at DKD boutons. Chloro/leu treatment completely rescues this phenotype, but has no 
significant effect on SC boutons (n= 3 fields of view/condition, >50 boutons/field; ** =p<0.005, 
unpaired t-test). Results were confirmed in 3 independent experiments. (C) Similar to B, but for 
epoxomicin treatment. Epoxomicin boosts EGFP::SV2 fluorescence by ~20% in the DKD 
background, but has no significant effect on SC boutons (n>3 fields of view/condition, >60 
boutons/field; **=p<0.005, unpaired t-test). Results were confirmed in 3 independent experiments. 
(D) Similar to B, but with ziram. Like epoxomicin, ziram boosts EGFP::SV2 fluorescence in the 
DKD background by ~22% but does not alter EGFP::SV2 intensity in SC boutons (n>3 fields of 
view/condition, >60 boutons/field; **=p<0.009, unpaired t-test). Results were confirmed in 3 
experiments. (E) Cumulative frequency distribution of EGFP::SV2 intensity at SC and DKD boutons 
treated with chloro/leu. Note that the DKD control curve is significantly left-shifted, but that 
chloro/leu treatment “rescues” the DKD intensity distribution to match those of the SC and SC 
chloro/leu conditions (n=130 SC control, 181 SC chloro/leu, 269 DKD control, and 166 DKD 
chloro/leu boutons). (F) Similar to E, but for epoxomicin treatment. Like chloro/leu, epoxomicin 
shifts the DKD curve to the right, indicating some rescue of the phenotype (n=180 SC control, 350 
DKD control, 469 SC epoxomicin, and 611 DKD epoxomicin boutons). (G) Similar to E and F, but 
for ziram treatment. Ziram also shifts the DKD curve to the right, but has no effect on the SC curve 
(n=180 SC control, 350 DKD control, 551 SC/ziram, and 495 DKD/ziram boutons). 
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3.4.6 Bassoon and Piccolo zinc finger domains mediate synaptic vesicle elimination in 
DKD neurons 
How could the loss of two active zone-associated proteins lead to enhanced protein 
ubiquitination? One possibility is that Bassoon and Piccolo regulate one or more of the 
enzymes that catalyze ubiquitination. Of these, the most plausible candidates are E3 ligases, 
which provide substrate specificity and exhibit restricted spatial and temporal expression 
patterns. Our collaborator Drs Gundelfinger, Altrock and Fejtova identified the E3 ligase 
Siah1 in a yeast two-hybrid screen for Bassoon interacting partners. Siah1 was particularly 
interesting to us in the context of SV degradation because it is expressed in neurons 
(Moriyoshi, Iijima et al. 2004) and a number of its targets (Synaptophysin, β-catenin, α- 
Synuclein, Synphilin-1) are SV-associated proteins (Wheeler, Chin et al. 2002; Matsuzawa, 
Li et al. 2003; Liani, Eyal et al. 2004; Santelli, Leone et al. 2005; Szargel, Rott et al. 2009; 
Dimitrova, Li et al. 2010). In addition, the region of Bassoon shown to interact with Siah1 by 
yeast two-hybrid, the N terminal domain containing amino acids 1-609, has two zinc fingers 
(ZFD) that are also present in Piccolo (Figure 3.35 A). 
As an initial test of a potential Siah link to the DKD phenotype, we examined whether the 
Zinc-finger region of Bassoon was capable of regulating presynaptic SV pool size. This was 
accomplished by expressing an EGFP-tagged N-terminal segment of Bassoon (residues 1-
609)(EGFP-BsnZFD) in neurons. This region of Bassoon contains both of its zinc fingers 
(ZF) and was previous shown to associate with SVs and become localized at presynaptic 
boutons, yet was not incorporated into AZs (Dresbach, Hempelmann et al. 2003). Monitoring 
the expression levels of endogenous Synaptophysin in neurons overexpressing EGFP-
BsnZFD), we observed a dramatic increase in the synaptic levels of Synaptophysin. The 
over-expression of BsnZFD did not affect the levels of other AZ proteins, such as Piccolo 
(Figure 3.35B). These results are consistent with a role for the Bassoon ZFDs in regulating 
SV pool size/bouton. 
In the next phase of this work, we sought to confirm that the Bassoon ZFs bound Siah. 
Siah is comprised of a RING domain that binds different E2 ligases and a Sina domain for 
docking proteins are targeted for ubiquitination (Wheeler, Chin et al. 2002). This was 
accomplished using a cellular binding/colocalization assay in which different segments of 
Bassoon were co-expressed with subdomains of Siah in COS7 cells. Here, full-length 
Bassoon and N-terminal segments that contained the ZFs of Bassoon colocalized with full-
length Siah and Siah’s RING domain, but not its Sina domain (Figure 3.35C, D). Next, we 
examined whether Siah1 interacted selectively one or both of the Bassoon ZFs as well as the 
two homologous ZFs in Piccolo using immunoprecipitation. Here, we co-expressed each of 
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the four ZFs tagged with mCherry in HEK cells together with myc-tagged Siah1. 
Immunoprecipitation with anti-myc antibodies followed by Western blotting revealed that 
each of the four ZFs could be co-immunoprecipitated with myc-Siah, (Figure 3.35E), 
confirming the YTH binding data. 
       
Fig. 3.35 Bassoon and Piccolo interact with Siah1 and modulate its activity 
(A) Schematic diagram showing the interacting domains of Piccolo, Bassoon, and Siah1. Piccolo and 
Bassoon each have two zinc finger domains (ZF1, ZF2), and all four of these interact with the RING 
domain of Siah1. (B) Fluorescent image of 14 DIV neurons expressing EGFP-Bsn1-609 and 
immunostaining with MAP2 (blue) and Synaptophysin (red) or Piccolo (red). (C) Images of HEK 
cells cotransfected with mCh-tagged Bassoon constructs and EGFP-Siah1. Note that full-length (FL) 
Bassoon has a relatively diffuse distribution when singly transfected, but is recruited to EGFP-Siah1 
positive structures when cotransfected. The zinc finger domain (ZFD) of Bassoon (amino acids 1-
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609)(Bsn-ZFD), which contains two zinc fingers (ZFs) and interacts with Siah1 by yeast two-hybrid 
screen, exhibits a similar behavior. (D) Images of HEK cells cotransfected with mCh-tagged Bassoon 
constructs and EGFP-tagged RING or Sina domains of Siah1. Both FL-Bassoon and Bsn-ZFD 
interacted with the RING but not the Sina domain based on colocalization. (E) Western blots 
depicting coimmunoprecipitation (co-IP) of mCherry-tagged Bassoon and Piccolo ZF domains with 
myc tagged Siah1. Left panels show immunoreactivity from total HEK cell lysates prior to co- IP, and 
right panels from material immunoprecipitated with myc antibody. Top row depicts mCherry 
immunoreactivity at 100kD, size of the mCh-Synapsin1a control; middle row depicts mCh-tagged 
Bassoon and Piccolo ZFs at ~37kD; bottom row depicts myc-Siah1 at ~30kD. Similar results were 
obtained in 3 independent experiments. (F) Western blots showing Synaptophysin (Syph) 
ubiquitination in the presence or absence of Siah1 and Bassoon ZF1 (BsnZF1). Upper two panels 
show total lysates probed with either myc antibody to detect Siah1, or mCh antibody to detect 
BsnZF1. Unrelated lanes are blocked out with gray background. Lower two panels show 
immunoprecipitated Synaptophysin, probed with HA antibody to detect ubiquitination and mouse 
Synaptophysin antibody to detect total Synaptophysin levels. Unrelated lanes are blocked out with 
gray background. (G) Quantification of C. HA-ubiquitin intensity is divided by total Synaptophysin 
intensity for each condition, giving relative HA-ubiquitin levels for Synaptophysin. Note that Siah1 
increases Synaptophysin ubiquitination above baseline, and that BsnZF1 blocks this effect (n=3 
experiments, *= p<0.05, unpaired t-test). 
 
The ability of the Piccolo and Bassoon ZFs to bind the RING domain in Siah suggest that 
an association of Siah with these two AZ proteins could inhibit its activity, perhaps 
explaining why enhanced ubiquitination in the absence of Piccolo and Bassoon leads to a 
reduction of SV pools. To test this hypothesis, we performed Siah dependent ubiquitination 
assays in HEK cells, as developed by Wheeler and colleagues (Wheeler, Chin et al. 2002). As 
a substrate, we used the SV protein Synaptophysin, a documented substrate of Siah1 
(Wheeler, Chin et al. 2002). In brief, HEK cells were co-transfected with Synaptophysin and 
HA-ubiquitin in the presence or absence of myc-Siah1 and mCherry-tagged ZF1 of Bassoon. 
Twenty-four hours after transfection and four hours after treatment with 0.1mM epoxomicin 
to inhibit the proteasome, Synaptophysin was immunoprecipitated from each sample, and the 
amount of ubiquitinated Synaptophysin measured by Western blotting with HA antibodies. 
As previously reported, the over expression of Siah1 significantly increased the baseline 
ubiquitination of Synaptophysin (Figure 3.35F, G)(Wheeler, Chin et al. 2002). Interestingly, 
the simultaneous expression of the first ZF of Bassoon (Bsn-ZF1) almost completely blocked 
this increase (Figure 3.35F, G). Similar results were obtained with each of the 
Piccolo/Bassoon ZFs (data not shown) indicating that Bassoon and Piccolo can negatively 
regulate Siah1 activity through their ZFs.  
One prediction of this model is that the overexpression of the Bassoon or Piccolo ZFs in 
neurons should suppress DKD-induced SV loss. To test this prediction, neurons were 
electroporated with pEGFP::SV2/SC or pEGFP::SV2/DKD were subsequently infected (on 1 
DIV) with either mCherry alone or one of the four Bassoon/Piccolo mCherry-tagged ZFs 
(Figure 3.36A). All of these constructs exhibited relatively diffuse expression patterns in cell 
bodies and dendrites but accumulated in axonal varicosities and exhibited a high degree of 
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colocalization with EGFP-SV2 (Figure 3.36A). While mCherry alone had no effect on 
presynaptic EGFP-SV2 fluorescence in SC and DKD neurons, each of the four ZFs largely 
rescued the loss of EGFP-SV2 fluorescence at DKD boutons (Figure 3.36A-C). Intriguingly, 
mChr-BsnZF2 expression significantly increased EGFP::SV2 fluorescence intensity at SC 
boutons (Figure 3.36B), suggesting that these domains play as specific role in the regulation 
of SV pool size perhaps through their binding to Siah1. Taken together, these findings 
suggest a model wherein Bassoon/Piccolo knockdown leads to the overactivation of Siah1 
within presynaptic boutons, followed by excessive ubiquitination of its SV-associated protein 
substrates and subsequent SV degradation.  
 
    
Fig. 3.36 Zinc finger domains in Piccolo and Bassoon regulate SV loss in DKD neurons 
(A) Fluorescent images of 14 DIV neurons expressing EGFP::SV2/SC or /DKD together with either 
soluble mCherry or one of the four mCh-tagged Zinc fingers from Piccolo (PcloZF1; PcloZF2) and 
Bassoon (BsnZF1; BsnZF2). Size bar is 10 µm. (B) Quantification of EGFP::SV2 fluorescence 
intensity in SC or DKD boutons co-expressing soluble mCh or one of the four mCh-tagged ZFs. Note 
that each ZF partially rescues EGFP-SV2 fluorescence (by ~30%) in the DKD background, and that 
BsnZF2 significantly increases EGFPSV2 fluorescence (by ~50%) in SC control boutons (n=3 fields 
of view/condition, >60 boutons/field; ***=p<0.0005, **=p<0.005, *=p<0.05, unpaired t-test). (C) 
Cumulative frequency distribution of EGFP::SV2 fluorescence intensity in DKD boutons expressing 
the ZFs. Each ZF partially rescues the DKD phenotype, shifting the intensity distribution toward the 
right. The distribution of EGFP::SV2 in SC control boutons expressing mCherry is shown for 
comparison (black curve)(n=350 SC/mCh, 215 DKD/mCh, 260 DKD/BsnZF1, 130 DKD/BsnZF2, 
130 DKD/PcloZF1, 190 DKD/PcloZF2 boutons). 
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4. Discussion 
The goal of this thesis is to define unique and shared functions of Piccolo and Bassoon 
within presynaptic AZs. A significant portion of this work has been devoted to the 
development of new technologies that allow the cell autonomous and synapse specific 
analysis of presynaptic boutons. Innovations included the creation of a library of bi and 
tricistronic plasmid and lentiviral vectors that support not only the expression of synaptic 
proteins at or near endogenous levels, but also the expression of shRNAs to dramatically 
reduce the expression of multiple neuronal proteins. In addition, this work explored strategies 
for the cryopreservation of genetically modified glia and neuronal cells, a technology that 
facilitates the sharing of reagents with defined characteristics, at reduced cost. These 
advances have allowed the detailed analysis of presynaptic boutons lacking Piccolo and 
Bassoon, uncovering functions that were hereto unattainable by other technologies. For 
example, utilizing bicistronic vectors expressing different XFP-tagged presynpatic proteins 
and shRNAs against Piccolo, it was possible to show that together the various Piccolo 
isoforms play a fundamental role in the regulated recycling of SVs by controlling the 
dynamic assembly of presynaptic F-Actin. Studies of boutons lacking both Piccolo and 
Bassoon demonstrate that these two AZ proteins contribute to the proteostasis of presynaptic 
bouton, as in their absence, SV pools and synapse integrity are compromised. 
Mechanistically, Piccolo and Bassoon were found to use their zinc finger domains to 
suppress the activity of Siah, an E3 ubiquitin ligase known to ubiquitinate SV-proteins.  
,Together these results suggest that Piccolo and Bassoon are important regulators of core 
functions within presynaptic bouton, such as the activity dependent assembly of F-actin and 
SV exocytosis as well as the local activity of components of the 
ubiquitin/lysosome/proteosome system. 
 
4.1 Cyropreserving hippocampal neurons 
Neuronal networks established by cultured neurons have become invaluable for studying 
the molecular, cellular and physiological mechanisms underlying neuronal morphogenesis, 
nascent synapse formation and synaptic function. Although dissociated cultures can be 
prepared from most brain regions, cultures prepared from the hippocampus, in particular 
those by the method of Goslin and Banker (Banker and Goslin 1988; Banker and Goslin 
1998; Tanaka 2002), are some of the most reliable for the long term study of mature neuronal 
circuits as well as early stages of neuronal differentiation, acquiring features nearly 
indistinguishable from cells in vivo.  Neurons in these cultures are also readily amenable to 
genetic manipulation via plasmids and viruses, yet the challenges and cost associated with the 
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preparation of separate glia and neurons are not trivial requiring dedicated personnel, hours 
of weakly preparation and large numbers of animal. In this project, we explored whether 
cryopreservation methods could be used to store stocks of glia and neurons for months and 
whether upon thawing they would readily differentiate, exhibit normal electrophysiological 
properties and survive pre-infection with lentivirus. Our studies demonstrate that 
cryopreservation of neurons and glia can not only be achieved but can reduce costs and 
provide collaborators with genetically defined and well-characterized neurons. 
Over the last three decade, multiples groups have made significant advances in 
cryopreserving cells from different brain regions, embryonic neuronal tissue and even blocks 
of brain tissue (Houle and Das 1980; Kawamoto and Barrett 1986; Ruwe and Trumble 1990; 
Otto, Gortz et al. 2003; Paynter 2008). Cyropreservation has also been achieved for specific 
human neuronal cell types including: mesencephalic dopamine neuron or adherent neuronal 
network (Silani, Pizzuti et al. 1988; Petite and Calvet 1997; Ma, O'Shaughnessy et al. 2006), 
as well as for transfected primary dorsal root ganglia (Negishi, Ishii et al. 2002; Seggio, 
Ellison et al. 2008) or Glia (Banker and Goslin 1988; Banker and Goslin 1998; Tanaka 
2002). A survey of this literature reveals that most of these protocol are very well develop for 
cryopreserving tissues but not dissociated cells (neurons and glia). For example, Banker and 
Goslin state that glia exhibit morphological and differentiation problem following 
cryopreservation. Based on these technologies, companies such as Invitrogen/Gibco now 
offer cryopreserved dissociated cells from cortex and hippocampus. Not surprising, the 
composition of the media used for cryopreservation is not stated and only very small amounts 
of cells are provided (e.g. 1 ml containing 1x106 neurons) making this avenue extremely 
expensive. 
Currently, investigators study non-neural cells use 90% FBS and 10% DMSO for 
cryoprotection, which provides more protection than simply using Cell Freezing Medium-I 
that contains DMEM 4.5 gm/l D-glucose, 20% Fetal Bovine Serum and 10% DMSO, as 
recommended by Applied Molecular Biology at University of Maryland, Baltimore County 
and Atlanta Biologicals. In my studies, it was found that large numbers of glia and >60% 
neurons survive using 90% FBS and 10% DMSO. Further improvement in cell survival by 
adding CNQX and APV, to block glutamate receptor mediated cytotoxicity, was not 
observed. For comparison, we examined whether freezing media sold by Invitrogen that 
contains serum supplemented with B27 was effective in cyropreserving neurons. 
Surprisingly, neurons did not survive well in this media even when CNQX and APV were 
included.  
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Beyond cell survival, we also examine whether the differentiation state and functionality 
of glia and neurons were maintained after cryopreservation in 90% FBS and 10% DMSO. 
For example, using this protocol it was possible to freeze/thaw primary cultures of glia at 
least three time without loss of their capacity to differentiated into GFAP positive astrocytes 
and support the growth and differentiation of primary hippocampal neurons. Notably, we 
found that using a simple “slap” technique, it was possible to dislodge and thus remove 
unwanted microglia form these cultures, a problem known to limit the propagation and 
maintenance of astrocytes in a form that support neuronal cell differentiation (Banker and 
Goslin 1988; Banker and Goslin 1998). 
With regard to neuronal functionality following cryopreservation, we found that our 90% 
FBS and 10% DMSO freezing media supported >60% nerve cell survival. Moreover, we find 
that these neurons differentiate at a normal rate, forming elaborate dendritic arbors with 
synapses studded along their length.  Electrophysiological recording reveal that these neurons 
are electrically active, and support synaptic transmission. Intriguingly, we found that post 
thawing neurons were readily infected with lentiviral vectors expressing and delivering 
reporter molecules such as EGFP-tagged Synapsin1a to presynaptic boutons. Moreover, we 
found that infecting neurons with lentiviruses prior to freezing did not affect neuronal cells 
viability or their capacity to differentiate forming extensive neuronal networks. This is a 
significant advance in this technology and will facilitate long-distant collaboration where 
genetically manipulated neuronal cells can be shipped and studied in greater detail. 
In summary, we have found that both glia and neurons can easily be cryoprotected with 
90% FBS and 10% DMSO, stored for month and used a later times or other laboratories. This 
simple technology should also dramatically reduce cost of producing primary neural cells and 
glia. 
 
4.2 Assessing the role of Piccolo and Bassoon in the assembly, function and integrity of 
excitatory hippocampal synapses 
A major focus of this thesis was to uncover the function of two large presynaptic AZ 
proteins, Piccolo and Bassoon. They are rapidly recruited to nascent synapses and are stably 
maintained at presynaptic AZs at mature synapses in the adult brain suggesting a core role in 
synapse assembly, function and tenacity (Gundelfinger and tom Dieck 2000; Fejtova and 
Gundelfinger 2006). Given their large size, complex gene structure and extensive alternative 
splicing traditional knockout strategies have only succeeded in eliminating Bassoon, but not 
Piccolo from synapse through out the brain (Altrock, tom Dieck et al. 2003; Hallermann, 
Fejtova et al. 2010; Mukherjee, Yang et al. 2010). These studies have clearly shown that 
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Bassoon is essential for tethering ribbons to the archiform density of ribbon synapses in the 
retina and inner ear. It has also been shown to regulate synaptic transmission at conventional 
synapses but is dispensable for synapse formation and stability. A likely explanation for these 
limited phenotypes is the broad and overlapping expression of Piccolo, a structurally related 
AZ protein. The experiments performed in this doctoral thesis were design to fill some of 
these gaps in our understanding primarily by first examining how the loss of Piccolo affects 
synapse assembly and function and second to assess the overlapping functions of Piccolo and 
Bassoon. 
 
4.3 Roles of CAZ proteins at presynaptic boutons 
Loss of function studies on CAZ proteins over the last two decades have primarily 
demonstrated defects in SV docking, priming and fusion, as seen for Munc18, Munc13 and 
Rim1α (Augustin, Rosenmund et al. 1999; Verhage, Maia et al. 2000; Schoch, Castillo et al. 
2002; Weimer and Richmond 2005; Schoch and Gundelfinger 2006; Bykhovskaia 2011; 
Deng, Kaeser et al. 2011; Han, Kaeser et al. 2011; Kaeser, Deng et al. 2011). Until recently, 
it was unclear whether Piccolo and Bassoon were involved in these processes. Their high 
structural similarity, near-complete overlap of binding partners (Wang, Kibschull et al. 1999; 
Fenster, Chung et al. 2000; Fenster, Kessels et al. 2003; Kim, Ko et al. 2003; tom Dieck, 
Altrock et al. 2005; Fejtova and Gundelfinger 2006; Fejtova, Davydova et al. 2009), and thus 
likely functional redundancy will make this issue difficult to resolve until the analysis of 
synapses lacking both proteins is possible.   
However, studies of synapses lacking Piccolo and/or Bassoon are beginning to reveal 
unique roles for each. For example, studies of photoreceptor ribbon synapses demonstrate a 
crucial functional role for Bassoon in the attachment of ribbons to the archiform density, and 
in neurotransmission at these synapses (Altrock, tom Dieck et al. 2003; Dick, tom Dieck et 
al. 2003; tom Dieck, Altrock et al. 2005). Furthermore, the increase in number of 
presynaptically silent synapses in Bassoon-deficient hippocampal neurons (Altrock, tom 
Dieck et al. 2003) argues for a potential role of Bassoon in key aspects of vesicle release, 
perhaps similar to Munc13, Munc18 and Rim1α (Weimer and Richmond 2005; Schoch and 
Gundelfinger 2006) and speed vesicle reloading at a central excitatory synapse (Hallermann, 
Fejtova et al. 2010). In contrast, we found no evidence that loss of Piccolo had any affect on 
the fraction of presynaptically silent synapses or on the size or release probability of the RRP 
of SVs. These data indicate that Piccolo does not directly participate in SV docking, priming 
or fusion. Instead, our data reveal that Piccolo, but not Bassoon, influences the translocation 
of SVs from the reserve pool to the RRP by regulating the dynamic properties of Synapsin1a 
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and F-actin. These findings suggest that Piccolo may perform an integrative function within 
presynaptic boutons, coupling SV docking and fusion to the mobilization/recruitment of SVs 
from the reserve pool to the AZ.  
 
4.4 Changes in the rates of SV exocytosis in neurons lacking Piccolo can be linked to 
altered Synapsin dynamics 
Synapsins are a well-characterized family of presynaptic phospho-proteins thought to 
regulate the translocation of SVs from the reserve to the readily-releasable pools (De Camilli, 
Benfenati et al. 1990; Greengard, Valtorta et al. 1993; Hilfiker, Pieribone et al. 1999). This 
concept is supported by knockout studies showing that Synapsins are essential for 
maintaining the size of the reserve pool of SVs (Li, Chin et al. 1995; Ryan, Li et al. 1996), 
and by dynamic imaging studies, including this one, demonstrating that they regulate SV 
exocytosis rates at a range of stimulus frequencies (Chi, Greengard et al. 2001; Chi, 
Greengard et al. 2003).  Importantly, the dynamic properties of Synapsin, particularly its 
activity-dependent dissociation from SVs and the actin cytoskeleton, are regulated by 
phosphorylation (Torri Tarelli, Bossi et al. 1992; Hilfiker, Pieribone et al. 1999). 
Although Synapsin is phosphorylated by multiple kinases, several studies have implicated 
CaMKII as its most prominent regulator (Schiebler, Jahn et al. 1986; Benfenati, Valtorta et 
al. 1992; Ceccaldi, Grohovaz et al. 1995; Stefani, Onofri et al. 1997). However, these studies 
utilized in vitro binding assays, and none assessed the direct contribution of CaMKII to either 
the dispersion kinetics of Synapsin or to SV exocytosis in intact neurons. Two studies that 
did examine these functions used serine to alanine phospho-mutants to demonstrate that the 
two identified CaMKII sites were important for regulating the rates of Synapsin dispersion 
and SV exocytosis (Chi, Greengard et al. 2001; Chi, Greengard et al. 2003). However, neither 
was performed at physiological temperatures, and neither used pharmacological tools to 
assess the role of CaMKII in these processes. 
In our analysis of boutons lacking Piccolo, we have carefully examined the relationship 
between Piccolo, Synapsin dispersion, SV exocytosis, and the regulation of these events by 
CaMKII in intact neurons at physiological temperature. Our analysis of thousands of boutons 
revealed a remarkable and previously unreported heterogeneity in the degree of EGFP-
Synapsin dispersion and FM5-95 destaining per bouton (from >50% to 0%) in wild-type 
neurons.  We also observed a tight correlation between Synapsin dispersion and SV 
exocytosis. Though other studies have suggested such a relationship, ours is the first to 
conclusively demonstrate it. We have also closely examined the role of CaMKII in regulating 
Synapsin dispersion. Surprisingly, blocking CaMKII activity with KN62 did not alter 
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Synapsin dispersion in wild-type neurons, suggesting that other kinases may mediate this 
activity. This concept is supported by several previous studies indicating that PKA and 
MAPK are important regulators of Synapsin, modulating its association with SVs or F-actin, 
respectively, and, in the case of MAPK, mediating SV exocytosis via Synapsin 
phosphorylation (Jovanovic, Benfenati et al. 1996; Hosaka, Hammer et al. 1999; Jovanovic, 
Czernik et al. 2000; Jovanovic, Sihra et al. 2001).  Intriguingly, removing Piccolo from 
synapses caused Synapsin dispersion to be regulated by CaMKII.  Furthermore, under these 
conditions, the enhanced rate of SV exocytosis was also CaMKII-dependent, as both 
phenotypes could be rescued by inhibiting CaMKII with KN62. These data support our 
general conclusion that Piccolo negatively regulates SV exocytosis, apparently via a 
CaMKII-mediated mechanism. 
We have also examined the phosphorylation state of Synapsin in the absence of Piccolo. 
We found that under basal conditions, Synapsin was hypophosphorylated at both CaMKII 
and MAPK sites. While the levels of phosphorylation at both sites increased during 
stimulation, absolute levels of phosphorylation were always below those found in wild-type 
neurons. This finding was unexpected, as we had predicted based on multiple previous 
studies and our own experiments with KN62 that hyperphosphorylation of Synapsin would 
mediate its enhanced dispersion. However, total phosphorylation levels of Synapsin may not 
be predictive of its dispersion kinetics, as two other imaging studies have demonstrated that 
Synapsin dynamics are regulated through a complex combinatorial code of phosphorylation 
and dephosphorylation at its seven phospho-sites (Chi, Greengard et al. 2001; Chi, Greengard 
et al. 2003). Furthermore, given Piccolo’s putative role as a molecular organizer of the AZ, 
multiple signaling pathways may be subtly altered in its absence, affecting the balance of 
presynaptic phosphorylation/dephosphorylation in ways that are difficult to detect or 
interpret. In such a scenario, Synapsin would likely be one of many phospho-proteins 
indirectly affected by the loss of Piccolo. On the other hand, if Synapsin 
dynamics/phosphorylation alone are altered (still a possibility given the lack of other 
detectable phenotypes), this would provide evidence for a more direct Piccolo-Synapsin 
interaction, perhaps through one of the F-actin regulating proteins (ie. GIT1, Abp1, Profilin, 
Daam1 and Trio) known to bind Piccolo. 
 
4.5 Altered phosphorylation of Synapsin in boutons lacking Piccolo cannot account for 
Piccolo dependent changes in SV exocytosis and Synapsin dispersion 
Initially, we considered the possibility that altered CaMKII phosphorylation of 
Synapsin1a caused the Piccolo knockdown phenotypes. Consistent with this hypothesis, the 
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CaMKII inhibitor KN62 rescued these phenotypes, and CaMKII-mediated phosphorylation 
of Synapsin1a was impaired in neurons lacking Piccolo. In addition, the Synapsin1a S23A 
phospho-mutant (lacking CaMKII phosphorylation) slowed SV exocytosis in wild-type 
hippocampal neurons (Chi, Greengard et al. 2001; Chi, Greengard et al. 2003) and rescued 
the enhanced SV exocytosis seen at boutons without Piccolo. However, this mutant did not 
rescue the enhanced Synapsin1a dispersion phenotype. Moreover, KN62 treatment attenuated 
the enhanced dispersion of the S23A mutant, suggesting that CaMKII substrates other than 
Synapsin1a were responsible for this phenotype. Since our data demonstrate that Synapsin1a 
dispersion and FM destaining are tightly linked, we hypothesized that an upstream molecule 
was responsible for coordinately regulating both events. One likely candidate is F-actin, 
previously shown to modulate both activity-dependent SV exocytosis and Synapsin1a 
dispersion (Morales, Colicos et al. 2000; Sankaranarayanan, Atluri et al. 2003; Cingolani and 
Goda 2008). 
 
4.6 Piccolo is an essential regulator of activity dependent presynaptic F-actin assembly 
Three functions have been ascribed to presynaptic F-actin. These include a barrier 
function at the AZ plasma membrane that limits SV fusion (Morales, Colicos et al. 2000), a 
translocation function that regulates RP maintenance and RRP refilling during periods of 
sustained synaptic activity, often in association with Synapsin1a (Greengard, Benfenati et al. 
1994; Hilfiker, Pieribone et al. 1999; Jensen, Walaas et al. 2007; Cingolani and Goda 2008), 
and an endocytic function that facilitates SV retrieval (Kuromi and Kidokoro 1998; 
Shupliakov, Bloom et al. 2002; Bloom, Evergren et al. 2003; Richards, Rizzoli et al. 2004). 
Whether these functions correspond to spatially and/or morphologically distinct pools of F-
actin within presynaptic boutons remains unclear. Also unclear is the precise regulatory 
nature of each function, which appears to differ depending on synapse type. At central 
glutamatergic synapses, F-actin negatively regulates several aspects of SV exocytosis. For 
example, acute F-actin depolymerization in dissociated hippocampal neurons has been shown 
to enhance Pr (Morales, Colicos et al. 2000), presumably by dismantling an F-actin “barrier” 
that limits SV fusion at the AZ. In addition, a recent study performed in hippocampal slices 
suggests that F-actin functions to separate the RP from the RRP, thus limiting SV 
mobilization into the RRP and preserving synaptic efficacy during sustained activity (Jensen, 
Walaas et al. 2007). Interestingly, this study also showed that mobilization of the RP was 
dependent on Synapsins 1 and 2, supporting the concept that both F-actin and Synapsins are 
important mediators of RRP refilling during sustained activity (Jensen, Walaas et al. 2007). 
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These studies indicate that F-actin negatively regulates both SV translocation and fusion at 
glutamatergic synapses. 
Which of these functions are regulated by Piccolo? Our experiments so far indicate that 
Piccolo regulates SV translocation. Activity-dependent Synapsin1a dispersion is dramatically 
enhanced in the absence of Piccolo, suggesting that Synapsin1a-associated functions of F-
actin are compromised. In addition, SV exocytosis rates during 10 Hz, 90 s stimulation, 
shown to mobilize the RP (Jensen, Walaas et al. 2007), are significantly enhanced at boutons 
lacking Piccolo, while F-actin levels are reduced, suggesting the absence of a regulatory 
barrier (i.e., F-actin) during SV translocation/RRP refilling. Whether Piccolo also regulates 
the AZ-associated barrier function or putative endocytic function of F-actin is unknown, 
although its binding partners Abp1and Profilin2 both have demonstrated roles in endocytosis 
(Kessels, Engqvist-Goldstein et al. 2001; Mise-Omata, Montagne et al. 2003; Gareus, Di 
Nardo et al. 2006), suggesting that Piccolo may also function in this process. Future studies 
should address these issues.  
We have also uncovered a novel role for Piccolo-mediated F-actin assembly in 
facilitating the activity-dependent recruitment of CaMKIIα to presynaptic boutons. 
Specifically, we found that like F-actin, EGFP-CaMKIIα failed to undergo activity dependent 
recruitment in the absence of Piccolo. This lack of translocation could account for the 
hypophosphorylation of Synapsin1a in neurons lacking Piccolo, although the functional 
relevance of this defect is unclear. Since CaMKIIα is an important signaling molecule with 
multiple presynaptic substrates, including Synapsin1a and BK channels (Wang 2008), it is 
possible that other aspects of presynaptic function and plasticity are affected by Piccolo loss 
(Ninan and Arancio 2004; Wang 2008). 
 
4.7 Piccolo dependent presynaptic phenotypes are not exhibited by neurons cultured 
from PcloΔEx14 mice 
Recently, Mukherjee and colleagues described a mouse with a targeted deletion of exon 
14 of the Pclo gene (PcloΔEx14) (Mukherjee, Yang et al. 2010). This exon encodes a small 
part of the C-terminal C2A domain.  Before excising exon14 with CRE, the authors reported 
a >95% loss of Piccolo protein, but no defects in neurotransmission or synaptic plasticity, 
while post excision the levels of Piccolo were not affected. This suggests that the neomycin 
(neo) selectable marker for the knockin was adversely affecting the expression of Piccolo. 
The lack of overt synaptic phenotypes in cultured neurons from these mice lead to the 
suggestion that Piccolo is dispensable for these processes (Mukherjee, Yang et al. 2010). 
These data are at odds with our studies using shRNAs to knockdown Piccolo. However, 
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using well-characterized antibodies that recognize a central region of Piccolo present in most 
of the >8 Piccolo isoforms, revealed that neo cassette near exon 14 only affects a subset of 
isoforms (>400 kDa) (Figure 3.28). This latter finding is consistent with known and predicted 
alternatively splicing of 3’ exons in the Pclo gene (Fenster and Garner 2002). Importantly, 
immuno-reactivity associated with the remaining (~200–400 kDa) isoforms was detected 
within presynaptic boutons of neurons cultured from (PcloΔEx14/neo) mice. Moreover, no 
deficits in activity dependent F-actin assembly could be detected in the presynaptic boutons 
of these neurons. Taken together these data suggest that the remaining isoforms support many 
of the activity dependent function of Piccolo. To test this hypothesis, we infected 
PcloΔEx14/neo neurons with the Piccolo shRNA Pclo28. Under these conditions, the 
remaining Piccolo immuno-reactivity in these boutons was loss and activity-dependent F-
actin assembly was disrupted. These observations suggest that the PcloΔEx14/neo mice will 
not be very useful for assessing core contribution of Piccolo to synaptic function. This said, a 
number of recent studies have shown that the C2A domain in Piccolo can be mutated in a 
subpopulation of patients with major depressive disorder (Bochdanovits, Verhage et al. 2009; 
Sullivan, de Geus et al. 2009; Furukawa-Hibi, Nitta et al. 2010). This suggest that 
PcloΔEx14-/- mice may prove useful for studying the underlying molecular mechanisms 
associated with of major depressive disorders (Bochdanovits, Verhage et al. 2009; Sullivan, 
de Geus et al. 2009; Furukawa-Hibi, Nitta et al. 2010). 
 
4.8 Bassoon and Piccolo regulate of SV proteostasis 
Although the loss of either Bassoon or Piccolo from central glutamatergic synapses 
produces relatively mild phenotypes, their striking shared structural homology along most of 
their length indicates that they likely have significant functional redundancy within 
presynaptic boutons. As an initial attempt to unmask these shared roles, we designed a 
tricistronic lentiviral vector that can simultaneous knockdown of both proteins with greater 
than 90% efficiency. As discussed below double-knockdown (DKD) of Bassoon and Piccolo 
induced a dramatic reduction of SV proteins in lysates from DKD neurons as well as a 
progressive loss of SVs from presynaptic boutons. Intriguingly, drugs that blocked the 
proteosome and lysosomal systems restored SV pool size. These findings indicate that 
Piccolo/Bassoon may function together to regulate aspects of pre-synaptic proteostasis. 
Several lines of evidence support a shared role for Bassoon and Piccolo in the 
proteostasis of SVs, also referred to as SV-stasis. First, knockdown of both proteins causes a 
dramatic reduction in the expression of multiple SV-associated proteins, including 
Synaptophysin, VAMP2, Rab3a, SV2, VGLUT1, and Synapsin1a, as assessed by Western 
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blotting, immunostaining, and expression of recombinant EGFP-tagged proteins. This 
reduction does not occur in neurons expressing scrambled control shRNAs or single shRNAs 
against either Piccolo or Bassoon. Importantly, this phenotype can be rescued by the 
expression of full-length, shRNA-resistant mRFP-Bassoon, arguing that it is not due to off-
target effects of the shRNAs. Second, ultrastructural examination of boutons lacking Bassoon 
and Piccolo reveals significant abnormalities in SV morphology and pool size, including 
decreased numbers of SVs/bouton, increased numbers of elongated/enlarged SVs, and the 
appearance of numerous pleiomorphic vesicles reminiscent of early and late endosomes. 
Between 9 and 14 DIV, pleiomorphic/endosomal structures increase dramatically in 
prevalence while SVs decreased, suggesting that these structures represent intermediates in a 
pathway for SV degradation. Finally, pharmacological manipulations that inhibit protein 
ubiquitination (Ziram), proteasomes (epoxomicin), or lysosomes (chloroquinone/leupeptin) 
mitigate the DKD-induced loss of SV-associated proteins. Taken together, these findings 
indicate that Bassoon and Piccolo are critically important for maintaining SV pools within 
presynaptic boutons.  
Although less robust, a similar phenotype of SV loss was observed by Mukherjee and 
colleagues in their recent study of neurons with reduced levels of Bassoon and Piccolo 
(Mukherjee, Yang et al. 2010). These authors performed an ultrastructural analysis of 
neurons cultured from PcloΔEx14/neo mice that were also infected with an shRNA against 
Bassoon. Under these conditions, they found a ~50% reduction in the numbers of both total 
and docked SVs/bouton. No other morphological defects were detected, leading the authors 
to conclude that Bassoon and Piccolo have a relatively minor role in SV clustering. However, 
we believe that their findings reflect a weak version of the DKD phenotype caused by 
incomplete knockdown of both proteins. This conclusion is supported by the authors’ own 
experiments demonstrating that only ~60% of Bassoon was eliminated by shRNA 
knockdown (Mukherjee, Yang et al. 2010). Moreover, our re-analysis of the PcloΔEx14/neo 
mice revealed that only three of the seven identified Piccolo isoforms are eliminated. 
Importantly, these remaining isoforms all contain the two Piccolo double Zinc Finger 
domains and localize to presynaptic boutons. Importantly, we also find that Piccolo loss-of-
function phenotypes are not present in neurons cultured from PcloΔEx14/neo mice, unless 
the remaining Piccolo isoforms are eliminated from these neurons by shRNA knockdown 
(Figure 3.29). Thus, we believe that the ultrastructural data from the study by Mukherjee and 
colleagues are consistent with ours, demonstrating a role for Piccolo and Bassoon in 
regulating SV pool size and not just SV clustering. 
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4.9 ZF domains in Bassoon and Piccolo modulate SV pool size 
We have also explored the molecular mechanisms underlying Piccolo/Bassoon dependent 
regulation of SV-stasis. Maintenance of SV pools requires a delicate balance between de-
novo synthesis, recycling, and degradation of SV-associated peripheral and integral 
membrane proteins. Ubiquitination is hypothesized to regulate two of these steps. The 
recycling of SV proteins during exo/endocytosis is potentially mediated by 
monoubiquitination, while their degradation by lysosomes or proteasomes is mediated by 
polyubiquitination (DiAntonio and Hicke 2004; Varshavsky 2005; Yi and Ehlers 2005; 
Waites and Garner 2011). To test whether enhanced ubiquitination contributes to the DKD 
phenotype, we treated neurons with ziram, a drug that blocks the initial step of protein 
ubiquitination. We find that ziram substantially attenuates DKD-induced loss of EGFP-SV2 
fluorescence, suggesting that Bassoon and Piccolo regulate the activity of one or more 
ubiquitinating enzymes. 
Consistent with this concept, studies by Altrock, Fetjova and Gundelfinger (Personal 
communication) have found in a yeast-two hybrid screen that several subdomains in Bassoon 
can interact with a number of E3 ligases. For our studies the most intriguing is Siah1a which 
was found to directly interact with the Zinc finger (ZF) domains in Bassoon. This E3 has 
been previously found to ubiquitinate a number of SV associated proteins including alpha-
synuclein, synaptophysin and beta-catenin (Wheeler, Chin et al. 2002; Liani, Eyal et al. 2004; 
Lee, Wheeler et al. 2008; Rott, Szargel et al. 2008; Dimitrova, Li et al. 2010). To explore 
whether the zinc finger domains in Bassoon, which are highly conserved in Piccolo (Fenster, 
Chung et al. 2000), we performed to types of experiments. First, we used immuno-
precipitation to confirm that the ZF domains in both Bassoon and Piccolo could associate 
with recombinant myc-tagged Siah1a. Next, we over-expressed the N-terminal segment of 
Bassoon (residues 1-609), which includes its two ZF domains, as a fusion protein with EGFP 
(EGFP-Bsn1-609). As reported previously, this region of Bassoon was found to localize 
within presynaptic boutons of wild-type neurons (Dresbach, Hempelmann et al. 2003)(Figure 
3.35). Intriguingly, double label immuno-fluorescent microscopy revealed that EGFP-Bsn1-
609 over-expression triggered a dramatic increase in the intensity of SV marker like 
synaptophysin compared to untransfected control neurons. Moreover, when EGFP-Bsn1-609 
was expressed in DKD neurons, the levels of SV proteins were restored. A similar result was 
obtained when the Bassoon and Piccolo ZnF domain were individually expressed in DKD 
neurons. Taken together, these data explain why the loss of SV phenotype is not observed in 
neurons lacking only Piccolo or Bassoon and/or in neurons from PcloΔEx14/neo mice 
infected with an shRNA that only modestly knocks down Bassoon. Mechanistically, our data 
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also indicate that the ZF domains in Piccolo and Bassoon function to regulate SV-stasis in 
part by negatively regulating the poly-ubiquitination of SV proteins within presynaptic 
boutons. 
 
4.10 Ubitination in presynaptic structure and function 
Ubiquitination has recently emerged as an important regulator of presynaptic function, 
with roles in SV exocytosis and presynaptic plasticity. For example, acute inhibition of 
protein ubiquitination by ziram has been shown to dramatically increase neurotransmitter 
release in cultured hippocampal neurons (Rinetti and Schweizer 2010), suggesting that the 
dynamic ubiquitination of presynaptic proteins regulates SV fusion. Moreover, the activity-
dependent ubiquitination and degradation of two CAZ proteins that regulate SV priming and 
fusion, RIM1 and Munc13, appears to underlie a form of presynaptic silencing induced by 
strong depolarization (Jiang, Litkowski et al. 2010). Specific E3 ligases are likely to mediate 
these effects, and several with presynaptic substrates have been identified. For instance, the 
synaptically-localized E3 ligases Scrapper and Fbxo45 have been shown to bind and 
ubiquitinate RIM1 and Munc13-1, respectively (Yao, Takagi et al. 2007; Tada, Okano et al. 
2010). Scrapper and Fbxo45 knockout mice both exhibit enhanced neurotransmitter release, 
consistent with the increased levels and decreased turnover of RIM1 and Munc13-1, 
respectively, observed in the brains of these mice. Interestingly, Scrapper may also regulate 
SV pool size, as its levels are inversely related to those of several SV-associated proteins, 
including Synaptophysin, SynapsinIIa, and Synaptotagmin (Yao, Takagi et al. 2007). 
Furthermore, ultrastructural analysis of presynaptic boutons from Scrapper KO mice shows 
that they have higher SV density than wild-type mice, indicating larger SV pools (Yao, 
Takagi et al. 2007). 
In addition to Scrapper, another group of E3 ligases that appear to regulate SV pool size 
is the PHR family, composed of human PAM, Drosophila highwire, C. elegans RPM-1, and 
mouse Phr (Jin and Garner 2008). Although these ligases have diverse functions depending 
on organism and synapse type, all seem to regulate the formation and/or stability of 
presynaptic boutons. For example, RPM-1 loss of function reduces total synapse density and 
the number of SVs/bouton in C. elegans, and also causes disorganized presynaptic 
architecture (Schaefer, Hadwiger et al. 2000; Zhen, Huang et al. 2000), suggesting a critical 
role for RPM-1 in bouton formation and/or stability. Studies of Phr knockout mice further 
support a role for this E3 ligase in presynaptic maintenance, as the neuromuscular junctions 
of Phr -/- mice undergo atrophy due to retraction of their presynaptic terminals (Lewcock, 
Genoud et al. 2007; Saiga, Fukuda et al. 2009). Interestingly, a similar phenotype is seen in 
                                                                                                                                    Discussion 
 119 
mice lacking Fbxo45, the murine homolog of C. elegans FSN-1, which functions in the same 
pathway as RPM-1/Phr (Liao, Hung et al. 2004; Saiga, Fukuda et al. 2009). 
 
4.11 Ubiquitination and neurodegeneration 
A common theme emerging from these and other E3 ligase loss-of-function studies is that 
subtle imbalances in protein ubiquitination within specific synaptic compartments can trigger 
neurodegeneration (Almeida, Takahashi et al. 2006; Chou, Maidment et al. 2008; Ding and 
Shen 2008; Engelender 2008; Lehman 2009). In addition to Phr and Fbxo45, knockout of 
several other presynaptically-localized murine E3 ligases, including Scrapper and the 
deubiquitinating enzyme UCH-L1, causes alterations in bouton morphology, including 
increased or decreased SV density, and eventual central or peripheral nervous system 
neurodegeneration (Yao, Sugiura et al. 2008; Chen, Sugiura et al. 2010). In our studies, we 
find that Bassoon/Piccolo knockdown also leads to the progressive loss of SVs and 
disorganization of synaptic architecture. Since these phenotypes emerge concomitantly with 
Bassoon/Piccolo loss, it seems reasonable to speculate that DKD induced changes in protein 
ubiquitination originate at or near the presynaptic AZ. Moreover, the phenotypic parallels 
between Bassoon/Piccolo DKD and other genetic manipulations that induce 
neurodegeneration, including UCH-L1 knockout or overexpression of α-Synuclein (Chen, 
Sugiura et al. 2010; Scott, Tabarean et al. 2010), suggest that the DKD will also adversely 
impact neuronal health over time. Future studies will explore this issue. 
 
5. General conclusions 
In summary, we have found that Piccolo is not essential for excitatory synapse formation, 
but is a negative regulator of SV exocytosis. These results indicate that one of Piccolo’s 
functions at the AZ is to regulate the translocation of SVs from the reserve to the readily 
releasable pool through modulation of Synapsin dynamics. Further, our results demonstrate 
that this role is not shared by Bassoon, providing one of the first indications that these 
proteins have non-overlapping functions. Rather puzzling is the absence of other presynaptic 
phenotypes, especially given the large size of Piccolo and its numerous binding partners. One 
likely explanation is that redundant features in Bassoon mask many of these. 
We have also demonstrated that Piccolo is an important regulator of presynaptic F-actin, 
functioning to coordinate its activity-dependent assembly from within the AZ and thereby 
modulating neurotransmitter release. Future studies should seek to resolve the molecular 
pathway through which Piccolo regulates F-actin polymerization, and which functions of F-
actin [i.e., initial synapse formation (Lucido, Suarez Sanchez et al. 2009), maturation (Zhang 
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and Benson 2001; Shen, Wu et al. 2006), or presynaptic plasticity (Jensen, Walaas et al. 
2007; Antonova, Lu et al. 2009)] are regulated by Piccolo.  
Through the creation of tricistronic lentiviral vectors that express multiple shRNAs, it has 
also been possible to efficiently knockdown the expression of both Piccolo and Bassoon and 
thus begin the exploration of their shared/redundant function. In our initial analysis, we 
observed that the DKD of Piccolo/Bassoon triggered the dramatic loss of SV pools, a 
phenotype that requires functional lysosomal, proteosome and ubiquitin systems. These data 
point to a fundamental role for these AZ proteins in SV-stasis. Although SV loss is the 
dominant phenotype observed in DKD boutons, it is currently unclear whether SV-stasis is 
the primary function of Piccolo/Bassoon or whether their loss triggers aberrant local protein 
hyper poly-ubiquitination, similar to what may occur in neurodegenerative disorders such as 
Parkinson’s, Huntington’s and Alzheimer’s diseases. Since Bassoon and Piccolo are core 
components of the CAZ, it is tempting to speculate that they normally regulate the local 
ubiquitination of presynaptic proteins and receptors as they dynamically transit into and out 
of the AZ plasma membrane. A number of emerging studies suggest that such a role would 
be instrumental for proper synaptic function, given the importance of ubiquitination in 
neurotransmitter release, presynaptic plasticity, and neurotrophin retrograde signaling (Hicke 
2001; Hicke and Dunn 2003; DiAntonio and Hicke 2004; Varshavsky 2005; Geetha and 
Wooten 2008; Rinetti and Schweizer 2010). Future studies will need to investigate the role of 
the Bassoon/Piccolo interaction in these processes. 
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7. Abbreviations 
 
°C    Degree Celsius 
aa   Amino acid 
Abp1    Actin binding protein 1 
AD     “Anno Domini,” which is Latin for “in the year of our Lord.” 
Amp    Ampicillin  
AMPA    Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ATP   Adenosine triphosphate 
AZ    Active Zone 
BC   Before Christ 
BD    Binding domain 
BDNF    Brain-derived neurotrophic factor, 
Bicine    N,N-bis-(2-hydroxyethyl)-glycine 
Bp   Base pair 
BRP   Bruchpilot 
Bsn   Bassoon 
C-terminal   Carboxy-terminal 
C. elegans   Caenorhabditis elegans 
C2    Calcium/phospholipid binding domains 
Ca2+    Calcium ion 
CaMKII   Ca2+/calmodulin-dependent protein kinases II 
cAMP   Cyclic adenosine monophosphate 
cAMP-GEFII  cAMP-guanidine nucleotide exchange factor II 
CAST   CAZ-associated structural protein 
CAZ   Cytomatrix at the active zone 
CC    Coiled coil 
cDNA   Complementary DNA 
CDS   Coding sequence 
Cl-    Chloride ion 
CoIP    Coimmunoprecipitation 
COS-7   African green monkey cell line 
CtBP   C-terminal binding protein 
DAT    Dopamine transporter  
DIV   Days in vitro 
DMEM   Dulbecco´s Modified Eagle Medium 
DMSO   Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
DNAse    Deoxyribonuclease 
dNTPs    Deoxyribonucleotide triphosphate 
DTT   Dithiothreitol 
E.coli   Escherichia coli 
E3    Ubiquitin ligase 
ECL    Enhanced chemiluminiscence 
EDTA   Ethylenediamine-N,N,N´,N´-tetraacetic acid 
EGFP   Enhanced green fluorescent protein 
EGTA    Ethylene glycol-bis(2-aminoetylether)-N,N,N’,N’-tetraacetic acid 
EM    Electron microscopy 
ERC    ELKS/Rab6-interacting protein 2/CAST 
EYFP    Enhanced YFP 
F-actin   Filamentous actin 
FBS   Fetal Bovine Serum 
Fig.   Figure 
g    Gram 
G-Actin    Globular-actin 
GABA    γ-aminobutyric-acid 
GIT   G protein-coupled receptor kinase interacting ArfGAP 1 
GK   Guanylate kinase-like domain  
h    Hour 
HBSS   Hank´s Balanced salts 
HEK293   Human Embrionic Kidney cells clone 293 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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Hz    Herz 
IF    Immunofluorescence 
IP   Immunoprecipitation 
IPSC   Inhibitory postsynaptic currents 
IWA    Unique COOH-terminal amino acid motif from CAST 
K+    Potasium ion 
kb    Kilo base pair 
kDa    Kilo Dalton  
LAR    Transmembrane protein-tyrosine-phosphatases 
LB    Luria- Broth 
Liprin    LIP related protein 
LV   Lentivirus vector FU(tag)W 
M    Molar 
MAGUK   Membrane-associated guanylate kinases 
MALS    The vertebrate homologs of C. elegans lin-7; 
MAP2    Microtubule associated protein 2 
METH    Methamphetamine  
mg    Milligram 
min    Minutes 
Mint1    The vertebrate form of C. elegans lin-10 
ml    Millilitre 
mM    Millimolar 
mRFP   Monomeric red fluorescence protein 
mRNA   Messenger ribonucleic acid 
ms   Mouse 
Munc13   Mammalian homologue of UNC13 
mut    Mutant 
N-terminal   Amino-terminal 
Na+   Sodium ion 
NAc    Nucleus accumbens  
nm    Nanometer 
NMDA    N-methyl-D-aspartic acid 
NMDAR   NMDA Receptor 
NMJ   Neuromuscular junction  
PAGE   Polyacrylamide gel electrophoresis 
PBH domain  Piccolo-Bassoon homology domain 
PBS   Phosphate buffered saline 
Pclo   Piccolo 
PCR   Polymerase chain reaction 
PDZ    PSD-95/Dlg/ZO-1 
PFA   Paraformaldehyde 
PKA    Protein kinase A 
PKC    Protein kinase C 
Pr    Probability release 
PRD    Proline-rich domain 
preLTP    Presynaptic forms of long-term potentiation  
PSD    Postsynaptic density 
PTV   Piccolo-Bassoon transport vesicle 
PVDF   Polyvinylidene fluoride 
Rab 3 protein  Ras-related protein 3 
Rb   Rabbit 
Rim   Rab3 interacting molecule 
RIMBP   Rim binding protein 
RNA   Ribonucleic acid 
RNAi    Ribonucleic Acid interference 
RRP   Ready releasable pool 
RT   Room temperature 
s    Second 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SH3 domain  Src-homology 3 domain  
SNAP   (Soluble NSF (N-ethylmaleimide-sensitive factor) Attachment Protein) 
SNAP-25  Synaptosome-associated protein 25 kDa 
SNARE   Soluble N-ethyl-maleimide-sensitive fusion protein attachment protein receptors 
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SV   Synaptic vesicle 
Syn   Synapsin. 
Syph   Synaptophysin 
TAE    Tris-Acetate-EDTA 
Taq    Thermus aquaticus 
TBE    Tris-Borate-EDTA 
Tris/HCl  Tris(hydorxymethyl)-aminomethanhydrochloride 
TX-100   Triton X-100 
U   Unit 
UNC13    Uncoordinated movement 13 
UV    Ultraviolet 
VAMP 2   Vesicle Associated Membrane Protein 2 
Veli    The vertebrate homologs of C. elegans lin-7; 
VGCC    N- and P/Q-type voltage gated Ca(2+) channels  
WB    Western blot 
YFP    Yellow Fluorescent Protein 
ZF    Zinc finger 
Δ   Deletion 
λ    Wavelength 
µg    Microgram 
µl    Microlitre 
µm    Micrometer 
  Curriculum Vitae 
 
 135 
8. Curriculum Vitae 
 
Name:    Sergio 
 
Family Name:   Leal-Ortiz 
 
Date of Birth:   October 11, 1973 
 
Place of Birth:   Rio Bueno (Chile) 
 
Nationality:   Chilean 
 
Parents:   Sergio Leal 
 Isabel Ortiz 
 
EDUCATION 
 
2009-2012 Doctoral Thesis, Leibniz Institute for Neurobiology, Otto-von-Guericke Universität 
Magdeburg, Otto-von-Guericke Universität Magdeburg, Magdeburg, Germany  
Sept 2009- 
Oct 2009 Neurobiology Training, Leibniz Institute for Neurobiology, Otto-von-Guericke 
Universität Magdeburg, Otto-von-Guericke Universität Magdeburg, Magdeburg, 
Germany  
2001  Bachelor of Science in Biochemistry, Austral University of Chile. 
 
RESEARCH EXPERIENCE 
 
2009-Present Senior Research Associate and General Laboratory Manager, Department of 
Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.  
Research: Molecular and synaptic mechanisms of synaptic vesicle membrane 
recycling during synapse degeneration. 
Supervisor: Dr. Craig Garner 
2002-2009 Research Associate and Laboratory Manager, Department of Psychiatry and 
Behavioral Sciences, Stanford University, Stanford, CA.  
Research: Defining the molecular and synaptic mechanisms underlying cognitive 
impairment in neurodevelopmental disorders.  
Supervisor: Dr. Craig Garner 
2001-2002  Research Assistant, Department of Neurobiology, University of Alabama at 
Birmingham.  
Research: Cellular mechanism of nascent synapse formation in autism.  
Supervisor: Dr. Craig Garner 
2000-2001  Research Assistant, Department of Biology, Universidad Nacional Andrés Bello, 
Santiago, Chile 
Research: Regulation of the expression of rRNAs during the acclimatization of the 
fish Cyprinus carpio 
Supervisor: Dr. Maria Ines Vera  
1999-2000  Academic Teaching Assistant, Department of Biology, Universidad Nacional 
Andrés Bello, Santiago, Chile.  
Taught laboratory practical courses in Neurophysiology, Neuroanatomy, 
Neurobiology, Cellular Biology and Biology.  
1998-2000  Undergraduate thesis, Department of Biochemistry, Austral University of Chile, 
Valdivia, Chile.  
 Thesis: Quantification of the seasonal transcription of the subunit β drive protein 
quinasa CK2 in the fish Cyprinus carpio 
 Advisor: Dr. Maria Ines Vera 
 
  Curriculum Vitae 
 
 136 
1998  Internship, Department of Chemistry, Universidad de Chile, Santiago, Chile and 
Department of Chemistry, Universidad Nacional Andrés Bello, Santiago, Chile.  
Research focus: Natural product extraction from Usnea barbata lichen from the XI 
region of Chile. 
 Mentor: Dr. Ramiro Arratia 
 
 
PUBLICATIONS: 
Waites CL, Leal-Ortiz SA, Okerlund N, Dalke H, Fejtova A, Altrock WD, Gundelfinger ED, Garner 
CC (2013) Bassoon and Piccolo maintain synapse integrity by regulating protein 
ubiquitination and degradation. EMBO J doi: 10.1038/emboj.2013.27 
Maas C, Torres VI, Altrock WD, Leal-Ortiz S, Wagh D, Terry-Lorenzo RT, Fejtova A, Gundelfinger 
ED, Ziv NE, and Garner CC (2012) Formation of golgi-derived active zone precursor 
vesicles. J Neurosci 32:11095-11108. 
Waites CL, Leal-Ortiz SA, Andlauer TF, Sigrist SJ, Garner CC (2011) Piccolo regulates the dynamic 
assembly of presynaptic F-actin. J Neurosci 31:14250-14263. 
Hua Z, Leal-Ortiz S, Foss SM, Waites CL, Garner CC, Voglmaier SM, Edwards RH (2011) v-
SNARE composition distinguishes synaptic vesicle pools. Neuron 71:474-487. 
Li D, Specht CG, Waites CL, Butler-Munro C, Leal-Ortiz S, Foote JW, Genoux D, Garner CC, 
Montgomery JM (2011) SAP97 directs NMDA receptor spine targeting and synaptic 
plasticity. J Physiol 589:4491-4510. 
Torres V, Barra L, Garces F, Ordenes K, Leal-Ortiz S, Garner CC, Fernandez F, Zamorano P (2010) 
A bicistronic lentiviral vector based on the 1D/2A sequence of foot-and-mouth disease virus 
expresses proteins stoichiometrically. J Biotechnol 146:138-142. 
Lucido AL, Suarez Sanchez F, Thostrup P, Kwiatkowski AV, Leal-Ortiz S, Gopalakrishnan G, 
Liazoghli D, Belkaid W, Lennox RB, Grutter P, Garner CC, Colman DR (2009) Rapid 
assembly of functional presynaptic boutons triggered by adhesive contacts. J Neurosci 
29:12449-12466. 
Waites CL, Specht CG, Hartel K, Leal-Ortiz S, Genoux D, Li D, Drisdel RC, Jeyifous O, Cheyne JE, 
Green WN, Montgomery JM, Garner CC (2009) Synaptic SAP97 isoforms regulate AMPA 
receptor dynamics and access to presynaptic glutamate. J Neurosci 29:4332-4345. 
Leal-Ortiz S, Waites CL, Terry-Lorenzo R, Zamorano P, Gundelfinger ED, Garner CC (2008) 
Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis. J Cell Biol 
181:831-846. 
Sabio G, Reuver S, Feijoo C, Hasegawa M, Thomas GM, Centeno F, Kuhlendahl S, Leal-Ortiz S, 
Goedert M, Garner C, Cuenda A (2004) Stress- and mitogen-induced phosphorylation of the 
synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and 
ERK1/ERK2. Biochem J 380:19-30. 
Sarmiento J, Leal S, Quezada C, Kausel G, Figueroa J, Ines Vera M, Krauskopf M (2000) 
Environmental acclimatization of the carp modulates the transcription of beta-actin. J Cell 
Biochem 80:223-228. 
Vera MI, Kausel G, Barrera R, Leal S, Figueroa J, Quezada C (2000) Seasonal adaptation modulates 
the expression of the protein kinase CK2 beta subunit gene in the carp. Biochem Biophys Res 
Commun 271:735-740. 
  
